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Abstract 
Magnetic Resonance Imaging (MRI) is an important tool in medical imaging, and is widely used 
for its high spatial and temporal resolution, and low safety concerns. However, the technique has its 
limitations due to the inherent low sensitivity, making it inferior to Computed Tomography (CT) in 
terms of spatial and temporal sensitivity and to nuclear medicine methods in terms of molecular 
imaging sensitivity. By hyperpolarization, the available signal can be enhanced by several orders of 
magnitude, and potentially close some of these gaps.  
In this thesis work, the purpose is to demonstrate that water, hyperpolarized by dissolution 
Dynamic Nuclear Polarization (d-DNP), can be applied as an MRI contrast agent for angiography and 
perfusion.  
The first part of the project focuses on development of a protocol for production of large 
samples of hyperpolarized protons in D2O. The samples are polarized and dissolved in a fluid path 
compatible with the installed base of commercial polarizers developed for clinical research. The solid-
state DNP is optimized at 6.7 T and 1.2 K by microwave frequency modulation. A solid-state 
polarization of 70% is obtained. The dissolution procedure is optimized by introduction of a 
fluorinated solvent to accelerate the transition from solid to liquid state, and efficient radical 
extraction is obtained with a two-phase system of water and heptane. A final liquid state polarization 
of 13% in samples of 16 mL is obtained, suitable for large animal experiments.  
In second part of the project, hyperpolarized water is applied for angiographic imaging and 
perfusion measurements in a pig model. Renal angiography of 0.55 mm in-plane isotropic resolution is 
demonstrated and perfusion measurements provides values comparable to conventional Gd-T1-DCE 
analysis. Finally, it is demonstrated that the method can be applied to acquire dynamic coronary MR 
angiography with temporal resolution of less than 1 s, apparent Signal-to-Noise Ratio of 269±169 and 
coronary sharpness of 0.31±0.086 mm-1, which is superior to coronary MRA available in today’s 
clinical practice.   
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Resumé 
Magnetisk resonans billeddannelse (MRI) er et vigtigt redskab i medicinsk diagnostik, og bliver 
brugt i stor udstrækning pga. den høje billedopløsning og lave sundhedsrisiko. Metoden har dog sine 
begrænsninger, da den naturligt har en lav sensitivitet, der gør den underlegen i sammenligning med 
CT mht. spatiel og temporal opløsning, og med nuklearmedicinsk billeddiagnostik mht. sensitivitet af 
molekylær billeddannelse. Det tilgængelige signal kan forøges med flere størrelsesordner ved 
hyperpolarisering. 
Formålet med denne afhandling er at demonstrere hvordan vand, hyperpolariseret ved 
Dynamisk Nuklear Polarisation (DNP), kan anvendes som MRI konstrastvæske til angiografi og 
perfusionsmålinger. 
Den første del af projektet fokuserer på udviklingen af en protokol til produktion af store doser 
af hyperpolariserede protoner opløst i D2O. Prøven polariseres og opløses i et aflukket væskesystem 
(fluid path), som er kompatibelt med de kommercielle polarisatorer der i dag er i brug til klinisk 
forskning. DNP optimeres ved 6.7 T og 1.3 K med mikrobølge-frekvensmodulering, og en faststof 
polarisation af 70% opnås. Opløsningsprocessen forbedres ved at introducere en fluoreret solvent, 
der øger hastigheden af overgangen fra fast til flydende form, og effektiv ekstraktion af radikalet 
opnås med et to-fase system af vand og heptan. Derved opnås 13% polarisation i den opløste prøve á 
16 mL; en passende mængde til forsøg i store dyr.  
I den anden del af projektet anvendes hyperpolariseret vand til angiografi og 
perfusionsmålinger i grise. Angiografi i nyren demonstreres med 0.55 mm isotropisk opløsning, og 
perfusionsmålinger giver værdier sammenlignelige med konventionel Gd-T1-DCE analyse. Tilsidst 
demonstreres det, at metoden kan anvendes til at optage dynamisk MR koronarangiografi med 
tidsopløsning af mindre end et sekund, signal-støj-forhold (aSNR) på 269±169 og koronarskarphed på 
0.31±0.086 mm-1, som er overlegent i sammenligning med nuværende kliniske MR 
koronarangiografier. 
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1 Introduction 
 
Hyperpolarized Metabolic MR is an exciting new imaging modality based on Magnetic 
Resonance Imaging (MRI) and hyperpolarization of biological molecules as probes of changes in 
cellular metabolism in vivo. The bio-probe is typically labelled with 13C in a chemical position with 
long relaxation time, and the hyperpolarization is achieved by the d-DNP method. In this way, the 
magnetic resonance signal can be enhanced by many orders of magnitude. The bio-probe is 
injected intravenously as a bolus, and allows studying the metabolism of tissues over a time 
window of approx. a minute to characterize disease. The method has emerged over the last 
decade and is now in clinical use. About a handful of prominent clinical research institutions have 
conducted human studies with [1-13C]pyruvate, and almost twenty groups are in the preparation 
of patient studies. These studies have been enabled by commercial polarizer technology, the 
SPINlab, from GE Healthcare.  
 In this thesis, another approach is taken. It is here claimed that hyperpolarized water 
protons (1H) has the potential to provide superior clinical angiographic and perfusion imaging. It is 
claimed that hyperpolarization of water protons (1H) by the d-DNP method can provide a nuclear 
magnetization that exceeds the thermal magnetization at clinical MRI field strengths by more than 
two orders of magnitude, and thereby allow high resolution, dynamic imaging. It is claimed that 
angiography and perfusion images of high diagnostic quality can be acquired within the short 
relaxation time of water protons in vivo when arterial injection in applied. 
 
1.1 Aims 
The aim of this thesis work was to investigate the potential of hyperpolarized water as a 
new contrast agent for angiography and perfusion.  
The first aim was to investigate and optimize the hyperpolarization of water by the d-DNP 
method under conditions compatible with clinical polarizers at collaborator sites, and for a 
formulation of the hyperpolarized product that is well tolerated. This involves developing a sample 
preparation method compatible with the SPINlab polarizer (Study I). The target was to 
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demonstrate that a proton magnetization more than hundred-fold above thermal equilibrium at 3 
T could be obtained for a volume of more than 10 mL and with a T1 of more than 10 s (Study II).  
 The second aim was to investigate the behavior of two common imaging sequences, 
balanced-Steady-State-Free-Precession and Gradient-Recalled-Echo, for angiography (Study III). 
This was done in a small animal model using a 13C-labelled molecule with long relaxation time in 
vivo. This would allow selection of the most suitable imaging sequence in subsequent large animal 
studies. 
 The third aim was to demonstrate perfusion (Study IV) and coronary angiography (Study V) 
in a large animal model with similar or superior diagnostic quality as state-of-the-art contrast 
agent based MRI.  
 
1.2 Clinical Motivation 
Cardiovascular disease is the leading cause of death worldwide, according to the World 
Health Organization [1]. It is estimated that 7.4 million people died from Coronary Artery Disease 
(CAD) in 2012, corresponding to 13% of global deaths. 
Imaging of the vasculature is crucial for diagnosis and treatment of CAD. High resolution 
angiographies are required to diagnose atherosclerosis, a precursor for CAD. In addition, 
treatment, such as angioplasty and stent placement, must be assessed by post-surgical flow 
measurements, and tissue blood supply must be validated by perfusion measurements. 
Angiographic techniques include magnetic resonance angiography (MRA), computed 
tomography angiography (CTA), cardiac catheterization using X-ray contrast, and ultrasound (US), 
each with advantages and downsides regarding which structures can be imaged, the safety and 
convenience of the patient, etc. Today, CTA is the gold standard for CAD diagnosis, and provides 
excellent spatial resolution, with the main drawback of exposing patients to ionizing radiation. 
MRI has a better soft-tissue contrast, but suffers from inherently low sensitivity. Coronary 
angiography requires high spatial resolution, while the acquisition time must be short to avoid 
motion artefacts. MR angiography thus fails to provide images of quality sufficient for CAD 
diagnosis. By hyperpolarization, the MR signal can be increased by several orders of magnitude. 
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Hyperpolarized water could overcome both the challenge of high spatial resolution and short 
acquisition time, while also being compatible with the equipment and MRI sequences already 
existing in the clinic. Furthermore, the tracer could serve as a perfusion marker for treatment 
assessment, to form a one-stop shop for CAD diagnosis and assessment. 
With the target of complementing existing MRI techniques to achieve a full MR cardiac 
package, a novel contrast agent consisting of hyperpolarized water will be presented. The 
hypothesis is that the signal of the hyperpolarized nuclei can provide enough sensitivity to 
produce images of similar resolution and quality as CTA. The main goal of this project was to 
demonstrate coronary angiography and perfusion using hyperpolarized water MRI in large 
animals. The hope was to form a basis for future perspectives of a novel CAD diagnostic tool, 
which could potentially replace CTA and hence save the radiation burden in millions of people 
every year. 
13C-labelled pyruvate is the main research target in the field of hyperpolarization by d-DNP. 
Pyruvate is the end product of glycolysis, and serves at the precursor to the tricarboxylic acid cycle 
for ATP production. By spectroscopic imaging or chemical shift imaging, concentrations of 
metabolism products such as lactate, alanine and bicarbonate, can be monitored, and thus the 
biochemical pathways can be followed over time. In addition to being a non-invasive, radiation 
free technology, the method provides otherwise unavailable measures of metabolism. 
The method has been applied in preclinical studies for several years [2], and several 
research groups have initiated clinical research with promising results [3,4]. 
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2 Angiography and Perfusion 
Medical imaging is essential in diagnosis and therapy assessment, where MRI and CT are 
the major modalities with 72 million and 26 million, examinations every year in the US alone [5]. 
Angiography is the field of visualizing the lumen of blood vessels and organs in the body, 
and can be achieved by several techniques and modalities.  
2.1 Coronary Catheterizations 
Every year, millions of people in the United States suspected of having CAD are examined 
with coronary catheterizations [6]. Coronary catheterizations is a minimally invasive method to 
obtain images of the coronary arteries, in which a catheter is inserted through an artery in the 
groin or arm to reach the heart. The end of the catheter is placed in the coronary arteries, where 
contrast agent is injected during X-ray imaging. An example is shown in Figure 1A. 
 
Figure 1: Luminal narrowing in proximal left anterior descending artery (LAD, arrow) and stenosis in middle 
LAD (arrow head) in a 66 year old male. A) Coronary catheterization X-ray image showing the fine structure 
of the arterial branches and apparent vessel narrowing. B) Thin-slab maximum intensity projection (MIP) 
across the LAD plane from a 64-slice multi detector CT scan, showing non-calcified plaque in proximal LAD 
and mixed calcified and non-calcified atherosclerotic plaque in middle LAD. Reprinted with permission from 
[7]. 
The method can provide images of high resolution, and the catheter can be applied for angioplasty 
and stent placement. However, several complications are associated with coronary 
catheterization. Smaller risks include infection, allergic reactions to the contrast agent and 
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abnormal heart rhythms, while serious side effects are stroke and heart attacks, among others. In 
addition, the radiation dose from fluoroscopy and X-rays adds several mSv [8]. The mortality 
associated with cardiac catheterization and coronary angiography has been reported to 0.11%, 
while the incidence of total major complications was 1.7% [9,10]. 
2.2 Computed Tomography 
Computed tomography (CT) applies X-rays from various angles to determine the spatial 
structure of the body. High resolution images (typically 0.4-0.625 mm in-plane resolution) can be 
acquired with temporal resolution of 82.5 ms with prospective ECG gating to freeze cardiac 
motion [11,12]. A valuable feature of CT coronary angiography is the visualization of intravascular 
plaque, for which calcified and non-calcified plaque can be distinguished (Figure 1B). With modern 
scanner systems and optimized procedures, angiographies can be acquired with as little as 1.2 mSv 
radiation dose [8,13]. However, the usefulness of CT coronary angiography still has to be weighed 
against the increased risk for later cancer development. 
2.1 Ultrasound 
Intravascular ultrasound assessment of the vessels is often performed in combination with 
CT angiography. An ultrasound wand is inserted into the artery and moved to the heart, from 
where images provide spatial information from within the vessels. The method provides 
visualization of the artery walls and plaques in these [14,15], and the procedure is recommended 
to determine the need for intervention [16]. The main risk of complications is related to the 
catheterization, and thus only adds little additional risks in procedures where coronary 
catheterization is already used.  
2.2 Magnetic Resonance Angiography 
MRI suffers from low SNR and long imaging time, but distinguishes itself from other 
diagnostic imaging modalities in that the patient is not exposed to any radiation burden. MRI 
provides great soft tissue contrast, but the inherently low sensitivity requires several minutes of 
acquisition to obtain images of adequate diagnostic quality. Whereas extended imaging time is 
inconvenient, but acceptable for non-moving objects, it complicates the application of traditional 
MRI for moving organs such as the heart, where the motion results in image artefacts. Thus, 
cardiac gating must be used to acquire images of moving targets, where sampling is repeated over 
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several cardiac cycles. With this technique, cine imaging, the heart function can be assessed. 
However, the image quality is limited, and the resolution of >1.5 mm is inadequate for CAD 
diagnosis [17,18].  
Due to its safety and good soft tissue contrast, MRI is the preferred technique for several 
types of diagnostic imaging today. However, in one third of the examinations, gadolinium based 
contrast agents are used. The use of gadolinium-based contrast agents is especially problematic 
for kidney patients, where development of Nephrogenic Systemic Fibrosis (NSF) since 2006 has 
been linked with contrast-enhanced MRI in patients with reduced kidney function [19]. A 
retrospective study of about 370 patients with severe renal insufficiency who had undergone 
contrast-enhanced MRI with the Gd-based contrast agent Omniscan estimated the risk of NSF to 
4%. Another study found gadolinium in the tissue of patients with NSF [20], another indication for 
the link between Gd and NSF. In addition, recent studies have determined high signal intensity in 
the dentate nucleus and globus pallidus in T1-weighted images of the brain for patients who had 
undergone 6 or more contrast-enhanced MRI examinations. The high signal intensity in these 
areas are associated with diseases such as multiple sclerosis and hepatitis dysfunction. Thus, new 
solutions for MRI signal enhancement are called for. Angiographic images using magnetic 
resonance can be acquired with or without injection of contrast agents. Non contrast-enhanced 
MRA can be obtained via the time-of-flight (TOF) principle, or by phase contrast (PC) [21–23].  
Time-of-flight 
TOF techniques change the magnetization of the tissue, so the NMR signal of the spins in 
the moving blood deviates from the stationary spins. Slabs are oriented orthogonal to the flow 
direction, and stationary spins in the tissue will lose magnetization from excitation by radio 
frequency (RF) pulses. Fully magnetized, fresh blood will then flow into the slab, yielding a contrast 
between tissue and the vascular system. The signal-to-noise (SNR) and contrast-to-noise (CNR) 
depend on the slab thickness, blood velocity, vessel orientation and the MRI sequence. Typically, a 
gradient echo sequence with short repetition time (TR) will be applied. A long TR allows more of 
the blood in the vessel to be replaced, but also allows tissue magnetization to recover between 
excitations. Thinner slabs will enhance the contrast by allowing more blood to be replaced, at the 
expense of acquisition time to improve SNR. The same principle can be used with 3D gradient echo 
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sequence, where a series of thin slices are imaged and stacked after reconstruction. An example is 
shown in Figure 2.  
Phase contrast 
In the phase contrast technique, bipolar gradients are used to encode the velocity of the 
spins. A gradient is applied, and after a delay, a second gradient of equal magnitude, but opposite 
direction, is turned on. Spins of flowing blood will be phase shifted, because the position in the 
gradient field has changed from the first to the second gradient. Stationary tissue spins will have 
zero phase shift. The NMR signal of the moving spins is linearly decreasing with their phase shift. 
The gradient pair can be applied in all three directions; thus, the flow is imaged in all directions. 
The phase shifted image is subtracted from an image without velocity encoding, and the resulting 
angiography provides quantitative information of flow velocity and direction.  
 
Figure 2: Time-of-flight imaging without (left) and with (right) contrast enhancement. The images are 
maximum intensity projections (MIP) of a rat cerebral area in a coronal plane, acquired with a 3D gradient 
echo sequence. The acquisition time was 24 min.  
Contrast enhanced angiography 
The contrast in the angiographic images can be further enhanced by administration of a T1 
shortening agent such as gadolinium or iron oxide [24,25]. Fluctuating magnetic fields of the 
unpaired electrons of the agent will interact with the 1H nuclei to contribute to T1 relaxation. Thus, 
the effect of the ions (or nanoparticles), rather than the ions themselves are imaged during CE 
angiography. The agent is typically injected intravenously, and the timing of signal acquisition can 
be used to determine whether only the arterial network, the entire vasculature or only the venous 
system is imaged. An image acquired before contrast agent injection can be used for reference, 
and the subtraction between the two displays the desired vessels. A fast, low angle T1-weighted 
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sequence such as FLASH is typically used for CE angiography. An example using the iron based 
blood pool agent Clariscan™ and a 3D gradient echo sequence is shown in Figure 2. 
2.3 Coronary Angiography 
Coronary angiography provides imaging of the arteries that supply freshly oxygenated 
blood to the heart tissue. The coronary arteries have diameter of 2-4 mm in proximal segments 
and smaller in distal segments (Figure 3), and thus require high resolution imaging to be used for 
diagnosis.  
 
Figure 3: Human coronary artery anatomy (Source: Baylor College of Medicine, credit: Scott Weldon). 
Though some studies have provided coronary MRA of sub-millimeter resolution with use of 
contrast agents [26,27], most recently published coronary MRA studies apply lower resolutions 
with corresponding loss of details, in order to achieve a sufficient signal-to-noise ratio (SNR) and 
robustness [28–30]. Coronary contrast enhanced MRA is usually acquired with ECG triggering, 
where signal is read out during steady periods of the cardiac cycle to avoid motion artefacts, and 
typically during free breathing. Ahlman et al. obtained apparent Signal-to-Noise Ratio, aSNR, of 24 
with 1 mm3 isotropic resolution using this technique in an optimized setup using gadolinium 
injections [31]. The total acquisition time is several minutes. Therefore, coronary artery disease is 
often diagnosed with invasive X-ray cardiac catheterization procedure, or more recently, CT 
angiography, where high resolution images (0.4-0.5 mm in-plane, isotropic [32,33]) can be 
acquired fast. However, these techniques have their drawbacks such as patient exposure to 
ionizing radiation, as well as blooming artefacts from highly attenuating coronary calcification. In 
summary, coronary MRA is not an established clinical approach, but several approaches for 
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feasibility are made due to the potential advantages over competing diagnostic technologies [34]. 
Other interesting tools such as assessment of atherosclerotic disease in vessel walls could follow 
from high resolution, motion-robust MRA techniques [35]. 
2.4 Perfusion 
In physiology, perfusion is the process of a body delivering blood to a capillary bed in its 
biological tissue. Perfusion is defined as the passage of fluid through the lymphatic system or 
blood vessels to an organ or a tissue. Myocardial perfusion provides an accurate means for 
diagnosing obstructive CAD, and post-surgical flow measurements are an integrated part of a 
number of treatments for cardiac disease. 
Perfusion measurements can be performed with MRI in several ways. The late gadolinium 
enhancement method images the temporal concentrations of a water soluble gadolinium chelated 
agent through the changes in relaxation time with a T1-weighted gradient echo sequence [36]. The 
main drawback is the gadolinium-related complications discussed earlier, and the low sensitivity. A 
noninvasive method using Arterial Spin Labelling (ASL) eliminates both catheterization and 
gadolinium, but the sensitivity is even lower than for the late enhancement method [37]. 
A method corresponding to the late gadolinium enhancement in MRI is the tracing of 
iodinated contrast agents using CT [33,38]. The method provides higher sensitivity, but 
incorporates the safety concerns of CT (cancer development) and adds new complications from 
toxicity of the iodinated contrast agent [39]. 
Stress SPECT myocardial perfusion imaging is the most commonly utilized stress imaging 
technique for patients with suspected or known coronary artery disease [40]. An example of SPECT 
perfusion, CT perfusion and invasive catheterization is shown in Figure 4 [38]. The perfusion 
defects detected by CT and SPECT are similar, and may be explained from the occlusion and 
significant stenosis visualized by cardiac catheterization. 
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Figure 4: Comparison of SPECT perfusion (left), CT perfusion (center), and invasive coronary angiography 
(right) in a 55 year-old man in stress (top) and rest (bottom). The perfusion defects detected by CT and 
SPECT are related to the stenosis in the left circumflex at stress (top, right) and occlusion in the LAD at rest 
(right, bottom). Reprinted with permission from [38]. 
PET is another modality for perfusion imaging, and studies suggest that is may provide 
better diagnostic quality than SPECT [41]. Due to the permeability differences and active transport 
limitations of contrast agents, it has been attempted to find a suitable tracer based on water 
molecules. Thus, 15O-labeled water as a tracer for positron emission tomography (PET) imaging has 
been suggested [42–44], with the main drawbacks of the limited spatial and temporal resolution 
of PET, the need for an on-site cyclotron, and the risk profile of the radioactive tracer. Other 
recent suggestions for a water based perfusion tracer include NMR detection of H217O in the blood 
after a short 17O2 gas inhalation [45]. 
 
  
  11  
 
3 Hyperpolarization 
When a sample is allowed to be undisturbed for a long time in a magnetic field, it reaches a 
state of thermal equilibrium. The populations of nuclear spin states follow the Boltzmann 
distribution. For a spin I, the number of spins in the state 𝑚 is given by [46] 
𝑁𝑚 = 𝑁0
𝑒
−𝐸𝑚
𝑘𝐵𝑇
∑ 𝑒
−𝐸𝑛
𝑘𝐵𝑇𝑛=𝐼
𝑛=−𝐼
 
where 𝑁0 is the total spin population, 𝑘𝐵 is Boltzmann’s constant, T is the temperature, and 𝐸𝑚 is 
the energy of the eigenstate m given by 
𝐸𝑚 =  −𝑚 𝛾 ħ 𝐵0 
where the state 𝑚, in the case of spin ½, can be parallel (𝑚 = +½) or antiparallel (𝑚 = −½) to 
the magnetic field, 𝐵0, γ is the gyromagnetic ratio and ħ is the reduced Planck’s constant. The 
polarization is defined as the normalized population difference,  
𝑃 =  
𝑁↑ − 𝑁↓
𝑁↑ + 𝑁↓
 
where N↑ and N↓ are the numbers of spins aligned and anti-aligned with the magnetic field, 
respectively.  The thermal polarization is then given as 
𝑃 =  tanh (
ħ 𝛾𝐵
2𝑘𝐵𝑇
). 
For 1H and 13C in a clinical MRI system of 3 T at room temperature, the polarization is 10 ppm and 
2.5 ppm, respectively.   
The potential for sensitivity improvement is therefore tremendous; in principle, close to 
five orders of magnitude depending on the nucleus and field strength. Since the earliest days of 
magnetic resonance, various ideas of enhancing the signal-to-noise ratio by increasing the nuclear 
spin polarization above thermal equilibrium have been investigated. Trivially, the polarization can 
be increased by raising the magnetic field and lowering the temperature, but there are limited 
possibilities in conventional NMR and MRI. Currently, the highest magnetic field strength is 23 T 
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for NMR and 9.4 T for whole body MRI. Only in solid-state NMR is there any room to optimize the 
sensitivity by lowering the temperature.  
Hyperpolarization is the process of polarizing spins beyond the Boltzmann distribution. 
Hyperpolarization signifies a spin polarization that deviates strongly from thermal equilibrium. A 
characteristic of hyperpolarization is that the polarization is created ex situ, and therefore cannot 
be restored to the initial state. The polarization decays irreversible by relaxation or signal 
acquisition. In 2003, a novel method for polarizing nuclear spins in molecules in solution was 
demonstrated. The method takes advantage of Dynamic Nuclear Polarization (DNP) in the solid 
state followed by rapid dissolution in a suitable solvent. The polarization is retained almost 
completely in the dissolution step creating a solution with a non-thermal nuclear polarization 
approaching unity. Enhancements of more than 10,000 can be achieved using d-DNP (dDNP) [47].  
3.1 Dynamic Nuclear Polarization 
At low temperatures, electron spins are polarized to almost unity due to their strong 
magnetic moment. Dynamic Nuclear Polarization (DNP) is the process of transferring the electron 
spin polarization to nuclear spins. The polarization of electron spins, protons and 13C at a magnetic 
field of 6.67 T is shown in Figure 5. At 1.2 K, electrons are polarized to 99.97 %, whereas the 
polarization of the protons is only 0.68 %. 
 
Figure 5: Spin polarization at thermal equilibrium for electrons, protons and 13C nuclei in a magnetic field of 
6.67 T. 
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The spin polarization of the unpaired electrons is transferred to nuclear spins by irradiation 
with microwaves close to the resonance frequency of the electron spin in the solid state. DNP was 
predicted by Albert Overhauser in 1953 for conduction electrons in a metal [48], and later, in the 
same year, Carver and Richter demonstrated the effect experimentally using metallic lithium, and 
later on using other materials [49,50].  Abragam extended the theory to electron spins in solution 
[51], and it was soon demonstrated that also nuclear spins in the solid state could be polarized 
dynamically [52]. Several mechanisms for DNP have been described.  
The solid effect invokes the interaction between low concentration free electrons and 
atomic nuclei by flip-flop transitions induced by the microwave field [53], where double quantum 
or zero quantum transitions are exited and exploits the hyperfine coupling between electrons and 
surrounding nuclei. The principle was described by Abragam and Goldman in 1978 [54]. The solid 
effect is generally observed when the electron paramagnetic resonance (EPR) linewidth is 
significantly narrower than the NMR frequency.  
Thermal mixing is a two-step process. The first step is a single quantum transition, and 
therefore thermal mixing requires less microwave power than the solid effect. Thermal mixing is 
efficient when the EPR linewidth is comparable to or larger than the NMR Larmor frequency, and 
when the electron spin concentration is high enough to ensure a common electron spin 
temperature through dipolar couplings [55,56]. 
Thermal mixing breaks down when the electron spin resonance is inhomogeneously 
broadened and a spin temperature cannot be assigned to the dipolar reservoir. In this situation, 
the mechanism has been named the cross effect, and the DNP efficiency is reduced. At low 
temperature, this situation may arise at high magnetic fields where the EPR linewidth is becoming 
much wider than the electron dipolar couplings. The DNP efficiency may be recovered by 
increasing the concentration of electron spins to increase the electron-electron dipolar interaction 
or by MW frequency modulation. 
The transfer of polarization from electrons to nuclei can be increased and accelerated by 
modulation of the microwave frequency. Thurber et al. [57] demonstrated in 2010 that DNP effect 
and rate can be enhanced by modulation of the magnetic field strength, and Hovav et al. [58]  
showed that modulation of the microwave frequency at 3.38 T and 30 K can yield even larger 
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effect, while being more flexible and depositing less heat than modulation of the static magnetic 
field. Later, Bornet et al. [59] published results on frequency modulation by sinusoidal frequency 
modulation at 6.7 T magnet and 1.2 K.  
The optimal carrier frequency, fµw, is determined by a frequency sweep. The sinusoidal 
modulation is characterized by the modulation frequency, fmod, and the modulation range, Δfµw, 
where the latter is sometimes expressed modulation amplitude amod = Δfµw/2. A graphical 
definition is shown in Figure 6. 
 
Figure 6: Graphical interpretation of frequency modulation and definition of parameters. Reprinted with 
permission from [59]. 
By implementation of frequency modulation in DNP, electron spins packets in a range of 
resonance frequencies are exited. Thus, the modulation of the microwave frequency should cover 
a substantial part of the inhomogeneously broadened radical EPR line for maximum efficiency. In 
addition, the modulation frequency should be higher than the inverse electron T1 for full 
utilization of electron polarization.  
The electron spin is typically provided by chemical doping with a stable organic radical. 
Nitroxides are a class of stable radicals with good properties for proton DNP. TEMPO (2,2,6,6-
Tetramethylpiperidine-1-oxyl, Figure 7) is an example, which is widely used for DNP due to its EPR 
properties [60,61] and solubility in hydrophilic solvents. 
 
Figure 7: Molecular structure of TEMPO. 
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Trityls are a group of narrow EPR linewidth radicals that are usually applied for 13C 
hyperpolarization. The linewidth of the trityl matches closely the Larmor frequency of 13C, and is 
therefore the best-known radical for direct 13C DNP. However, the narrow EPR line width makes it 
inefficient for proton polarization, since the solid effect is difficult to drive at high magnetic field 
and low temperature. The trityl OX063 is used in Study III for hyperpolarization of the 13C labelled 
compound HP001 (long T1 quarternary carbon labelling).  
Frozen water (ice) is a crystalline sample that will not provide a uniform doping of the 
electron paramagnetic agent. Thus, a glassing agent such as glycerol or dimethyl sulfoxide (DMSO) 
is typically used in the sample to ensure good glassing. However, the glassing agent may be 
omitted and replaced by techniques such as rapid freezing [62]. For in vivo studies the glassing 
agent has to be well tolerated. This limits the choice, and typical options are glycerol, DMSO, 
ethanol, or mixtures thereof. 
3.2 Dissolution-DNP (d-DNP) 
D-DNP is the most versatile method for obtaining hyperpolarized nuclear spins in solution. 
DNP in the solid state at low temperature allows high nuclear polarization of a range of nuclei and 
molecules. The polarized solid sample is rapidly dissolved without substantially loss of polarization 
[47,63]. The dissolved sample is transferred for detection in either an NMR spectrometer for in 
vitro experiments, or to an MRI system for imaging in vivo. The longitudinal relaxation time, T1, 
reduces significantly once the sample has been dissolved, and the transfer from polarizer to 
detector must therefore be fast. Ardenkjær-Larsen and coworkers demonstrated in 2003 that 13C-
urea could be dissolved and transferred to an NMR tube in a spectrometer in less than 6 s [47]. For 
in vivo studies of metabolism, T1 has to be relatively long. Both from a logistical perspective, but 
also to ensure enough time for circulation and metabolism. Therefore, 13C-labelling of carboxylic 
acids or carbonyls in small molecules has been preferred. The longitudinal relaxation time is 
affected by many parameters. Generally, small molecules (<100 Da) have fast dynamics, averaging 
interactions such as dipolar and chemical-shift-anisotropy. A high temperature favors fast 
dynamics, further averaging the interactions. The magnetic field environment has to be favorable; 
sudden changes of magnetic field orientation in low magnetic fields can be detrimental, if the 
change is non-adiabatic. Relaxation may be enhanced in low field if the hyperpolarized nuclear 
spin is coupled to a quadrupolar nucleus or if paramagnetic impurities are present. After 
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dissolution, the relaxation induced by the paramagnetic agent used for DNP is typically 
insignificant. This is the case for trityls, and therefore no removal of this radical is necessary. 
However, nitroxides have higher relaxivity and are used in higher concentrations, and may 
therefore have to be removed. Likewise, molecular oxygen is paramagnetic and will contribute 
significantly to water proton relaxation. 
For in vitro studies with fast transfer systems, nuclear spins with sub-second T1 has been 
detected [64]. An automated injection system for in vivo studies was published in [65], where it is 
demonstrated that the time from dissolution to injection can be reduced to 3 s. Recently, Shang et 
al. suggested a handheld electromagnet carrier to conserve polarization in the dissolved sample by 
placing it in a >50 G field [66], and others [67] have proposed a magnetic tunnel to prolong T1. 
3.3 Hyperpolarized 13C Angiography and Perfusion 
Hyperpolarization of nuclear spins is interesting for angiography and perfusion due to the 
large magnetization, and hence signal, that can be created. The large signal can be exchanged for 
high SNR images with high spatial and temporal resolution. 13C-labelled exogenous compounds are 
favorable due to their long T1. In 2001, Golman and coworkers [68] demonstrated that 13C can be 
hyperpolarized with the PHIP method and applied for MRA. A 13C polarization of 4% was obtained, 
and angiographic imaging of the vena cava and its branching veins was demonstrated in the rat. 
Svensson et al. [69] achieved 13C polarization of 15% of bis-1,1-(hydroxymethyl)-[1-
13C]cyclopropane-d8 (HP001)  at time of injection using d-DNP, and acquired angiographies of the 
head and neck region, as well as the abdominal area, in the rat. In 2006, Olsson et al. [70] 
published the first study of hyperpolarized MRA in a large animal, when 13C-enriched 
hydroxyethylproponate polarized to 30% was injected intra-arterially into the coronary artery of a 
pig to obtain coronary angiographies. The images of ECG triggered acquisition are shown in Figure 
8. The LAD in Figure 8c had SNR of 16.  
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Figure 8: Hyperpolarized 13C angiogram of a pig heart with pixel size 1.5×1.5 mm2. Injection in left and right 
coronary arteries. Images were acquired every heartbeat after ECG triggering with acquisition time of 422 
ms. Arrows show artefacts, believed to be caused by intensity variation. Reprinted with permission from 
[70]. 
In addition to angiography, hyperpolarized 13C compounds have been suggested as 
perfusion markers. The method was first demonstrated for cerebral perfusion in rats [71,72], and 
later on used for investigation of rat tumor perfusion [73,74]. Recently, Lau et al. demonstrated 
that flow sensitizing gradients could be applied to reduce the signal of hyperpolarized 13C urea 
from the blood pool in the heart, and measure the myocardial perfusion in rats [75], and the same 
group has used the concept in combination with [1-13C]pyruvate to assess myocardial perfusion 
and metabolism simultaneously, Figure 9. The intravenously injected agent rapidly reached the 
cardiac chambers, and was later observed in the myocardium. 
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Figure 9: Myocardial perfusion in rats with hyperpolarized 13C urea. a) Images of every 5th frame of an ECG 
triggered acquisition without (upper row) and with (lower row) flow sensitivity. The in-plane resolution was 
1.25×1.25 mm2. b) and c) Time course for the first pass of urea signal in the right ventricle (RV, blue), left 
ventricle (LV, red) and myocardium with no flow encoding (dashed, black) and with flow sensitization (solid, 
black). Reprinted with permission from [75]. 
3.4 Hyperpolarized Water 
Hyperpolarized protons, and water protons in particular, have several advantages over 
hyperpolarized 13C: 
 Large magnetization and sensitivity due to high concentration, large magnetic 
moment and large gyromagnetic ratio (detection frequency) 
 Higher spatial resolution due to larger gyromagnetic ratio for given gradient 
performance 
 Optimized sequences and coils are widely available for 1H imaging.  
The disadvantage of hyperpolarized protons is the short T1, which will limit the available 
time window significantly. The proton T1 may be increased by dilution to reduce the efficient 
proton-proton dipolar relaxation. The most obvious solvent for dilution is D2O, since deuterium 
has a low magnetic moment (1/6 of the proton), leading to a square reduction of dipolar 
relaxation mechanisms. The relaxation time of protons in D2O is given as 
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1
𝑇1
= 𝜂
1
𝑇1𝑤
(𝛼 + (1 − 𝛼)𝑅), where 𝑅 =
2
3
𝛾2𝐼𝑑(𝐼𝑑 + 1)
𝛾2𝐼𝑝(𝐼𝑝 + 1)
= 0.0419 
𝐼𝑑 and 𝐼𝑝 are the spin numbers of deuterium (𝐼𝑑  = 1) and the proton (𝐼𝑝= 1/2), respectively [76]. 
The relaxation times of various H2O/ D2O ratios are shown in Table 1. 
Volume ratio, (V H2O/ V D2O) 1.0 0.8 0.6 0.4 0.2 0.1 0.05 
T1  (21.5 °C) 3.2 s 3.9 s 4.7 s 6.7 s 11 s 18 s 25 s 
Table 1: Proton relaxation times for H2O-D2O mixtures in degassed samples. Data from [76]. 
Another important factor determining T1 is the sample temperature. The relaxation times 
over a range of temperatures are given in Table 2 [77]. 
Temp. 293K / 
20°C 
303K / 
30°C 
313 K / 
40°C 
323K / 
50°C 
333K / 
60°C 
343K / 
70°C 
353K / 
80°C 
363K / 
90°C 
373K / 
100°C 
T1  3.0 s 3.8 s 4.8 s 5.8 s 6.8 s 7.9 s 9.1 s 10.3 s 11.6 s 
Table 2: Relaxation times for oxygen-free waters. Data from [77]. 
The relaxation of protons in D2O was measured as a function of concentration and 
temperature [78], Table 3. For a concentration of 6 M at 40 °C, the T1 of protons in deoxygenated 
D2O can be as long as 36 s. 
 T (°C) H2O 
5% H
2
O 
in D
2
O 
10% H
2
O 
in D
2
O 
4.8% 1:1 (w:w) 
glycerol:H
2
O in D
2
O 
4.8% 1:1 
glycerol:H
2
O and 30 
mM TEMPOL in D
2
O 
+ 100 mM 
asorbate* 
D
2
O 
25 3.3 25 16 26 3.0 20 38 
40 5.0 36 22 37 4.3 28 53 
60 7.4 51 26 53 6.5 41 76 
80 10 64 35 68 9.0 53 93 
[H+] 111 6.26 11.8 4.56 4.56 5.30 0.74 
Table 3: Longitudinal relaxation time constants (T1) measured at 9.4 T for 1H in various sample 
compositions. All T1 values are reported in s. The lower row is the proton concentration in M. 
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Dissolved molecular oxygen, O2, and the nitroxide radical are two dominant relaxation 
sources. The relaxivity of dissolved molecular oxygen is given in [79] as RO2 = 0.0094 L/mg/s. At 25 
°C, water dissolves 8.6 mg/L O2, and therefore removing 90% of the dissolved oxygen would bring 
the relaxation rate contribution to 0.008 s-1. It is therefore not too demanding to eliminate this 
contribution by thorough degassing of all solvents and containers. It should be noted that organic 
solvents can have much higher solubility of molecular oxygen. Höfer et al. [80] provides a 
relaxation rate contribution for a nitroxide radical of RNitroxide = 0.55 s-1mM-1 at 25 °C in low field. 
To have minimal effect on T1, the relaxation rate contribution should be less than e.g. 0.02 s-1, 
which means that the concentration of the nitroxide should be less than 40 µM. Several 
techniques have been applied for minimizing the relaxation from the radical after dissolution. One 
way is to quench the radical with ascorbic acid. The method has been demonstrated to be useful 
[78,81], although polarization is lost during the quenching process, because the redox reaction is 
relatively slow and requires high ascorbic acid concentration. In addition, the ascorbic acid is 
unstable in the heated solutions, and browning can be observed. Furthermore, the method leaves 
unwanted residues in the solution, which may be problematic for clinical application. Another 
method is to filter out the nitroxide by using a cation such as amino-TEMPO, which can be 
removed with ion exchange. However, few working systems have been demonstrated, and the 
relaxation of water protons in the filter is unknown. Instead, the radical has been suggested 
removed by extraction in an organic solvent [61,82]. This method has the advantage that the 
organic solvent can be used to provide heat for dissolution of the sample, such that the dissolution 
medium and hence dilution can be minimized. 
With dilute water protons, a large initial magnetization can theoretically be achieved. Table 
4 calculates the magnetization for three different situations. Relaxation factor is calculated from 
the T1 and a transfer time of 15 s. A dilution factor estimates the dilution in the vasculature, for 
intra-arterial or intravenous injection methods.  The tissue water proton signal is taken as 
reference, assuming a T1 and repetition time of 1 s. As example, and based on a target T1 of 20 s, 
the magnetization of 5 M protons in D2O is 628 times larger than the tissue proton magnetization 
at 3 T, if it is assumed that 20% polarization can be achieved. For a 13C-labelled molecule of 500 
mM concentration and initial polarization of 50%, the magnetization is 79 times higher than the 
tissue magnetization, but 8 times smaller than the hyperpolarized proton magnetization. 
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Depending on assumptions for dilution and relaxation, the effective magnetization at time of 
imaging can be difficult to predict. However, the fast mixing of the water protons with blood, 
means that the T1 will quickly reduce to around 1.6 s, the T1 of blood at 3 T [83].  
Nucleus Initial 
conc. 
[M] 
P 
[ppm] 
Initial M
0
 
[mA/m] 
T
1
 
[s] 
Relaxation 
factor 
Dilution 
factor 
M
0
 at 
imaging 
[mA/m] 
1
H (H
2
O/D
2
O) 5 200,000 4,895 20 e
-15/20
 = 0.5 0.2 490 
13
C agent 0.5 500,000 615 60 e
-15/60
 = 0.8 0.1 49 
Thermal 
1
H 80 10 @ 3T 7.8  1  0.6 1  4.7 
Table 4: Comparison of magnetization for three situations. The proton magnetization of tissue is used as 
reference. 
 In 2014, Ardenkjær-Larsen et al. proposed to hyperpolarize the protons of water molecules 
with d-DNP for angiography [78]. A polarization of 3.5% at a concentration of 3.9 M was measured 
at time of injection, which proved to be sufficient for angiographies of the head and neck region 
after intra-arterial injection in the carotid artery, and imaging of the vena cava after intravenously 
injection into a tail vein of a rat. Concurrently, hyperpolarized water has been applied for signal 
enhancement in biomolecular NMR studies [61,82,84]. 
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4 Safety of the formulation and administration 
The formulation that was developed in this thesis work, and used in pig experiments, was 
approx. 5 M 1H in D2O with 9 g/L NaCl, 1 mM calcium disodium ethylenediaminetetraacetic acid 
(EDTA), approx. 25 mM glycerol and trace amount of heptane. No formal safety studies have been 
performed, but the formulation was well-tolerated in animal studies. The safety concerns with the 
formulation are discussed only by principle. 
The temperature of the formulation was close to body temperature at time of injection, i.e. 
in the range 35-40 °C. The pH of the formulation was close to physiologic, but unbuffered. Only the 
weak EDTA concentration provides a minimal buffering capacity. The formulation was adjusted to 
isotonic with sodium chloride. On these parameters, the formulation was considered optimal and 
safe. However, it may be that some further optimization of the composition of salts (Ca2+, Mg2+, 
K+) in the formulation could be introduced similar to iodinated contrast agents [85]. 
The solubility of heptane in water is 0.0003% (v/v), or 3 ppm, at 25 °C (logP of 4.274). This 
means that the pig could receive a dose of 45 nL (60 ng) when 15 mL of the formulation is given. 
The acute oral toxicity of heptane has been determined to >5,000 mg/kg in rat [86]. This means 
that a high, acute toxicity, safety margin should be present. However, local toxicity at point or 
organ of injection is unclear and needs to be determined, as well as other long term side effects of 
heptane. It is a general concern that, potentially, pure heptane could be injected into the animal, if 
complete separation is not accomplished. Alternatively, an organic solvent with lower solubility 
and/or better safety profile, may be applied for the extraction. 
Deuterium oxide (D2O) is an inherent and major component of the formulation. Approx. 15 
mL of D2O (3.3 g of deuterium) is given to a pig of 30 kg in the experiments performed as part of 
this thesis. Deuterium accounts for 0.0156% of all hydrogen, or 0.0312% by mass. A 70 kg person 
contains approx. 7 kg (10%) [87] of hydrogen and would thus have a natural level of deuterium of 
2.2 g. The dose of deuterium given in these experiments are thus at the level of the endogenous 
level. The injected deuterium will exchange with exchangeable protons in proteins and 
metabolites as well as be incorporated in molecules by e.g. hydration reactions. 
Experiments in mice, rats, and dogs have shown that a degree of 25% deuteration causes 
(sometimes irreversible) sterility, because neither gametes nor zygotes can develop [88]. High 
  23  
 
concentrations of heavy water (90%) rapidly kill fish, tadpoles, flatworms, and Drosophila. 
Mammals (for example, rats) given heavy water to drink die after a week, at a time when their 
body water approaches about 50% [89]. The mode of death appears to be the same as that in 
cytotoxic poisoning (such as chemotherapy) or in acute radiation syndrome (though deuterium is 
not radioactive), and is due to deuterium's action in generally inhibiting cell division. It is more 
toxic to malignant cells than normal cells. As in chemotherapy, deuterium-poisoned mammals die 
of a failure of bone marrow (bleeding and infection) and intestinal-barrier functions (diarrhea and 
fluid loss). Oral doses of heavy water in the range of several grams, typically 0.2 g D2O per kg body 
weight, as well as heavy oxygen, 18O, are routinely used in human metabolic experiments; the 
double-labelled-water method [90]. It is known from this method that much of the deuterium will 
be excreted with water by renal elimination. 
Cardiac catheterization is a procedure to examine the function of the heart. A thin catheter 
is inserted into a large blood vessel that leads to the heart. During the procedure, the pressure and 
blood flow in the heart can be measured. Coronary angiography is done during cardiac 
catheterization. A contrast dye visible in X-rays is injected through the catheter. X-ray images show 
the dye as it flows through the heart arteries. This shows where arteries are blocked. The chances 
that problems will develop during cardiac catheterization are low. A small number of people have 
minor problems. Some develop bruises where the catheter had been inserted (puncture site). 
Overall, arterial line placement is considered a safe procedure, with a rate of major complications 
that is below 1% [91]. It is not entirely without risks, however, and it requires appropriate 
knowledge of the anatomy and procedural skills. Arterial lines can be placed in multiple arteries, 
including the radial, ulnar, brachial, axillary, posterior tibial, femoral, and dorsalis pedis arteries. In 
1995, a total of approx. 1 million patients underwent cardiac catheterization in Europe alone [92]. 
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5 Studies and Results 
5.1 Study I: Dissolution Dynamic Nuclear Polarization capability study with fluid path 
5.1.1 Introduction 
The aim of this study was to develop a method for filling of the fluid path that allows reuse, 
and to determine the capability of the fluid path system for d-DNP by validation of the 
reproducibility of the produced sample properties. 
 
Figure 10: Fluid path for d-DNP for research purposes. Dissolution medium is heated and pressurized in the 
syringe (right) before transfer through the inner concentric tube to the sample vial (right), and the dissolved 
sample is transferred back through the outer concentric tube, where an exit tube can be attached. 
The fluid path was introduced in 2011 [93]. In contrast to the earlier vapor pressure driven 
dissolution systems [94,95], the fluid path dissolution is driven by pressure driven piston in the 
syringe. The primary purpose of the fluid path was to provide a sterile environment during 
polarization and dissolution, and the technology is now being used in 20 SPINlab facilities 
worldwide.  
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The fluid path exists in two different versions. One version, the fluid path for research 
purposes, Figure 10, applies a ferrule union, and the sample vial and lower outer tube can thus be 
replaced, to facilitate reuse of the rest of the fluid path. During initial testing, variation in the 
dissolution time was observed. The union was believed to be the main source of variation, 
because the manually tightened ferrule would manipulate the geometry of the outer concentric 
tube, and thus hinder the flow. Even though a system using a torque wrench was established to 
avoid this issue, the modification of the tube and irreproducible dissolution times were still 
observed. The fluid path for research purposes has successfully been applied in numerous 
hyperpolarization experiments. However, for hyperpolarization of water, the dissolution time is 
crucial for obtaining high final polarization, because of the short relaxation time, the need for fast 
dilution in D2O, and rapid radical extraction. Hence, the variation was unacceptable for these 
studies. The fluid path for clinical purpose has no union. Instead, the concentric tubes are 
uninterrupted from syringe to sample vial and back. The standard filling protocol implies one time 
use of expensive, sometimes limited available fluid paths, where the sample is pipetted into the 
sample vial before attaching the vial to the outer tube with a UV-curing adhesive.  
In the method developed in this study, a filling tube is guided through the inner tube for 
dispersion of the sample. By introduction of the method, fluid paths can be reused, which is a 
large asset for labs using the system. In addition, the need for UV cured gluing is only needed for 
the first time use of a fluid path. 
The method was originally developed and optimized for hyperpolarization of water. Later 
on, it was expanded to pyruvate hyperpolarization, to accommodate the general need in modern 
d-DNP. The main difference between fluid path use for water and pyruvate is the need for 
degassed solvents to minimize the T1 of water samples. 
5.1.2 Methods 
Fluid path system 
A fluid path system was used for dissolution of samples polarized in a homebuilt and a 
clinical polarizer. It was made up of two parts, as shown in Figure 11; Part A consisted of a syringe 
for dissolution medium, concentric tubes leading the dissolution medium to the sample placed in a 
vial and back to a valve in the syringe, and an exit tube leading the dissolved sample to a receiver. 
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Part B consisted of a receiver, an EPA filter, and a quality control module for assessment of the 
dissolved sample.  
 
Figure 11: SPINlab and fluid path for clinical use, consisting of Part A and Part B. 
A PEEK tube of outer diameter 1/32” and inner diameter 0.5 mm was found applicable for the 
filling purpose. It was found that the end should be cut in a slanted manner to better enter the inner 
tube and fit though the nozzle, as well as to minimize the size of the last droplet, which was drawn 
back into the tube to not contaminate inner walls at retraction. The tube was adequately rigid for 
insertion through the entire inner tube of >1.5 m, and sufficiently bendable to fit through the 
dissolution syringe valve bore and inner tube entrance without buckling. 
The sample was drawn into the filling tube. The tube was wiped off and inserted into the 
inner concentric tube and guided to the vial, where the sample was injected. The exact position of 
the tube outlet was indicated by a mark. 
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Large Samples 
1.47 g µL [1-13C]pyruvic acid containing Electron Paramagnetic Agent (EPA, 15 mM 
AH111501) was injected into the sample vial with the filling tube. 38.0 g ultra-pure water with 0.1 
g/L EDTA was added to the dissolution syringe. 26.2 g ultra-pure water with 0.1 g/L EDTA and 15.0 
g 0.72 M NaOH, 0.4 M TRIS base, 0.1 g/L EDTA were added to the receiver of the fluid path Part B. 
The samples were polarized a clinical polarizer (SPINlab, GE Healthcare) operating at 5 T 
and 0.85 K and dissolved in a fluid path Part A with an attached Part B receiver with EPA filter.  
The quality control (QC) module measured 6 parameters of the dissolved sample in 15 s 
without direct contact.  
6.7 T Homebuilt Polarizer 
The initial aim of Study 1 and Study II was to develop filling techniques and protocols for 
hyperpolarized water. Hence, a 6.7 T magnet (Magnex, Oxford, UK) was adapted to facilitate the 
fluid path technology, so that the methods could be transferred to SPINlab polarizers for 
preclinical imaging. The magnet was modified with a flow-type variable temperature insert. A 
microwave source provided 55 mW microwaves at 188.0±0.6 GHz. A heater-pressure module was 
implemented for heating the dissolution medium and driving dissolution. A valve was 
implemented to keep a pressure of 12 bar during heating, adequate to sustain the vapor pressure 
of the heated solvents. At dissolution, the pressure was increased to 16 bar and the dissolution 
medium syringe valve was opened. Solid-state NMR was performed with a saddle coil connected 
to an NMR console. The operating temperature was 1.1-1.2 K. The dissolution process was 
controlled by a LabVIEW program, and the various phases of polarizing, dissolution medium 
heating, and dissolution process could be controlled individually.  
Small Samples 
40 µL [1-13C]pyruvic acid containing 15 mM AH111501 was injected into the sample vial 
with the filling tube. The filling tube was connected to a helium gas source to flush remaining 
sample into the vial. 13.3 g 0.2 M tris-hydroxymethyl aminomethane (TRIS base) with 0.1 g/L EDTA 
and 138 µL NaOH (10 M) was added to the dissolution syringe.  
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The samples were polarized in the homebuilt polarizer for one hour. Liquid state NMR data 
was acquired on a 9.4 T spectrometer. 13C polarization and relaxation time was measured with 
excitations of α = 3⁰ every 2 s, starting approx. 10 s post dissolution. The thermal signal was 
acquired by adding 15 µL Omniscan to reduce T1 to <1 s with 2000 averages of repetition delay 0.5 
s and α = 3⁰. 
5.1.3 Results 
Two sample size were tested in the study.  
1) A human dose for clinical studies of 1.47 g pyruvic acid/EPA was polarized and dissolved in 
a clinical polarizer, aiming for 40 mL 250 mM pyruvate sample, reaching an average 
polarization of 34.2%. Six quality control parameters were measured online on the SPINlab. 
The relevant measures and standard deviations are shown in Table 5. 
 Average Standard deviation Relative STD (%)  
 
PA/EPA added (g) 
 
1.47 
 
0.02 
 
1.4 
DM in syringe (g) 38.0 0.1 0.2 
DM in receiver (g) 
NM in receiver (g)                    
 
25.8  
14.3 
0.3 
0.2 
1.0 
1.4 
PA/NaOH mol ratio                    1.6 0.002 0.2 
    
Pyruvate conc. (mM) 246 19 7.7 
pH 7.71 0.17 2.2 
EPA conc. (µM) 1.17 0.28 24 
Temperature (⁰C) 32.0 1.3  4.0 
Volume (mL) >40 mL             
Polarization (%) 34.2 2.9 (n = 3)* 8.5 
Table 5: Results from dissolutions with large sample filling (n = 11). 
2) A smaller dose for small animal preclinical studies of 40 mg pyruvic acid/EPA was polarized 
and dissolved in a homebuilt polarizer aiming for 5 mL 80 mM pyruvate sample, reaching 
an average polarization of 43.7%.  
Six quality control parameters were measured: Final pyruvate concentration, pH, EPA 
concentration, temperature, output volume and polarization, Table 6. They all showed high 
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reproducibility with low standard deviations, and concentrations 3-10 times smaller than the 
acceptance criteria for clinical studies.  
 Average Standard deviation Relative STD (%) 
PA/EPA added (mg) 40   
DM in syringe (g) 13.4           0.6 4.5 
NaOH (10M) syringe (g) 0.138   
 
Pyruvate conc. (mM) 
 
70 
 
7.4 
 
11 
pH 7.8 0.1 2 
EPA conc. (µM) 70.5 7.5 11 
Product in receiver (g) 5.3 0.6 12 
Temperature (⁰C) 54 2.6 5 
Polarization (%) 43.7 5.5 (n = 4) 13 
T1 53.8 2.0 (n = 4) 4 
Recovery (%) 82 12 15 
Table 6: Results from dissolutions with small sample filling (n = 7). 
5.1.4 Discussion 
The filling method was developed to be able to reuse the fluid paths. The optimization of 
the protocol for hyperpolarized water has required hundreds of dissolutions in the fluid path. With 
the high purchase cost of the sterile fluid path, this would not have been possible with a PhD 
project budget, if each system could only be used once. Thus the method has facilitated a trial-
and-error investigation of dissolution parameters and new ideas such as radical extraction 
solvents, as well as a systematic optimization of the system.  
 The method is complicated, because the insertion of the filling tube requires know-how for 
how to get the tip into the inner tube though the geometry of the dissolution medium syringe, and 
a steady hand to get the tube through the inner tube nozzle without buckling. The best way to 
learn the technique may be from the videos published as supplemental material to Paper I. Several 
aggregates were 3D printed and tested to guide the tube into the system and make the procedure 
more straightforward, but none were successful. Thus, buckling and rupture of the filling tubes 
was experienced occasionally. 
 Despite of these difficulties, it is believed that the method and the reproducibility of the 
sample properties can be an asset for research sites using the fluid path technology. 
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5.1.5 Conclusion 
A novel fluid path filling method has been developed. The method facilitates reproducible 
polarization and low variance in the quality control parameters. In addition, the method allows 
multiple reuses of the fluid path, and potentially saves preparation time, because the UV cured 
gluing or laser welding process is only needed for first time usage.  
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5.2 Study II: Large dose hyperpolarized water with dissolution-DNP at high magnetic field 
5.2.1 Introduction 
The aim of this study was to develop a protocol for production of hyperpolarized water 
samples of volumes suitable for large animal experiments, and to optimize polarization, relaxation 
time and radical removal.  
The end goal is to deliver a safe sample of highest possible polarization at time of injection 
into the animal. The latter requires a high solid-state polarization, efficient dissolution with 
minimal polarization loss, and long relaxation time to conserve polarization during the transfer 
and injection. The fluid path system described in Study I is applied to be able to use the method in 
clinical setups with SPINlab facilities.  
Dipolar relaxation is the main source of relaxation in the sample. Pure water has a T1 of 3.2 
s, due to the dipolar relaxation between neighboring protons. The polarized sample is therefore 
dissolved in D2O. Due to its smaller magnetic moment, which enters quadratically in the relaxation 
process, a deuteron should be about ten times less effective for the relaxation of neighboring 
protons than another proton [76]. The relaxation times of various H2O/ D2O ratios were shown in 
Table 1. Determination of the proton concentration in the dissolved sample is a balance between 
achieving long relaxation time, while keeping the protons concentrated to get the highest possible 
signal. A sample size of 1 mL sample was determined to achieve sample sizes suited for large 
animal experiments. In order to secure a uniform radical distribution in the sample, half of the 
sample volume was substituted for glycerol. By dissolution in 16 mL D2O dissolution medium, the 
final H2O volume fraction is 0.031. Thus, the relaxation from neighboring protons alone will give a 
T1 of more than 25 s, which is acceptable. 
The radical is another contributor to relaxation. In the low magnetic field, the sample is 
exposed to during the transfer and injection time, nitroxide relaxation rate contribution of RNitroxide 
= 0.55 s-1mM-1 at 25 °C has been reported [80]. For the 1 mL 30 mM TEMPO sample dissolved in 16 
mL dissolution medium, the radical would result in a T1 of less than 1 s, if not removed. Several 
techniques has been discussed earlier to minimize relaxation from the radical. Quenching of the 
radical by ascorbic acid has been successfully applied in other studies [78,81], but the process 
takes time and leaves unwanted products in the final sample. Filtration of the radical is another 
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solution, but few working systems have been demonstrated, and the relaxation mechanisms in the 
filtering process are unknown. Therefore, the radical was extracted in an organic phase. 
The relaxation contribution from the oxygen in the system originating from air in the fluid 
path and dissolved in the solvents contributes to the relaxation rate with 0.0094 L/mg/s [79]. The 
concentration of dissolved oxygen in air saturated water at 25 °C is around 8.6 mg/L, which leads 
to a relaxation rate contribution of 0.081 s-1. The corresponding oxygen concentrations in the 
organic solvents used for extraction, heptane and NFBME, are a factor of 10 and 20 higher, 
respectively [96,97]. The dissolution medium and the extraction solvent were therefore degassed 
before use. The dissolved sample relaxation from the oxygen originating from the 1 mL sample is 
negligible. However, the oxygen can affect the DNP, and was therefore investigated by comparing 
degassed and non-degassed samples.  
5.2.2 Methods 
The standard water sample consisted of 30 mM TEMPO (2,2,6,6-Tetramethylpiperidine 1-
oxyl) in H2O/glycerol 1:1 (w/w). In addition, corresponding 20 mM TEMPO in water/glycerol and 
30 mM TEMPO in H2O/dimethyl sulfoxide-d6 (DMSO-d6) 1:1 (w/w), were prepared. 1100 mg 
sample (~1 mL) was filled in the sample vial as described for Study I. The dissolution medium 
syringe was filled with 7.60 g (5 mL) nonafluorobutyl methyl ether (NFBME) and 17.72 g (16 mL) 
dissolution medium, consisting of D2O with 1 mM calcium disodium ethylenediaminetetraacetic 
acid (EDTA) and 9 g/L NaCl. The solvents were degassed in the syringe by bubbling with helium gas 
for 10 minutes through an adapter, leading the wet vapor away from the inner tube to prevent ice 
blockage when cooled in the magnet.   
 
Figure 12: The two isomers of nonafluorobutyl methyl ether, used to accelerate dissolution and extraction 
process. 
Samples to be degassed with the freeze-pump-thaw method were exposed to 3 cycles of 
freezing, vacuum and melting. The fluid path was sealed off to prevent condensation of moist air, 
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and the sample was frozen by placing the vial in a liquid nitrogen bath for 2 minutes, before the 
fluid path was flushed with helium gas and checked for pressure leaks.  
The samples were polarized in the homebuilt polarizer described in Study I at 188 GHz. 
Only Part A of the fluid path system was used. A sealed separatory funnel with 25 mL degassed 
heptane was used as receiver. The funnel was shaken vigorously during dissolution, extracting 
most of the TEMPO radical. The lower, denser, aqueous phase was drawn into a 25 mL disposable 
syringe, and injected into a 5 mm NMR tube placed in the NMR spectrometer through 1 m tubing. 
Funnel, syringe, tubing and NMR tube had all been flushed with helium gas and sealed off.  
NMR acquisition 
Liquid state NMR data was acquired on a 9.4 T spectrometer. Hyperpolarized water 
samples were excited with a 1° flip angle (α) for a series of 200 spectra of 1 s intervals. The proton 
concentration in the samples was measured by addition of 0.2 M potassium formate before 
thermal scans with α = 90°.  
Absorbance for radical quantification 
The radical extraction was evaluated by optical absorbance spectroscopy of the dissolved 
samples. Data was acquired with a light source (Ocean Optics DH-2000) and a UV- spectrometer 
(Ocean Optics USB2000+UV-VIS) in quartz cuvettes of 10 mm path length. The dark spectrum was 
recorded, and a quartz cuvette with reference medium was inserted. The reference spectrum was 
recorded after letting the light source stabilize for 30 minutes. The cuvette was flushed with the 
relevant solution 3 times before the transmitted spectrum was recorded. 
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5.2.3 Results 
Solid-state polarization 
The solid-state polarization was quantified by letting a sample polarize for 19 hrs towards 
thermal equilibrium, and the corresponding background signal was acquired with an empty 
sample vial, Figure 13.  
 
Figure 13: Thermal polarization build-up of a 30 mM TEMPO in water/glycerol 1:1 (w/w) sample at 6.7 T 
after subtraction of background signal. The time constant was T1 = 583 min. 
The background signal was subtracted from the sample signal, and the NMR signal time 
series, 𝑆(𝑡), was fitted with a function 
𝑆(𝑡) = 𝑃thermal [1 − exp (
−𝑡
𝑇1
)] 
yielding a T1 of 583±62 min. The constant 𝑃thermal corresponds to the thermal equilibrium value,  
𝑃thermal = tanh (
ħ 𝛾𝐵
2𝑘𝐵𝑇
) = 0.61% 
where ħ is the Planck constant, γ is the proton gyromagnetic ratio, 𝐵 is the magnetic field, 𝑘𝐵 is 
the Boltzmann constant, and 𝑇 is the temperature.  
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Figure 14: Frequency sweep of 30 mM TEMPO in water/glycerol 1:1 (w/w) with no frequency modulation (○) 
and modulation amplitude of 25 MHz (+), 50 MHz (*) and 75 MHz (x). Modulation frequency  fmod = 1 kHz.  
The effect of frequency modulation was investigated by acquiring frequency sweeps with 
60 s DNP for each frequency step for a series of 4 different modulation amplitudes, Figure 14. The 
optimal modulation amplitude of 50 MHz yielded an increase of 30% compared to no modulation.  
The signal of the thermally polarized sample was used to quantify the DNP build-ups shown 
in Figure 15. An overview of the polarization after one hour and the fitted build time constants are 
stated in Table 7. The standard sample of 1100 mg 30 mM TEMPO in water/glycerol polarized at 
188.12 GHz with 50 MHz modulation amplitude and 1 kHz modulation frequency showed a 
polarization of 63.1±3.7% after 1 hr (N = 4), whereas the corresponding 20 mM TEMPO sample 
only reached 48.1±4.9% after one hour, with a longer buildup time of 37±5 min. The solid-state 
polarization increased to 71.5±4.5% when the sample was degassed before DNP.  
 
Figure 15: DNP build-up curves for 20 mM TEMPO in water glycerol at 188.12 GHz (□), 30 mM TEMPO in 
water/glycerol at 188.12 GHz (◊), degassed 30 mM TEMPO in water/glycerol at 188.06 GHz (Δ) and 
degassed 30 mM TEMPO in water/DMSO-d6 at 188.06 GHz (○). All with frequency modulation of amod = 50 
MHz and fmod = 1 kHz.  
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Experiment  N P(1 hr) [%] DNP time const. 
20 mM TEMPO in water/glycerol 6 48.1 ± 4.9 37 ± 5 min 
30 mM TEMPO in water/glycerol 4 63.1 ± 3.7 24 ± 4 min 
Degassed 30 mM TEMPO in water/glycerol 5 71.5 ± 4.5 23 ± 2 min 
Degassed 30 mM TEMPO in water/DMSO-d6 3 42.8 ± 1.7 41 ± 2 min 
Table 7: DNP results for various sample compositions and polarization parameters.   
Liquid state polarization 
The dissolution resulted in 16±1 mL (N = 8) hyperpolarized water with a temperature of 
50±2 °C (N = 6). The free induction decay (FID) of the first hyperpolarized signal decays rapidly due 
to radiation damping (Figure 16a). The time constant of the FID fit was 0.25 ms, implying a 
linewidth of more than 1200 Hz due to radiation damping. The integral of each acquisition is 
shown in Figure 16b. The polarization was measured by comparing the first signal to the thermal 
signal. On average, the standard experiments of 30 mM TEMPO in water/glycerol 1:1 (w/w) 
showed a polarization of 7.8±3.3 %, and the data were fitted to a T1 of 17.0±0.9 s (N = 6). A 
validation experiment where the fully relaxed sample was introduced into the 9.4 T magnet 5 min 
later, yielded consistent T1 of 16.6 s, Figure 16b. 
The results of the dissolutions are shown in Table 8.  
a)    b)  
Figure 16: a) FID of first hyperpolarized signal fitted with a decaying exponential function b) Normalized 
NMR signal of hyperpolarized 30 mM TEMPO in water/glycerol 1:1 (w/w) sample (○) and build-up of relaxed 
sample at 9.4 T to validate T1 (□). The signal from the first point was 3761 times that at thermal equilibrium. 
The time constant for hyperpolarized relaxation was 17.0 s, whereas the validation measurement of thermal 
build-up was T1 = 16.6 s. 
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Experiment N Pol. [%] T1 [s] 
20 mM TEMPO in water/glycerol 1:1 (w/w) 5   8.6 ± 1.5 16.1 ± 1.0 
30 mM TEMPO in water/glycerol 1:1 (w/w)  6   7.8 ± 3.3 17.0 ± 0.9 
Degassed 30 mM TEMPO in water/glycerol 1:1 (w/w) 3 13.0 ± 0.9 15.7 ± 1.2 
Degassed 30 mM TEMPO in water/DMSO-d6 1:1 (w/w) 2   7.2 ± 1.3 18.8 ± 1.6 
30 mM TEMPO in water/glycerol 1:1 (w/w) without 
NFBME, long exit tube 
2   2.4 ± 0.6 19.6 ± 0.8 
30 mM TEMPO in water/glycerol 1:1 (w/w) without 
NFBME, short exit tube 
2   4.8 ± 0.5 20.1 ± 1.3 
Table 8: Liquid state polarization and T1 at 9.4 T. 
5.2.3.1 Radical Quantification 
The radical concentration in the dissolved sample solution was quantified with optical 
absorption spectroscopy measurements. TEMPO has an absorbance peak around 240 nm, and no 
other substances in the composition has significant absorbance around this range. Thus the 
absorbance A at 240 nm follows the Beer-Lambert law and scales linearly with concentration,  
𝐴𝜆 = 𝜀𝜆𝑐 𝑙 
where 𝐴𝜆 is the absorbance at wavelength 𝜆, 𝜀𝜆 is the extinction coefficient at wavelength 𝜆, c is 
the concentration of the absorbing molecule and 𝑙 is the optical path length. The linearity is valid 
in the range A = [0.1:1]. The measurement is repeated 3 times, and the absorbance spectrum is 
calculated as  
𝐴𝜆 = − log10 (
𝑆𝜆 − 𝐷𝜆
𝑅𝜆 − 𝐷𝜆
) 
where 𝑆𝜆 is the sample intensity at wavelength 𝜆, 𝑅𝜆 is the reference intensity at wavelength 𝜆, 
and 𝐷𝜆 is the dark intensity at wavelength 𝜆. 
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a)  b)  c)  
Figure 17: a) Absorbance spectra of example measurement. The spectra of the three repetitions overlap. b) 
The standard curves for TEMPO in water and heptane (N = 3 for each point). c) The TEMPO concentration in 
the water phase after extraction in heptane for various degree of shaking (N = 3 for each point). 
The absorbance spectra of an experiment are shown in Figure 17a. The 3 spectra in the 
figure cover each other, confirming the reproducibility. Absorbance spectra of known 
concentrations of TEMPO in water and heptane was used to produce the standard curves shown 
in Figure 17b. Having established the relation between concentration and absorbance, the 
equilibrium value of concentrations in the two phases, the partition coefficient P, could be 
determined.  The partition coefficient of TEMPO in water and heptane was PHeptane = 22 at room 
temperature, where extraction from TEMPO in water reference sample into equal volume of 
heptane in separatory funnel was measured. The corresponding partition coefficient in NFBME 
was PNFBME = 23, and extraction in a 25% NFBME/75% heptane mixture showed partition 
coefficient between the two other reported values.  
The extraction was tested for different schemes of shaking in the separatory funnel. Using 
the volumes of dissolved sample and heptane volumes in dissolution experiments, extraction was 
tested for 2, 5 and 10 individual shakes, and for 5 s, 30 s and 5 min continuous shaking, 
respectively (3 repetitions each, Figure 17c). It appears that maximum extraction was obtained 
after 5 s of continuous shaking, and that no further gain could be achieved by longer shaking. In 
dissolution-DNP experiments, the extraction should be started as soon as the front of the 
dissolved sample reaches the heptane in the receiver, but continue long enough to obtain 
maximum extraction of the latest arriving drop of the sample. 10 s of shaking from dissolution 
start was chosen to meet these requirements. This fits conveniently with a popping sound when 
the valve controlling the dissolution is closed (valid for both the homebuilt polarizer and GE 
SPINlab clinical polarizers).  
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A final TEMPO concentration of 50±12 µM (30 mM TEMPO in water/glycerol 1:1 (w/w), N = 
5) was measured in the dissolution experiments. This is compared to the theoretical value of final 
water phase concentration  
𝑐𝑊𝑃 = 𝑐𝑆𝑎𝑚𝑝𝑙𝑒
𝑉𝑆𝑎𝑚𝑝𝑙𝑒
𝑉𝐷𝑀 + 𝑉𝑆𝑎𝑚𝑝𝑙𝑒 + 𝑃 𝑉𝐻𝑒𝑝𝑡𝑎𝑛𝑒
= 53 µM 
for the sample concentration of 𝑐𝑆𝑎𝑚𝑝𝑙𝑒 = 30 mM, sample volume of 𝑉𝑆𝑎𝑚𝑝𝑙𝑒 = 1 mL, dissolution 
medium volume of 𝑉𝐷𝑀 = 16 mL, heptane volume 𝑉𝐻𝑒𝑝𝑡𝑎𝑛𝑒 = 25 mL, and partition coefficient 𝑃 = 
22. The small amount of NFBME reaching the receiver was ignored in this calculation. 
Proton Concentration 
The proton concentration in the dissolved sample is a delicate balance, where a high 
concentration increases the magnetization of the sample, but simultaneously increases the 
relaxation rate by dipole-dipole relaxation. The proton concentration was measured by 
quantitative NMR after addition of a potassium formate reference solution. A spectrum is shown 
in Figure 18. The formate peak (left) and water peak (right) were integrated (red regions) to 
5.0±0.5 M (N = 18). 
 
Figure 18: Proton concentration measurement. Large integrated peak of water in the dissolved sample, and 
small integrated peak of 0.2 M formate for reference. Other peaks represent the glycerol in the sample. The 
proton concentration was estimated to 5.0 M. 
5.2.4 Discussion 
The liquid state polarization of the 20 mM sample was higher than for the 30 mM sample. 
Although the T1 after radical extraction was marginally lower than for the 30 mM sample, the 
  40  
 
relaxation in the important time window of 1-2 s from dissolution of the sample to extraction of 
the radical could be the explanation. Yet, it should be noted that the differences in polarization 
and T1 are within the uncertainty range of the measurements, where only five 20 mM sample 
dissolutions and six 30 mM sample dissolutions were conducted.  
The NFBME was added to accelerate the dissolution process, so that the time from sample 
melting to dilution and radical extraction was shortened, and the relaxation was reduced. The 
volume of NFBME was tested with volumes of 5, 8 and 11 mL, where the lower volume yielded the 
most controlled and efficient dissolution, and highest polarization in the liquid state. The effect of 
the NFBME was examined by replacing it with additional dissolution medium. The polarization of 
the dissolved sample decreased to 4.8±0.5%. The main drawback of using NFBME is the weakening 
of the otherwise chemically stable polyphenylsulphone, which the fluid path is made of. Extended 
heating time with fluid path exposure to NFBME during polarization was observed to cause 
bursting dissolution medium syringes in several occasions.  Other nonpolar solvents were tested to 
replace the NFBME. 1-Octanol stressed the syringes even more than NFBME and was discarded. 
Another fluorinated, organic solvent (3M™ Novec™ HFE-7500 Engineered fluid) with boiling point 
of 130 °C and density similar to NFBME (ρ = 1.559 g/mL) yielded a decrease of 35% in the observed 
polarization in dissolved state in comparison, indicating that the driving force of the superheated 
NFBME is important for quick extraction of the radical (identical solvent volumes and parameters, 
3 repetitions each).  
It was determined that the final radical concentration of 50 µM matched the theoretical 
value for the given solvent volumes in equilibrium. Hence, the 10 s shaking may be more than 
needed, and a few seconds may be saved without affecting the relaxation time. As the maximum 
possible radical extraction has been achieved with the applied shaking scheme, further extraction 
would require increased heptane volume. In this case, heated heptane would be required to 
conserve a high sample temperature for relaxation considerations. 
 An important feature for the final sample polarization is the length of the exit tubing. The 
standard exit tubes are longer than 2 m to fit the clinical polarizers and reach the QC module. For 
hyperpolarized 13C compounds with long T1, the long exit tube transfer time is not a problem. 
However, for hyperpolarized water with short T1 and need for rapid dilution and radical extraction, 
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the transfer time of the concentrated, radical containing sample is crucial, and the cooling of long 
tubes should be minimized. The experiments showed that the final polarization was halved for 
standard exit tubes, compared to 50 cm exit tubes.  
5.2.5 Conclusions 
The method succeeded in producing large volumes, 16 mL, of hyperpolarized water 
suitable for large animal experiments. The sample was polarized to 71.5% for the most efficient 
sample composition and optimized frequency modulation. The liquid state polarization was 13.0%, 
indicating that most polarization is lost during dissolution. This is unavoidable, but the dissolution 
and radical extraction may be further optimized to provide injectable samples of higher 
polarization.  
A standard deviation of more than 40% in liquid state polarization was experienced for 
some experiments. The dissolution in a two-phase system of D2O and organic solvents yielded 
rapid radical extraction of 97.2%±0.7%, but the manual shaking may be the main contributor to 
the irreproducibility. Thus, an automated extraction scheme or a radical filtering system may be 
beneficial. 
  
  42  
 
5.3 Study III: Hyperpolarized 13C MR Angiography 
5.3.1 Introduction 
The aim of this study was to establish optimal conditions for hyperpolarized 13C 
angiography, by comparing the behavior of two common sequences, balanced-Steady-State-Free-
Precession (bSSFP) and Gradient-Recalled-Echo (GRE). In addition, the study was performed to 
provide in house data as a benchmark for the later work on hyperpolarized water angiography. 
The 13C compound HP001 (Bis-1,1-(hydroxymethyl)-[1-
13C]cyclopropane-D8, Figure 19), was selected to yield a high 
polarization and long relaxation time (in vitro, 2.35 T: T1 ≈ 82 s, T2 ≈18 
s; in vivo, 2.35 T: T1 ≈ 38 s, T2 ≈ 1.3 s [69]) to optimize angiographic 
image quality in a preclinical facility.  
5.3.2 Methods 
Healthy male Sprague Dawley rats of 240-320 g were catheterized in the carotid artery (N = 
18) or tail vein (N = 5) before administration of hyperpolarized HP001. 
The preclinical polarizer (HyperSense, Oxford Instruments) operated at 3.35 T and 1.4 K. 
18.0 mg trityl (OX063), 500 mg HP001, 180 mg water and 15 µL Dotarem (1:10 dilution) was 
prepared. 100 µL sample was dissolved in 1 mL PBS buffer with 0.01 g/L EDTA diluted in 3 mL NaCl 
(9 g/L). The polarization of the sample was 20-25% at time of injection. 
A preclinical scanner of 4.7 T (Agilent, Direct Drive, VnmrJ 4.0) equipped with a 1H/13C 
volume transmit/receive and 4-channel surface array 13C receive coil setup was used. 
HP-13C, bSSFP: The hyperpolarized signals were acquired using a single-shot bSSFP 
sequence with α = 110°. An α/2 preparation pulse was implemented at time TR/2 before the first 
excitation pulse to approach a steady-state like situation faster, and a corresponding flip-back 
pulse was implemented at the end of each image acquisition to restore the longitudinal 
magnetization for the following time frame. The angiographic images had a FOV of 70×35 mm2 
and a slab thickness of 30 mm placed coronal in the head and neck region. The matrix size was 
128×64. The repetition time and echo time were set to minimum, TR/TE = 6.95/3.48 ms. A 
Figure 19: Molecular 
structure of HP001. 
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bandwidth of 50 kHz yielded a total image acquisition of 450 ms for each image. The sequence was 
started when the solution had been fully injected to capture the maximum possible signal.  
HP-13C-MRA, GRE: The GRE sequence was applied with an FOV of 70×35 mm2, a slab 
thickness of 20 mm and with matrix size 256×128. The pulse length was 2 ms and the repetition 
and echo times were TR/TE = 10.16/5.10 ms. The total acquisition time for an image was 1300 ms 
with α = 5° and imaging was repeated over 30 time frames. Acquisition was started when injection 
was initiated to capture the maximum signal strength. 
1H MRA: Proton angiographic images were acquired with a 1H quadrature coil with inner 
diameter of 35 mm. A 3D GRE sequence with TR/TE = 90/2.47 ms, α = 40°, FOV of 30×35×20 mm3, 
matrix size 256×256×64 was used after an intravenous injection of 50 µL Clariscan™. The total 
acquisition time was 25 minutes. 
5.3.3 Results 
A gradient echo (GRE) sequence of α = 5° was determined as optimal for carotid artery 
injections, producing images of the right vascular arterial and venous network (Figure 20, left). 18 
injections in 10 animals yielded SNR of 17.6±4.5. The GRE sequence was not efficient for 
intravenous injections, where the hyperpolarized agent is diluted in the vasculature before 
reaching the cerebral network, yielding SNR <10. A bSSFP sequence proved more useful for 
intravenous injection, where the venous structure of the rat head appeared, and larger veins could 
be identified (Figure 20, center). 5 injections in 4 different animals yielded SNR of 31.3±20.0. The 
sequence was optimized on a thermal 13C phantom, finding α = 110° the optimum. This was 
confirmed by initial tests with intravenous injections of hyperpolarized HP001 in the tail vein 
(Figure 21). A 128×128 matrix with FOV = 60×60 mm2 was used in these experiments. 
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Figure 20: Rat cerebral angiography after hyperpolarized injection in the carotid artery, imaged with a GRE 
sequence (left) and tail vein imaged with a bSSFP sequence (center). The images are coronal planes, with 
the brain in the center and the eyes underneath, and the nose in the bottom of the FOV. The right pane 
shows an anatomical spin echo 1H image for navigation. 
 
Figure 21: Time series of bSSFP imaging of intravenous injections of hyperpolarized HP001. The image 
quality and SNR was highest for α = 110° (top row), lower for α = 60° (middle row), and further decreased 
for α = 30° (bottom row). These images were acquired in a 128×128 matrix with FOV = 60×60 mm2.  
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5.3.4 Discussion 
It was unclear why the bSSFP sequence was unsuccessful for imaging of the intra-arterial 
injections. The sequence optimally would produce images with higher signal, and for the minimal 
background signal, higher CNR. However, the images were unusable due to the artefacts. The 
artefacts were believed to origin from movements of the arteries, which could be either from 
mechanical impacts from the catheter, or from physiological reactions.  
The hyperpolarized 13C MR angiography study was designed to be a precursor for 
hyperpolarized 1H coronary angiography in rats, which could later be translated into a clinical 
setup with large animals. However, the study was complicated for several reasons. Working in 
small animals with fine vascular system requires high spatial resolution. In addition, the 
physiological dynamics are faster than in large animals, challenging the temporal measurements 
such as flow and diffusion.  
Furthermore, issues of a preclinical scanner without modern imaging tools and with 
challenging artefacts in many images, were the main arguments for following another path for the 
hyperpolarized water studies. It was determined to design the 1H hyperpolarization methodology 
for doses for large animals, and applicable to the currently existing polarizers at clinical facilities.  
5.3.5 Conclusion 
The bSSFP sequence was useful for intravenous injections, where SNR of 31.3±20 was 
observed with 0.55×0.55 mm2 pixel size, although the large standard deviation indicated that the 
method yielded unstable results. The gradient echo sequence yielded SNR <10 with intravenous 
injections. Comparing the results of the two sequences for intravenous injections, the bSSFP would 
be preferred for achieving high signal for intra-arterial injections. However, the bSSFP sequence 
proved unsuitable for intra-arterial injections, where artefacts prevented useful images. 
 Angiographies of the right carotid arterial network of rats were acquired with a gradient 
echo sequence at 4.7 T with resolution of 0.27×0.27 mm2 pixel size, and SNR of 17.6±4.5 resulting 
in a high image quality.  
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5.4 Study IV: Renal MR Angiography and Perfusion in the Pig using Hyperpolarized Water 
5.4.1 Introduction 
The aim of this study was to demonstrate hyperpolarized water MR angiographies and 
perfusion maps in a large animal model.  
Whereas the target of the project was coronary angiography and myocardial perfusion, the 
kidney serves as an easier accessible organ for catheterization, and without the complications of 
cardiac motion. Renal investigations therefore served as a precursor to the cardiac study. 
However, development of a gadolinium and radiation free angiography and perfusion technique of 
the kidney has its own justification as well.  
 
Figure 22: Anatomy of the human kidney. The renal artery and arteries are shown in red. Figure from [98]. 
The kidney is supplied with oxygenated blood through the renal artery (Figure 22). Renal 
artery stenosis is prevalent in 6.8% of the elderly population, and is associated with progressive, 
decreased kidney function and renal failure [99]. Hence, studies of renal MRA is regularly gaining 
attention [100,101], since early diagnosis can form the basis of preventive surgery or medical 
treatment before development of renal failure [102]. In addition to renal angiography, the 
extravasation into the renal tissue provides valuable information, in that renal perfusion is linked 
to hypertension. Several methods for perfusion measurements exist, but most employ imaging of 
other molecules than water. Direct assessment of water atoms diffusing into the vascular bed has 
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been asked for, and suggested by H215O PET imaging [103,104], again with the exposure to ionizing 
radiation. Hyperpolarized water as a perfusion marker could solve both of these issues.   
5.4.2 Methods 
Hyperpolarization 
The 30 mM TEMPO in H2O/glycerol 1:1 (w/w) sample was prepared as described for Study 
II. Due to bursting of the dissolution syringes during extended time of heating while exposure to 
organic solvents, the NFBME was left out and replaced by additional dissolution medium to a total 
of 31.01 g (28 mL). The fluid path was prepared with sample, dissolution medium and heptane as 
described for Study I and Study II. A 50 cm exit tube was used. 
 The sample was polarized in a SPINlab for one hour. Since the SPINlab only has 13C 
channels installed, the electron resonance frequency was determined from a 13C sample. 
Animals 
Healthy 30 kg female Danish domestic pigs were sedated and anesthetized before 
catheterization of the main renal artery for administration of 12-15 mL hyperpolarized water. The 
catheter was placed using fluoroscopy (Figure 23).  
 
Figure 23: Renal arterial tree imaged by fluoroscopy during insertion of catheter. 
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Imaging 
Hyperpolarized water angiographies in pigs and phantom scans were acquired on a 3 T 
scanner (HDx, GE) with an 8-channel cardiac array receiver coil. Phantom experiments were 
performed by placing the filled sample syringe next to a saline filled syringe in the scanner, before 
acquisition with a gradient echo sequence of α = 1°, matrix size 128×128, field-of-view, FOV = (24 
mm)2  in a slab of 40 mm with TR = 3 ms, TE = 0.784 ms. The acquisition time of each frame was 
450 ms, and images were acquired with a time delay of one second. 
Axial and coronal images covering the kidneys of the pig were acquired to allow for 
planning of the angiography slab for hyperpolarized water imaging. The sequence was as follows: 
a 3D T1 weighted sequence with a standard steady-state free precession sequence (TE =  1.1 ms, 
TR = 2.7 ms, flip angle α = 35°, image matrix 256×256, FOV = 340x340 mm2, in-plane resolution 1.3 
mm, slice thickness 3 mm). 
Angiographies were acquired in the coronal plane of the left kidney. Following the 
conclusions of Study III, a gradient echo sequence gave high signal and was robust towards 
artefacts for intra-arterial injections. Hence, a gradient echo sequence with α = 5°, slice thickness 
40 mm, TR = 3.4 ms, TE = 0.984 ms, 256×256 matrix, FOV = 140×140 mm2 was used. The 
acquisition time was 870 ms. The Gd-perfusion sequence was executed with the following 
parameters: spoiled gradient echo, inversion time = 850 ms, α = 10°, slice thickness 50 mm, TR = 2 
s, TE = 1.4 ms, 128×128 matrix, FOV = 290×290 mm2. 
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5.4.3 Results 
Four phantom scans of sample polarized in a clinical polarizer were performed, giving 
average polarizations of 5.3±0.9% and T1 of 24±1 s (Figure 24). The proton concentration of the 18 
mL samples was 3.84±0.22 M (N = 10). 
 
Figure 24: Hyperpolarized water phantom experiment. The phantoms consisted of two syringes. Stacked 
images (same scale) are shown from 0 to 240 s with an image every second. The graph shows ROI signal 
means of the hyperpolarized 1H in D2O (green, decaying signal) and the H2O thermal phantoms (blue, steady 
signal). The hyperpolarized MR signal is initially 211 times stronger than the thermal H2O signal, and the T1 
of the decay is 24 s. The hyperpolarized signal decays into the noise since the 1H density is ca 20 times lower 
than the thermal H2O sample.   
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Angiographies of the left kidney arterial system were produced in 4 animals with high 
contrast from kidney tissue. A time series with 2 s intervals is shown in Figure 25. The second 
frame shows the highest signal in the arteries, where the contrast agent has filled the main 
arteries after 5 s. The signal dereases in the followin frames due to relaxation and washout. This 
trend is visualized in the plot, where the time trends of the mean signal intensity in the input site 
and cortex are shown. Whereas the input signal depicts a step function with high intensity during 
the injection, the filling of the vascular bed increases continoulsy, before relaxation and washout 
occurs.  
 
 
 
Figure 25: Renal angiographies in a pig at 3, 5, 7 and 9 s after injection of 15 mL hyperpolarized water. The 
color maps show the signal intensity from no signal (blue) to high signal (yellow) in arbitrary units. The 
mean signal in the input ROI (blue) and cortex ROI (green) are plotted versus time.  
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The perfusion maps derived from the time series are shown in Figure 26. The average 
perfusion in the cortex was 504±123 mL/100 mL/min (green circumference), in agreement with 
Gd-T1-DCE analysis of 450±57.3 mL/100 mL/min (N = 2), and values reported in the literature. 
 
 
Figure 26: Perfusion maps of the kidney of four individual pigs after injection of 15 mL hyperpolarized water. 
The time series of Figure 25 is the data used for frame C. 
5.4.4 Discussion 
Hyperpolarized water MR angiography has been demonstrated in the pig kidney. The 
dynamics of the time series was used to produce perfusion maps, which provided perfusion values 
comparable to the standard Gd-T1-DCE method. The study opens for direct measurement of water 
in the tissue, instead of tracing perfusion of e.g. gadolinium complexes with other perfusion 
characteristics. In addition, the method saves the burden of NFS related complications from Gd 
based contrast agents. 
During injection and mixing with the blood in the arteries, the relaxation time of the 
protons is reduced to around 1.6 s, the T1 of blood at 3 T [83]. This is important for the perfusion 
analysis, and should be validated experimentally, and taken into account in a prospective 
automated perfusion data analysis.  
The main drawback is the need for renal catheterization, an invasive procedure. However, 
avoiding traditional contrast agents or, alternatively, radiation burden from CT scan may justify 
this. Comparing to state-of-the-art renal MR angiography of in-plane resolution 0.8×0.8 mm2 
[105,106], the presented method provides 0.55×0.55 mm2 resolution without the burden of 
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gadolinium-based contrast agent, which is problematic for kidney patients in particular. Whereas 
conventional MRA may be a suitable screening tool for renal artery stenosis detection, the 
increased resolution of hyperpolarized water MRA may also be feasible for stenosis grading. 
The protocol for hyperpolarized water was developed on a system, where several 
parameters could be controlled individually. However, using the SPINlab, the hyperpolarization 
process is automated. As a consequence, the dissolution syringes are pressurized and heated 
during the entire polarization. Even though the pressure and temperature in the homebuilt system 
mimicked those of the SPINlab, the extended heating time resulted in several breakings of the 
syringes. The breaking is problematic in terms of losing the sample, but can also result in damage 
of the polarizer and person damage from squirting of hot solvents. Thus, it was necessary to 
replace the NFBME in the syringe with additional dissolution medium. This may be the main 
reason for the lower polarization than that of the homebuilt polarizer. Other relevance differences 
between the two systems are the field strength (5 T of SPINlab vs. 6.7 T of the Magnex), 
temperature (0.8 K of SPINlab vs. 1.2 K of the Magnex), and the absence of frequency modulation 
on the SPINlab.   
The SPINlab is designed for application of the full fluid path system, where Part A is 
connected to part B through an almost 2 m exit tube (see Figure 11). The system is closed off 
during polarization and dissolution. However, as determined in Study II, shortening of the exit 
tube is important to achieve high polarization. Thus, it was necessary to remove the protective 
Plexiglas plate, and run the short exit tube directly out through the window (Figure 11). 
5.4.5 Conclusion 
MR angiography in large animals using hyperpolarized water was demonstrated feasible for 
the first time. The method yielded reproducible results in 4 different animals, and the derived 
perfusion maps gave values corresponding to those of conventional methods. The protocol for 
hyperpolarized water developed in Study II was transferable to a clinical environment, although 
substantial loss in polarization was observed for the SPINlab experiments.   
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5.5 Study V: Dynamic Coronary MR Angiography in the Pig using Hyperpolarized Water 
5.5.1 Introduction 
Cardiovascular magnetic resonance imaging is an efficient tool for radiation free diagnosis 
of cardiac diseases, and is routinely used in clinical praxis. However, coronary magnetic resonance 
angiography is troublesome due to the fine structure of the coronary arterial network, and the 
cardiac and respiratory motion. Thus, coronary MRA remains an unresolved challenge for cardiac 
disease diagnosis.  
The aim of this study was to demonstrate that hyperpolarized water can be used as a 
contrast agent to obtain coronary angiographies in a large animal model. The major challenge was 
the heart beating, where sampling within the diastole is required to avoid motion artefacts, and 
thus to acquire adequate signal to obtain a satisfactory resolution within less than a cardiac cycle. 
The method provides direct tracing of water molecules, contrary to established techniques 
which measures perfusion of radioactive nuclei, iodine contrast, or MR relaxation compounds. 
5.5.2 Methods 
The 1 mL 30 mM TEMPO in water/glycerol 1:1 (w/w) sample was prepared as described in 
Study II and filled in the fluid path using the method developed in Study I. The sample was 
polarized as described in Study IV. 
Images were acquired in a tilted plane covering the LAD with equipment and parameters as 
in Study IV. A gradient echo sequence of matrix size 256×256 and FOV = 140×140 mm2 yielded 
isotropic resolution of 0.55 mm. The acquisition time was 870 ms. 
Animals 
Healthy 30 kg female Danish domestic pigs were sedated and anesthetized before 
catheterization of the coronary artery (N = 3), for administration of 15 mL hyperpolarized water. 
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5.5.3 Results 
A gradient echo sequence was used to produce dynamic time series of the coronary 
perfusion with frame acquisition time of 870 ms after hyperpolarized water injection in the 
coronary artery with 3 successful injections in each of the 3 animals. Angiographies of each animal 
are shown in Figure 27. The injection site, the LAD and the left circumflex appear with the highest 
intensity, and some flow into their smaller branches is observed.  
 
Figure 27: Coronary angiographies after hyperpolarized water injections in three different animals. Images 5 
s after injection of sample. 
The apparent SNR, aSNR, defined as the ratio between the mean signal intensity in the 
vessel and the standard deviation of a background ROI, in left main stem was 269±169. The 
coronary sharpness, defined as the mean of the inverse distances between the 20% and 80% point 
on both sides of the 1D cross-section profile of a coronary segment in the proximal LAD, was 
0.31±0.086 mm-1. 
A dynamic time series is shown in Figure 28. Since no cardiac triggering was applied, 
motion artefacts were observed in some time frames (Frames 3, 4, 6 and 7, in particular). Frame 1 
shows the first detection of hyperpolarized signal. The signal rapidly increases in the injection site, 
the proximal LAD, in Frame 2. The signal distributes throughout the main arteries, and later 
throughout the arterial branches. From Frame 5, the extravasation in the myocardial tissue 
appears. No hyperpolarized signal was observed after 14 s. 
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Figure 28: Time series of consecutive images acquired every second from injection of sample. Major and 
minor vessels of the coronary tree can easily be identified. The frames are scaled collectively, with blue 
indicating no signal and yellow indication maximum signal. The animal of this time series is the center pane 
of Figure 27. 
The signal in the injection site, the main arteries and the distal branches all have different time 
delays from injection to signal increase and subsequent signal decrease due to relaxation and 
washout. The temporal profiles of average signal in these sites are shown in Figure 29. The rapid 
increase in the injection site (the proximal LAD) and the later increase in the smaller branches 
describe the perfusion into the coronary vasculature. 
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Figure 29: Time of arrival of hyperpolarized water at proximal LAD, medial LAD and at a distal branch of 
LAD. 
5.5.4 Discussion 
The method for MR angiography using hyperpolarized water demonstrated in Study IV 
translated successfully into coronary angiography. The method demonstrated high resolution 
dynamic MR coronary angiography for the first time.  
The method was robust; three consecutive injections of hyperpolarized water in an animal 
yielded reproducible results. The method is believed to be translational into clinical practice, 
because the samples can be produced in a sterile environment, with the safety profile discussed in 
Chapter 4. The safety of the formulation should be investigated thoroughly before human studies. 
The main drawback of the method is the invasive nature of the coronary catheterization. However, 
in combination with other examinations and treatments that requires catheterization, such as 
angioplasty and stent placement, the method may be feasible.  
The high temporal resolution provided detailed information about the perfusion of the 
vasculature and tissue. However, the lab did not facilitate ECG triggering, and hence movements 
of the heart, and artefacts were observed in several time frames. In a setup of ECG triggered 
imaging and respiratory control, the method is believed to provide data suitable for automated 
perfusion analysis, which could be of great value for CAD treatment assessment.  
Several optimizations are believed to potentially enhance the image quality further. The 5% 
proton polarization was adequate for 0.55 mm2 isotropic resolution with aSNR in the left main 
stem of 269±169, superior to value in the literature of 25.3, obtained in the right coronary artery 
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of humans with Gd enhanced MRI [31]. The large standard deviation is believed to be a result of 
the different positioning of the 3 animals.  
By enhancing the solid-state polarization, optimizing the dissolution and extending the 
relaxation time, a potential 50% polarization could improve the image quality dramatically. In 
combination with a clinical setup suited for cardiac images, the method could provide 
angiographies matching the resolution of CTA, and cardiac perfusion analysis with the advantages 
of direct water perfusion measurement and avoidance of ionizing radiation and toxic contrast 
agents. 
5.5.5 Conclusion 
The main finding of this study was the feasibility of coronary MR angiography using 
hyperpolarized water. Images were acquired in less than 1 s, allowing for cardiac triggering, and 
providing detailed information about the extravasation into the myocardial tissue. It was 
demonstrated, that the aSNR, and with that, image quality, was superior to that of other coronary 
MR angiographic methods. The method can be improved in several ways, to provide state-of-the-
art perfusion data of the myocardium.  
 
 
  
  58  
 
6 Discussion 
This chapter discusses the main findings and their relevance, and recommendations for 
future research is presented. The largest obstacles for clinical translation are discussed. The main 
purpose of this project was to investigate if hyperpolarized water could be applied as an MRI 
contrast agent for coronary angiography and perfusion measurements in large animal models.  
The major challenge is the fast relaxation of the polarization of the water protons, which 
has led to a skepticism for the application of hyperpolarized water for angiography and perfusion 
imaging [107]. Overhauser enhanced water provides low magnetization and short T1 [107]. Water 
polarization by parahydrogen has been proposed [108], but without success so far. The advantage 
of d-DNP, and the method proposed in this thesis, is the dilution of the protons in D2O to achieve a 
long T1 before injection, and the high polarization achievable by DNP. 
The solid-state 1H polarization obtained in this study was 70% in good agreement with 
literature under similar experimental conditions (6.7 T and 1 K). Higher proton polarization has 
been reported for similar polarizer conditions, up to 90%, but for samples with lower proton 
density to reduce the heat capacity of the proton spin bath. It could be investigated if lower 
proton density, e.g. by deuteration of the glycerol (glycerol-d5 or glycerol-d8) would lead to higher 
polarization. However, further reduction of the proton density would increase the required sample 
size beyond practical for a clinical/large animal dose. In this thesis, a 1 mL sample was polarized to 
produce 15 mL of hyperpolarized solution. The fluid path would in principle accommodate up to 2 
mL of solid sample, but further than that would require major hardware modifications. 
The DNP build-up time constant was typically more than 30 min, and limited by the 
available microwave power. However, final polarization was fully saturated, and microwave 
frequency modulation was found to be very efficient in overcoming the inhomogeneous 
broadening of the nitroxide EPR line at high magnetic field. Microwave frequency modulation is 
particular preferable to increase electron-electron dipolar couplings in this context, compared to 
increasing the nitroxide concentration (leading to relaxation losses in dissolution and liquid state). 
Reduction of the microwave attenuation of the waveguide transmission system or exchanging the 
microwave source with a higher power source is feasible, and could improve the throughput of d-
DNP by shortening the build-up time. It was found that degassing the solid sample leads to 
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significant improvement of the DNP efficiency. This is consistent with literature, and is explained 
by the increased relaxation times of the nitroxide when molecular oxygen is removed. The 
shortening of the nitroxide relaxation times by oxygen cannot be overcome by increased 
microwave power. It was verified that the degassing did not lead to an increase of the T1 of the 
protons after dissolution, i.e. it is not an effect of insufficient degassing of the final product. The 
degassing of the solid sample was omitted in preclinical studies with the SPINlab due to practical 
limitations at the hospital site.  
There are recent developments within the field of d-DNP that can further advance the 
method. It has been demonstrated that non-persistent radicals can be created by photo induction 
of 13C-labelled pyruvic acid [109,110]. UV radicals generated from pyruvic acid in water [109] could 
be thermally annihilated and radical free solutions could be obtained. In [111], 70% proton 
polarization in the solid state in water/pyruvic acid 1:1 (v/v) was demonstrated. Liquid state 
proton polarization has not yet been demonstrated by this method, but it would eliminate the 
need for radical extraction and hence eliminate the heptane. Lower losses in dissolution and 
longer T1 may also be expected with this method since the paramagnetic centers are eliminated in 
the solid state prior to dissolution. Hirsh et al. demonstrated that a brute force polarized sample 
(without paramagnetic centers) could conserve polarization during a 10 min. transfer from 
polarizing site to imaging site by keeping it in the solid state and only dissolve immediately before 
imaging [112]. This may also open up new perspectives for hyperpolarized water, even though the 
solid-state T1 of protons should be significantly shorter than for 13C. Finally, parawater has been a 
“hot topic” in magnetic resonance for the past many years [108]. So far, no one has succeeded, 
but a long-lived singlet state would open up for intravenous administration and more reliable 
perfusion and angiography. Another, possibly more likely, way of maintaining the magnetization 
for longer, would be to encapsulate the hyperpolarized water in liposomes or similar, to prevent 
the dilution with blood and shortening of T1. 
The fluorinated solvent proposed to accelerate the dissolution process resulted in a large 
enhancement of the liquid state polarization, but failed the translation into preclinical use. The 
reason was that the heating time could not be controlled manually on the SPINlab, and syringes 
burst from the extensive exposure to the solvent under high temperature and pressure. The 
dissolution acceleration was omitted from the protocol for imaging experiments, and a substantial 
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part of polarization was lost when the fluorinated solvent was compensated by increasing the 
amount of D2O in the dissolution syringe. Other methods for dissolution acceleration could be 
desirable for further enhancement of the polarization. In particular, if even larger samples are 
used. The two-phase extraction system was optimized to ensure almost complete extraction of the 
nitroxide. However, it may be further improved by increasing the heptane volume, which would 
require heating of the heptane to retain long relaxation time. An alternative for extraction of the 
radical, could be implementation of an inline filter (solid-phase extraction) in the exit tube, or 
acidic precipitation for radicals such as 4-carboxy-TEMPO. The solid-phase-extraction was not 
attempted, and could lead to significant proton relaxation. It is, however, recommended to 
investigate this method in further studies. Precipitation of the nitroxide could be challenging, since 
even the protonated 4-carboxy-TEMPO has water solubility. The two-phase extraction could be 
optimized by an automated stirring system, which could also eliminate the variability of manual 
shaking as well as reduce the transfer time.  
An automated injection system could control the injection rate of the hyperpolarized 
product into the animal. This could also ensure that no heptane droplets were injected (by proper 
quality control), which would be critical for clinical translation. The delivery to the patient has to 
be as fast and efficient as possible. In this thesis, it is shown that a manual transfer can be done in 
approx. 25 s. This is longer than the approx. 20 s T1 of the formulation, and accounts for most of 
the loss from solid state (P = 70%) to time of measurement in the liquid state (P = 13%). An 
automated transfer and injection system may potentially reduce the transfer time to 10 s as 
shown in [65], and thereby increase the polarization by a factor two. 
In this project, it was demonstrated that the technique can be applied for perfusion 
measurements in the pig kidney, and that the obtained perfusion values are in agreement with 
existing literature based on DCE-MRI. This demonstrates that despite the short T1 of the 
hyperpolarized proton signal, reliable perfusion values can be calculated by standard dynamic 
contrast enhanced models. Furthermore, it was demonstrated that the dynamic coronary MR 
angiography time series could be acquired using hyperpolarized water; something that that no 
other method has provided. The 5% proton polarization was adequate for 0.55 mm2 in plane 
resolution with aSNR in the left main stem of 269, superior to reported clinical numbers of 
typically 25 in the right coronary artery with Gd enhanced MRI. Although other works have 
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demonstrated that hyperpolarized water could be applied for angiography in rats [78,113], the 
technique has here been translated into a clinical setup, producing large sample volumes in clinical 
polarizers for large animal imaging. Some artefacts and tissue movement were observed in the 
coronary angiography time series. Implementation of cardiac and respiratory triggering could 
eliminate these and is straight forward, and thus may enable perfusion measurements of the 
cardiac tissue as well as higher quality angiograms. Optimally, this would be in a new, state-of-the-
art clinical MRI setup suited for cardiac imaging, including an MRI system with cardiac package, 
suitable heart array coils, and optimized sequences for 3D coverage of the heart. 
The method was also tested for cerebral angiography in the pig [114]. Although great 
established techniques for cerebral angiography already exist [115], the direct perfusion 
measurement from hyperpolarized water may offer new insight into cerebral cardiovascular 
disease and its diagnosis. Since water crosses readily the blood-brain-barrier (BBB), it is an “ideal” 
contrast agent for investigating changes in the permeability of the BBB and water dynamics, e.g. in 
patients after a stroke.  
Catheterization of the coronary arteries is an invasive technique that is only used in 
patients with severe cardiovascular disease. However, as previously mentioned, the annual 
number of arterial catheterizations amounts to millions worldwide. A major step forward would 
be if new methods of hyperpolarization could provide higher polarization and longer relaxation 
time, which opens for intravenous injection, without the risk of occluding the coronary vessels or 
other morbidity associated with catheterization.  
With the fluid path filling method presented in Study I, a sterile contrast agent can be 
provided using the SPINlab technology. This will enable human studies if sufficient safety profile 
can be documented for the formulation. A more controlled radical extraction method than the 
manual separatory funnel shaking can provide more efficient and reproducible extraction, as well 
as validation of a heptane free, injectable sample suitable for humans.  
The term Hyperpolarized water may be misleading. The 0.5 mL H2O sample is dissolved in 
16 mL D2O. The protons and deuterons exchange rapidly, and will reach an equilibrium distribution 
long before injection. Assuming a statistical distribution, and ignoring the exchangeable protons of 
the glycerol, the injected sample will be composed of 0.1% H2O, 5.9% HDO and 94% D2O. The final 
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low radical concentration and the amount of deuterium are of some concern for human usage 
[116]. However, based on the existing literature safety data, the 0.5 g deuterium per kg body 
weight used in the pig experiments is not far from the typical 0.2 g/kg dose, given with the water 
double labelling method. In the studies presented here, multiple injections were given in the same 
animal with no observed adverse events. The toxicology of the formulation should be investigated 
carefully before clinical research can be initiated. However, it is our opinion that further 
development of the method will lead to significant changes to the formulation. Thus, formal safety 
studies would be premature at this stage. 
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7 Conclusion 
In this thesis work, it has been demonstrated that hyperpolarized water can be applied for 
coronary angiography in a large animal model, and shows potential for myocardial perfusion 
measurements.  
A technique for preparation and hyperpolarization of large volumes of water was presented 
and optimized. Solid-state polarization >70% was achieved with frequency modulated microwaves, 
and a fluid path was used for efficient dissolution to reach a signal enhancement of 4,000 times 
above thermal equilibrium, corresponding to a liquid state polarization of 13%, with T1 of 16 s. A 
radical extraction system was designed, demonstrating removal of 97% of the nitroxide used for 
DNP. The properties of the sample were suitable for preclinical experiments, although it is 
believed that they could be further optimized to achieve even higher liquid state polarization. 
The hyperpolarization method was implemented in a preclinical setup based on the SPINlab 
technology. This, in principle, allows clinical translation of the method. Liquid state polarization of 
5.3% with T1 of 24 s was obtained. The lower polarization in these experiments was due to 
omitting the degassing of the solid sample, and the less efficient dissolution without the 
fluorinated solvent.  
First, renal angiography and perfusion was demonstrated. It was concluded that high 
resolution, 0.55 mm isotropic, was obtainable, and that the image time series could be applied to 
derive perfusion measurements in agreement with values reported in the literature.  
The central result of the project was the realization of dynamic coronary MR angiography in 
large animals, something that has not been achieved before. The images are considered to have 
diagnostic quality, and the dynamics in the time series is believed to be suitable for perfusion 
measurements, when obstacles such as cardiac triggering can be realized.  
The results may impact the field of CAD diagnosis and treatment assessment, as it potentially 
provides complementary parts to a full MR cardiac package, where both pre- and post-surgical 
examinations can be achieved with high accuracy and low safety profile.  
A novel method for filling of fluid paths for hyperpolarized samples was developed and tested. 
A filling tube inserted through the inner tube enabled reuse of the fluid path, and facilitated 
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reproducible sample sizes and control parameters with standard deviations 3–10 times smaller 
than the acceptance criteria intervals in clinical studies. The method is useful in experiments using 
the fluid path technology, and was an important element in the later preclinical studies.  
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ARTICLE INFO            ABSTRACT 
 
 
 
 
 
1 Introduction 
Increase of the NMR signal of molecules by hyperpolarization is a 
technique, which has many applications in the field of NMR spectroscopy and 
imaging. The most commonly used method is dissolution-Dynamic Nuclear 
Polarization (d-DNP) [1], in which the hyperpolarized nuclear spins are 
transferred from the solid state to the liquid state by a quick dissolution while 
retaining the nuclear spin polarization. 
In this study, the d-DNP technique will be demonstrated by 
hyperpolarization of pyruvate; being a key intersection in various metabolic 
pathways, [1-13C]pyruvate is by far the most common molecule for studies with 
d-DNP [2,3]. It has an advantageously long relaxation time T1 and high 
polarization levels can be achieved [4]. Other molecules can be used to probe 
biological pathways as well; [U-13C;U-2H]glucose [5], [1,4-13C2]fumarate [6], 
[1-13C]bicarbonate [7] among many other biologically relevant molecules. 
Similarly, hyperpolarized 13C-labelled biologically inert molecules have been 
applied for angiography and perfusion studies [8,9]. Besides the bioprobe, an 
electron paramagnetic agent (EPA) should be present to enable Dynamic 
Nuclear Polarization. The commonly used EPAs for hyperpolarization are 
OXO63 [10], BDPA [11] and TEMPO [12]. In this study, AH111501 is used, 
a stable trityl radical, which precipitates in low pH and can be removed by 
filtration in the receiver previous to the neutralization step. In 2013, the first 
clinical study with hyperpolarized [1-13C] pyruvate was published, 
demonstrating technical feasibility and showing promising results in the phase 
I trial on patients with prostate cancer [13]. 
Studies on the performance of the d-DNP process with the aim of 
demonstrating efficient dissolution, i.e. high concentration and large volume 
with minimal loss of polarization have been published [14,15]. The principle of 
dissolution in these studies is the use of a solvent that is heated to an elevated 
temperature to create a vapor pressure that can drive the flow of solvent past 
the cold, polarized sample. In the case of aqueous dissolutions, a temperature 
of 180 C is typically used, creating a vapor pressure of 10 bar. Another principle 
of dissolution was introduced in 2011 [16], where the concept of a closed fluid 
path (FP) was presented. The primary objective of the closed FP was to secure 
a sterile environment throughout the polarization and dissolution process [16]. 
In terms of dissolution capability, two key principal differences between the FP 
and previous designs should be noted: (1) the solvent is not driven by the vapor 
pressure at the given temperature, but by a syringe, (2) the independent inlet 
and outlet tubes are replaced by two concentric tubes with the inlet as the inner 
lumen and with return flow in the outer lumen. From the first point follows that 
solvent temperature can be
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Signal enhancement by hyperpolarization is a way of overcoming the low sensitivity in magnetic resonance; 
MRI in particular. One of the most well-known methods, dissolution Dynamic Nuclear Polarization, has been 
used clinically in cancer patients. One way of ensuring a low bioburden of the hyperpolarized product is by use 
of a closed fluid path that constitutes a barrier to contamination. The fluid path can be filled with the 
pharmaceuticals, i.e. imaging agent and solvents, in a clean room, and then stored or immediately used at the 
polarizer. In this study, we present a method of filling the fluid path that allows it to be reused. The filling 
method has been investigated in terms of reproducibility at two extrema, high dose for patient use and low dose 
for rodent studies, using [1-13C]pyruvate as example. We demonstrate that the filling method allows high 
reproducibility of six quality control parameters with standard deviations 3–10 times smaller than the acceptance 
criteria intervals in clinical studies. 
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controlled independently of solvent flow rate. In [17] it was shown that 
a syringe and solvent temperature of 130 C and piston drive pressure 
of 16 bar was optimal for the dissolution. These conditions are extreme 
for most plastic materials, but is tolerated by e.g. polyphenylsulfones 
or polyetheretherketones. The second point is expected to affect 
dissolution efficiency, but was introduced to facilitate a dynamic seal 
that allows sample introduction into the cryostat through an air lock 
without raising the pressure of the 1 K sample space to atmospheric 
pressure. The FP consists of two major parts: part A, which contains 
sample and solvent, and allows the hyperpolarized solution to leave the 
polarizer through an open ended tube, and part B, that consists of a 
receiver connecting to the exit tube of part A, allowing non-contact 
quality control of the dissolved product. Part B also includes a filter 
that removes the EPA in-line with the dissolution process. The EPA 
precipitates in aqueous solution at acidic pH and can be removed 
effectively by mechanical filtration. 
The objective of this work was to study the dissolution capability 
of the FP for two different sample sizes of [1-13C]pyruvic acid. (1) A 
sample of 1.47 g, producing a human dose, dissolved in dissolution 
medium (DM) and neutralized with Neutralization Medium (NM) to a 
target concentration of 250 mM [1-13C]pyruvate using the SPINlab 
polarizer and quality control system (involving FP part A and B). (2) 
A sample of 40 mg, producing a small animal dose, dissolved in DM 
to a target concentration of 80 mM, using a home-built polarizer 
involving only part A of the FP. 
 
2 Materials and methods 
2.1 Polarizer 
Large samples were polarized on a SPINlab (GE Healthcare), Fig. 
1, operating at 5 T and 0.85 K. Small samples were polarized on a home 
built polarizer [1] operating at 6.7 T and 1.1–1.2 K modified to 
accommodate the fluid path dissolution system. 
2.2 Sample 
[1-13C]pyruvic acid (PA) (GE Healthcare, Norway) containing 15 
mM AH111501 (EPA), 94.9% purity (GE Healthcare, USA). 
2.3 Dissolution medium (DM) 
Large sample: Ultra pure water (CHROMASOLVPlus HPLC 
grade, Sigma Aldrich) with 0.1 g/L ethylenediaminetetraacetic acid 
disodium salt dihydrate (EDTA) (VWR). 
Small sample: 0.2 M tris-hydroxymethyl aminomethane (TRIS 
base) (VWR) with 0.1 g/L EDTA. 
2.4 Neutralization Medium (NM) 
Large samples: 0.72 M NaOH (MERCK), 0.4 M TRIS base, 0.1 
g/L EDTA. 
Small sample: NaOH (10 M). 
2.5 Fluid path (FP) 
The FP (type 1293, GE Healthcare, USA) used for this study is 
shown in Fig. 1. Part A of the fluid path consists of a vial which can 
hold up to 2 mL of sample, the dynamic seal that allows the tubing 
to move inside the polarizer under vacuum, the co-axial tubing for 
DM inlet and outlet, the valve that opens the inlet and outlet 
simultaneously and the dissolution syringe that can hold up to 60 
mL of solvent. Fig. 2B and C shows the vial with the position of the 
inner tube. The inner tube has a nozzle to provide a more efficient 
dissolution as demonstrated in [15,17]. Part B of the FP, Fig. 1, 
consists of the transfer tube, the EPA filter, receiver vessel with 
quality control (QC) appendage, the sterile assurance filter and a 
Medrad 65 mL MR syringe (Bayer, Denmark). On first use of the 
FP, the vial was attached to the outer tube by the use 
 
Fig. 1. (A) SPINlab polarizer. The polarizer operates at 5 T and 0.9 K [16]. The polarizer has four independent channels that allow simultaneous polarization of up to four samples (fluid 
paths). The QC module (cylindrical black unit) is seen to the right of the photo below the touch screen. (B) Fluid Path (FP). Part A: (1) vial, (2) dynamic seal, (3) co-axial tube, (4) 
valve, (5) dissolution syringe. Part B: (6) transfer tube, (7) EPA filter, (8) receiver vessel, (9) QC appendage, (10) sterile assurance filter, (11) Medrad 65 mL MR syringe. Part A loads 
into the polarizer (behind the sliding door). The vial is inserted into one of the four airlock and the dissolution syringe is inserted into the corresponding heater-pressure module. After 
some pump-flush cycles, the airlock gate-valve will open and the vial can be pushed through the dynamic seal to the 0.9 K sample space. Part B is initially loaded into the corresponding 
warmer module seen to the lower right in (A). Shortly before dissolution part B is moved from the warmer to the QC module.  
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Fig. 2. (A) PEEK tube (a), sleeve (b), adapter (c), ferrule (e) and screw (f) assembled to result in the filling tube used for filling of the FP. (B) Filling tube placed in correct position in 
a demonstrational set-up (C) section of a vial with sample; (1) outer lumen, (2) inner tube, (3) nozzle, (4) sample (pyruvic acid). 
 
of UV adhesive (Dymax 1161-M). On reuse, the FP part A was 
cleaned with 40 mL washing buffer (10% NM in distilled water), 
and then twice with 40 mL distilled water. Initially, the FP was 
thoroughly examined for any potential defects or irregularities. The 
FP was placed on a pressure check fixture and briefly flushed with 
Helium gas to secure unhindered flow. Reused FPs containing 
visible moisture were flushed for 10 min, or until dry, with 
compressed air or helium gas. Part B is not reused since it contains 
a small amount of HPTS (8-hydroxypyrene-1,3,6-trisulfonic acid, 
trisodium salt) dye used for the optical pH determination. 
2.6 Filling tube for sample addition 
For adding the sample, a syringe with a filling tube (Mikrolab 
Aarhus A/S, PEEK O.D. 1/32”  I.D. 0.5 mm, 1.5 m, VI 
JRT5620M3) attached through an adapter, a ferrule and a screw 
(Tefzel P628, Tefzel P200 and Tefzel P215, Mikrolab Aarhus A/S, 
Denmark) were used. To fit into the adapter, a sleeve (Sealtight, 840 
lm, F247, Mikrolab Aarhus A/S, Denmark) was glued (UV 
adhesive) onto the filling tube, Fig. 2. The end of the tube was cut 
in a slanted manner in order to pass the nozzle and minimize 
residual sample at the end of the tube. Before first use of the filling 
tube, it was inserted through the dissolution syringe valve bore and 
through the inner tube, all the way to the sample vial. When the tube 
reached the bottom of the empty vial, it was retracted such that the 
end of the tube just passed the nozzle of the inner tube (Fig. 2B). 
Thus no sample would contaminate the inner tube upon addition. A 
mark was put on the filling tube by the dissolution syringe valve 
bore, so the correct position would be easily found upon next use. 
 
2.7 Addition of sample, DM and NM 
2.7.1 Addition of large samples 
Approx 0.5 mL of sample was pulled into a 3 mL single use plastic 
syringe (carefully avoiding air bubbles) after which the filling tube was 
attached. The sample was then pushed through the filling tube in order 
to fill the dead volume (approx. 380 µL). An Eppendorf tube with 
sample was placed on the balance, tared, and sample (1.47 g) was 
drawn into the syringe. Air (few centimeters) was then drawn into the 
tube to prevent contamination of the FP inner wall. The syringe and 
filling tube were weighted before and after addition, to confirm correct 
addition of sample. The surface of the filling tube was thoroughly 
cleaned for potential impurities and inserted through the inner tube of 
the FP until the tube reached the bottom of the vial. The slanted tip 
made it possible for the filling tube to pass the nozzle of the inner tube. 
The filling tube was then retracted to the correct position, as indicated 
by the mark. The sample was carefully added by push of the syringe 
piston. After addition, air was drawn into the filling tube, and it could 
then be retracted from the FP without contaminating the inner tube. 
38.0 g of DM was added to the dissolution syringe. The outlet of 
the syringe was plugged and the syringe put on the filling stand purge. 
The sample vial was carefully submerged into liquid nitrogen (vertical 
position to avoid splashing) and allowed to freeze (2 min). The FP was 
then flushed with helium for 2 min after which the system was pressure 
tested (40 psi for 2 min without losing pressure). When the FP tests 
were completed, the valve rotor was inserted and put into the closed 
position. The dissolution syringe was then connected to a part B, Fig. 
1. Ca. 15.0 g of NM and 26.2 g of DM were added to the receiver of 
part B, a Medrad power injector syringe was attached and the FP and  
receiver were ready to be inserted into the polarizer and QC module, 
respectively. 
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2.7.2. Addition of small samples 
The filling tube was cleaned, dried and attached to a 1 mL syringe. 
Sample (40 µL) was placed in an Eppendorf tube, and drawn into the 
filling tube as a bolus, followed by ca. 10 cm air (Supplementary data 
Video 1). The filling tube was carefully inserted into the FP and pushed 
to the bottom of the vial. It was then retracted 0.5 cm. The syringe was 
removed, and helium was flushed through the filling tube (10 psi, 2 
min) (Supplementary data Video 2). The filling tube was then removed 
from the FP. 13.3 g of DM and 138 µL NM were then added to the 
dissolution syringe. The FP was pressure tested as described for large 
samples. A short exit tube was attached (50 cm) and the FP was ready 
for being inserted into the polarizer. An empty 50 mL Falcon tube was 
used as a receiver for small samples. 
2.8. SPINlab QC (online measurements; large sample only) 
The QC module measures six parameters by methods that are non-
contact with the product. The syringe valve is open for 10 s during the 
dissolution. The dissolution takes approx. 6 s. 5 s after the syringe valve 
closes, a part of the hyperpolarized sample is allowed to flow through 
a series of cavities by opening a valve in the bottom of the receiver. 
The QC parameters are measured in approx. 15 s, which means that the 
product (in the Medrad syringe) is released approx. 30 s after the 
dissolution is initiated. Pyruvate concentration is determined by 
absorbance at 360 nm, EPA concentration is determined by absorbance 
at 470 nm, pH is determined by ratio metric absorbance at 405 and 450 
nm for a hydroxypyrene-1,3,6-trisulfonic acid (HPTS) dye in one of 
the cavities, polarization is measured by NMR and corrected for 
relaxation, temperature is measured by IR on the receiver and volume 
is a capacitance threshold sensor on the Medrad syringe. The QC 
module was calibrated prior to the experiments. Pyruvate 
concentration, EPA concentration and pH all required measurement of 
a dark, blank and several calibrants (GE Healthcare, USA) according 
to manufacturer’s instructions. Polarization and flip angle calibration 
were performed by the use of a 13C reference sample (13C3glycerol 
doped to shorten T1, QC daily check sample, GE Healthcare, USA) 
according to manufacturer’s instructions. Temperature was calibrated 
by the use of a receiver filled with water of known temperature. 
2.9. Offline measurements 
pH: LAQUA pH/ION meter F-72 (HORIBA) with pH electrode DJ 
113662-1385 (VWR) or Knick Portamess pH-meter 913 with pH 
electrode Hamilton mini electrode (KLC). Polarization: measured on a 
400 MHz NMR (Agilent Technologies, USA). Acquisition parameters: 
3 flip angle every 2 s, starting approx. 10 s post dissolution. The 
thermal signal was acquired by adding Omniscan (15 lL) to reduce T1 
to <1 s. 2000 averages with repetition delay 0.5 s, 3 flip angle. Software 
for analysis: MestReNova 10.0 and MATLAB R2015a, by which 
polarization and T1 were calculated. PA concentration: For large 
samples the concentration was measured by quantitative NMR. 
Sample: sample from receiver (450 µL), [13C]urea (15 µL, 400 mM), 
D2O (100 µL) and Omniscan (15 µL). Acquisition parameters: 90 flip 
angle, repetition delay 1.5 s. Software for analysis: TopSpin 3.2. For 
small samples the concentration was measured by absorbance on a 
BioTek EPOCH 2 microplate reader (Holm & Halby, Brøndby, 
Denmark) at wavelength 360 nm. Temperature was measured by the 
use of thermometers of type OMEGA HH804U Thermometer or Testo 
110, AG Germany. EPA concentration: measured by absorbance at 465 
nm (EPOCH plate reader with 10 mm cell). Output volumes were 
measured by weighing 
an empty Falcon tube before and after dissolution (Discovery Ohaus 
balance). 
3. Results 
3.1. Large samples 
Eleven experiments were performed using four FP. The samples 
were polarized for 2.5 h on average to more than 90% of maximum 
polarization, followed by dissolution. The data from the QC module 
have been compared to offline measurements of the respective 
samples, Table 1. To secure a physiological acceptable pH, the NM 
in the receiver was adjusted accordingly to the amount of PA added 
(PA/NaOH ratio 1.6), which was in the range of 13.9– 14.6 g. The 
target concentration in the case of large samples was 250 mM, 
which mimics a human dose. 
3.2. Small samples 
To demonstrate filling of small samples, seven experiments 
were performed, Table 2, using the same four FP as in the large 
sample study. The experiments were designed to mimic a target 
concentration, suitable for small animal dose (80 mM). Polarization 
measurements were made for four of these. 
4. Discussion 
The study shows that the new filling method of the FP can be 
performed in a reproducible manner, validated by QC parameters 
from the SPINlab and offline measurements. The method is robust 
with small relative standard deviations. We have demonstrated two 
extreme conditions; filling of large samples mimicking a human 
clinical dose, and small samples suited for small animal studies. 
For the human dose, base is added to the receiver, in order for the 
radical to precipitate and be filtered off before entering the receiver.  
 
Table 1  
Results from dissolutions compared to the respective off-line measurements (n =11) 
 
*The NMR flip angle was incorrectly calibrated in the first experiments leading to 
saturation of the receiver and incorrect estimation of the polarization. 
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 Average Standard 
deviation 
Relative STD 
(%) 
PA/EPA added (g) 1.47 0.02 1.4 
DM in syringe (g) 38.0 0.1  
DM in receiver (g) 25.8 0.3 1.0 
NM in receiver (g) 14.3 0.2 1.4 
PA/NaOH mol ratio 1.6 0.002 0.1 
Online results 
Pyruvate conc. (mM) 
246 19 7.7 
pH 7.71 0.17 2.2 
EPA conc. (µM) 1.17 0.28 24 
Temperature (C) 32.0 1.3 4.0 
Volume (mL) >40 mL   
Polarization (%) 34.2 2.9 (n = 3)* 8.5 
Offline results 
Pyruvate conc. (mM) 
247 
 
8.3 
pH 7.75 0.15 1.9 
EPA conc. (µM) 0.68 0.21 31 
Volume (mL) (product in Medrad 
syringe) 
44.2 1.0 2.3 
Temperature (C) 31.7 0.5 1.6 
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Table 2 
Results from dissolutions with small sample filling (n = 7). 
 Average Standard deviation Relative STD (%) 
PA/EPA added (mg)a 40   
DM in syringe (g) 13.4 0.2 1.6 
NaOH (10 M) syringe (g) 0.138   
Pyruvate conc. (mM) 70 7.4 11 
pH 7.8 0.1 2 
EPA conc. (µM) 70.5 7.5 11 
Product in receiver (g) 5.3 0.6 12 
Temperature (C) 54 2.6 5 
Polarization (%) 43.7 5.5 (n = 4) 13 
T1 53.8 2.0 (n = 4) 4 
Recovery (%) 82 12 15 
a 40 mg was assumed to be added with no loss under the addition process. 
The acceptance criterion for residual EPA in the product is less than 3 
µM [18]. The measured value is 1.2 ± 0.3 µM, well within 
specification, and demonstrating >99% removal. The mean value of 
the EPA concentration is five standard deviations below the acceptance 
criterion. The pyruvate concentration acceptance criteria are 220–280 
mM [18], which is also achieved with three standard deviations 
margin. The acceptance criteria for pH are 6.7–8.2 [18]. The study was 
not perfectly centered in the range, which could be achieved by 
changing the volume of NM in the receiver. However, the range is 
about ten standard deviations in this study. pH is a critical safety 
parameter, demonstrating that filling and process performed very well 
and is robust. Since only approx. 44 mL are transferred to the Medrad 
syringe, recovery has been disregarded in the large sample case, since 
some of the sample is used in the QC and thereby trapped in the dead 
volume of the system. However, the volume transferred to the Medrad 
syringe is four standard deviations above the acceptance criterion. The 
FP’s have been reused for demonstrational purposes and are not sterile, 
but we believe the approach could be translated into a low bioburden 
version by appropriate cleaning of the FP before filling. Sterility 
assurance can then be achieved by a validated, in-line sterile filter. The 
filling procedure should be compatible with normal pharmacy clean 
room environments. 
For small samples, base is added to the dissolution syringe, which 
means that all the PA and EPA is transferred to the receiver upon 
dissolution, and recovery can thereby be estimated. Recovery is 
calculated from the product of pyruvate concentration and volume, and 
assume that the full 40 mg was deposited in the sample vial. Most of 
the 15–20% loss of sample is likely due to loss in the filling process. 
The pyruvate concentration in the receiver is highly linked to the 
performance of the fluid path, since the dead volume vary. The 
variability of 11% for the pyruvate concentration is acceptable for most 
animal studies. We have not systematically studied the minimal 
possible sample amount that can be deposited in the vial by our 
method, but we have tested volumes down to 10 mg. This could have 
significance for e.g. cell or perfused organ studies that only require 
dilute substrate concentrations. More important is the minimal volume 
that can be applied in the dissolution. We believe that the product 
volume of app 5 mL achieved in this study, is close to the minimum 
volume that can be reached without loss of polarization and reduced 
recovery. This is close to the same performance as e.g. the Hypersense 
optimized for small sample polarization. It would be reasonable to 
expect that the use of two-phase dissolution could reduce the effective 
dissolution volume even further as previously demonstrated [19]. 
The lower temperature of the solvent in the dissolution allows the 
use of all plastic components. Plastic components eliminates leaching 
of paramagnetic ions from e.g. stainless steel components and potential 
enhanced relaxation from these ions. The polyphenylsulfone that is 
used in the fluid path is a plastic with high toughness and impact 
strength, good long-term hydrolytic stability and chemical resistance. 
It withstands steam sterilization without any significant loss of 
properties. For other solvents than water, the chemical resistance at the 
given temperature and pressure conditions needs to be taken into 
consideration and tested. 
The SPINlab corrects the polarization to the start of dissolution by 
assuming a T1 of 65 s. This means that the measured polarization is 
corrected by a factor of approx. 1.5 in this study. The polarization for 
low dose is the actual measurement without any correction. However, 
the delay is only approx. 10 s from start of dissolution to measurement. 
The difference in polarization for the two situations is partly due to the 
higher magnetic field strength of the prototype polarizer (6.7 T vs 5.0 
T), but also that some polarization loss is known to occur in the QC 
system. 
The reusability of the FP’s means reduced cost for research 
purposes, and no failed FP were observed within the ten times reuse 
that we arbitrarily defined as the maximum number of reuses on the 
SPINlab. The filling method has been tested extensively (>100 
dissolutions) at Aarhus University Hospital, Skejby on the SPINlab, 
without failure of the fluid path during dissolution that have led to 
contamination of the polarizer. Failure in dissolution can happen due 
to e.g. moisture in the tubing that lead to blockage and prevention of 
flow. This happens at a low rate depending on operator skills. In our 
laboratory we use the fluid paths until failure since contamination of 
the polarizer is easier to clean. However, most failures occur during 
handling as fatigue of glue joints, typically after 20–50 uses. Wear and 
tear can also lead to failure in the pressure test and discard of the fluid 
path. More rarely the FP fails early in use due to defects in the plastic. 
The failures due to defects in the plastic appear to be unrelated to the 
filling method, but can lead to a burst inside the polarizer during 
dissolution depending on location of the defect. With the hundreds of 
dissolutions that we have performed with this method, there does not 
seem to be a higher frequency of fatal incidents than by single use. 
5. Conclusion 
The principle of the fluid path for dissolution-DNP enables 
independent control of solvent temperature and flow rate. The benefit 
is efficient dissolution at lower solvent temperature and use of all 
plastic components. The reproducibility of the dissolution process is 
high on all parameters relevant for clinical use. The fluid path can be 
used for any sample size from 10 µL to 1.1 mL, and produces a 
minimum product volume of approx. 5 mL up to the full volume of 44 
mL for a patient. 
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Abstract 
We demonstrate a method for the preparation of hyperpolarized water by dissolution Dynamic 
Nuclear Polarization at high magnetic field. Protons were polarized at 6.7 T and 1.1 K to >70% with 
frequency modulated microwave irradiation at 188 GHz. 97.2 ± 0.7% of the radical was extracted 
from the sample in the dissolution in a two-phase system. 16 ± 1 mL of 5.0 M 1H in D2O with a 
polarization of 13.0 ± 0.9% in the liquid state was obtained, corresponding to an enhancement 
factor of 4,000 ± 300 compared to the thermal equilibrium at 9.4 T and 293 K. A longitudinal 
relaxation time constant of 16 ± 1 s was measured.  
The sample was polarized and dissolved in a fluid path compatible with clinical polarizers. The 
volume of hyperpolarized water produced by this method enables angiography and perfusion 
measurements in large animals, as well as NMR experiments for studies of e.g. proton exchange 
and polarization transfer to other nuclei. 
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Graphical Abstract 
 
 
 
 
 
 
 
Highlights: 
 16 mL of 5.0 M 1H in D2O is hyperpolarized to 13% with a T1 of 16 s. 
 Solid state polarization of 71.5% at 6.7 T with a time constant of 23 min using dynamic 
nuclear polarization with frequency modulation. 
 Dissolution in a two-phase system of D2O and organic solvents yields rapid radical 
extraction of 97.2% ± 0.7%.  
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Introduction 
NMR is an important analytical tool for e.g. structure analysis, chemical quantification, and investigation of 
biochemical pathways. Similarly, MRI is a valuable and safe diagnostic tool in medical applications. However, 
both techniques share a key weakness – poor sensitivity caused by low polarization of nuclear spins. 
Through the use of hyperpolarization, the signal can be enhanced by several orders of magnitude; leading 
directly to an increase in sensitivity. This increase in signal obviates the need for time-consuming signal 
averaging, permitting real-time experiments with unprecedented time resolution. An especially promising 
application of this capability is the study of chemical and biochemical reactions both in vitro and in vivo.  
The field of dissolution-Dynamic Nuclear Polarization (d-DNP) has developed rapidly since the first 
demonstration in 2003 [1]. The main focus has been on hyperpolarization of 13C nuclei for metabolic 
imaging, where preclinical studies of hyperpolarized 13C labelled pyruvic acid was injected for 
characterization of cancer [2–4] or other metabolic diseases in animal models [5,6]. Hyperpolarization has 
also been used for angiographic and perfusion imaging [7–9] with agents that are not metabolically active. 
Concurrently, hyperpolarized 13C has been applied for signal enhancement in NMR experiments, such as 
kinetic studies of metabolism [10–12] or structure analysis of biochemical compounds [13,14]. 
In recent years, the interest in hyperpolarization of protons diluted in heavy water has increased [15,16]. 
Due to the high gyromagnetic ratio of the proton and the high proton concentration in water, the 
achievable magnetization may exceed what is possible with hyperpolarized 13C or other nuclei. 
Furthermore, hyperpolarized proton imaging is facilitated by already existing MRI coils and sequences, in 
contrast to hyperpolarized 13C that requires non-standard equipment.  In one approach, water, polarized by 
the Overhauser effect at 0.35 T, was applied for MRI [17,18]. However, the Overhauser effect typically 
achieves an enhancement of 100 times at 0.35 T for pure water, corresponding to a polarization of only 
0.001%. Secondly, the short T1 of pure water, 3.6 s, limits the available time window significantly. Both of 
these limitations can be overcome by d-DNP. A 3.35 T HyperSense polarizer was used to produce 
angiographic images in the rat venous system and head with 1H polarization of 3.5% and 1H concentration of 
3.9 M [19], and hyperpolarized water has been used for signal enhancement in NMR experiments [20,21]. 
Hyperpolarized protons have been applied to enhance the inherent low sensitivity of larger biomolecules, 
and proton exchange has facilitated increased sensitivity leading to large reduction in scan time [22], or to 
accommodate studies of protein-ligand interactions for drug discovery [23].  Polarization, dissolution and 
radical extraction for water/DMSO-d6 samples was shown to give polarization of approximately 25% and T1 
> 40 s [24]. 6% proton polarization and T1 of >36 s has been demonstrated by attaching nitroxide radicals to 
polymer-based backbones that could be filtered out at dissolution [25].  
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In this work we study the hyperpolarization of 1H in D2O with d-DNP at 6.7 T and 1.2 K using the fluid path of 
[26]. The aim of the study was to investigate the polarization and dissolution at these experimental 
conditions. 
Theory 
DNP relies on the presence of electron spins, from which polarization is transferred to nuclear spins by 
microwave (MW) irradiation. An increase in performance has recently been demonstrated when the MW 
field is frequency modulated [27,28]. The unpaired electron spins are typically added to the system in the 
form of stable organic radicals such as nitroxides or trityls. Paramagnetic species, such as radicals, efficiently 
promote nuclear spin relaxation, yet they are a key requirement in the DNP process. A key challenge in 
dissolution-DNP is supplying sufficient paramagnetic agent to perform DNP, without negatively influencing 
the relaxation properties of the sample after dissolution. This trade-off is more pronounced due to the high 
gyromagnetic ratio of 1H that renders it more susceptible to paramagnetic relaxation. Hence, the radical 
should be segregated from the nuclei upon serving its purpose.  
Nitroxides are well suited for DNP of protons due to their broad electron paramagnetic resonance (EPR) 
lines [29].  With a reported relaxation rate contribution of 0.55 s-1 mM-1 at 25 °C in low field [30], the 
dissolved sample would lose the enhanced polarization in a few seconds with the radical present. Thus, 
radical extraction is a crucial element for achieving long T1 and, ultimately, high polarization after the 
dissolution and transfer process. Small animal angiography with hyperpolarized water has been 
demonstrated in a 3.35 T polarizer [19], where the radical induced relaxation was eliminated by scavenging 
with ascorbic acid, as demonstrated earlier in [31]. However, the ascorbic acid needs to be hundreds of mM 
to quench the radical effectively, and the quenching process takes a significant amount of time, during 
which relaxation occurs. Furthermore, the ascorbic acid undergoes thermal degradation that leads to 
browning during the solvent heating process, complicating the process further. Hence, we describe a system 
where the nonpolar nitroxide radical is rapidly extracted into an organic phase immediately after 
dissolution, as previously demonstrated in [32]. 
In addition, the T1 is sensitive to the proton concentration. A high proton concentration will enhance the 
final magnetization, but will concurrently increase the dipolar relaxation between proton nuclei, and thus 
cause faster relaxation. A proton concentration of 5.0 M is determined to achieve a high signal in the 
injectable sample, giving rise to a relaxation rate contribution of less than 0.04 s-1 at 21.5 °C [33]. A final 
relaxation contributor is the temperature, where a warmer sample will have higher proton diffusivity, and 
thus retain polarization longer, within the relevant temperature range [34]. 
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Rapid dissolution and radical extraction are crucial for maintaining a high solution state polarization. We 
accelerate the dissolution by addition of Nonafluorobutyl methyl ether (NFBME) with boiling point of 60 °C 
and density ρ = 1.529 g/mL to the dissolution medium syringe. The low boiling point results in a high 
pressure to drive the flow in the fluid path, and the density ensures that the sample will be dissolved and 
diluted in D2O rapidly, and that the denser NFBME will follow, due to the vertically aligned, upwards facing 
syringe. Another feature of addition of an immiscible solvent in the dissolution medium syringe is reduction 
of variation in the volume reaching the sample, because all dissolution medium is flushed out of the tubes, 
while the dead volume consists of the organic solvent only.  
The oxygen in the system originating from air in the fluid path and dissolved in the solvents contributes to 
the relaxation rate with 0.0094 L/mg/s [35]. The concentration of dissolved oxygen in air saturated water at 
25 °C is around 8.6 mg/L, which leads to a relaxation rate contribution of 0.081 s-1. The corresponding 
oxygen concentrations in heptane and NFBME, are a factor of 10 and 20 higher, respectively [36,37]. The 
system thus requires degassing of the solvents, as well as flushing of the entire fluid path and receiver 
system with inert gas. 
Radiation damping: The precession of the transverse magnetization of the protons after excitation induces a 
current in the NMR coil that contributes to restoring the magnetization to the longitudinal direction. 
Considering the large magnetization of hyperpolarized water protons, this mechanism will have a significant 
effect on the transverse relaxation rate. In addition to the magnetization, the contribution to the reduced 
time constant of the free-induction-decay (FID) is affected by parameters such as the Q-factor and the filling 
factor of the coil [38], or it can be treated by the reciprocity principle [39]. The observable transverse 
relaxation time 𝑇2
𝑜𝑏𝑠 is given by 
1
𝑇2
𝑜𝑏𝑠 =
1
𝑇2
∗ +
1
𝜏𝑅𝐷
, where 𝑇2
∗ is the time constant of the FID in the absence of 
radiation damping (typically due to field inhomogeneity) and τRD is the radiation damping time constant. We 
show that the radiation time constant, τRD, can be used as a measure of polarization, with a series of 
concentration dependent, thermally polarized radiation damping time constants as reference. The method 
complements quantification of polarization by comparison of integrals for spectra that are hyperpolarized 
and at thermal equilibrium.  
Methods 
DNP: All experiments were performed using a homebuilt DNP polarizer (6.7 T magnet from Magnex, Oxford, 
UK) with a flow-type variable temperature insert. The DNP probe was conceptually based on the idea 
introduced in 2003 [1]. Microwaves were provided by a microwave source VCOM-10/94-WPT (ELVA-1, St. 
Petersburg, Russia) and a 200X2R4 frequency doubler (VDI, Charlottesville, VA, USA), which provided an 
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output power of 55 mW at 188 GHz. The source had a tuning range of ±0.6 GHz. The output power after 
transmission through the 800 mm circular waveguide and the microwave window [40] was measured to 5 ± 
1 mW using a horn and an Ericsson power meter (VDI, Charlottesville, VA, USA). Solid state NMR was 
performed with a saddle coil formed around a polytetrafluoroethylene (PTFE) former connected to a 
nonmagnetic coaxial cable (type Stainless Steel 304/Beryllium Copper, SCB Service and Consulting, Neuss, 
Germany) and a tune and match box. NMR measurements were performed with a Varian INOVA console 
(Palo Alto, CA, USA). The polarizer was fitted with a heater-pressure module, airlock and insertion module 
to allow use of the fluid path (both described in [26]). The microwave frequency was sinusoidally swept with 
a rate of fmod and amplitude amod. The samples were polarized for 60 min. 
Solid state NMR: The build-up of polarization was monitored by acquisition of NMR spectra every 120 s 
from initiation of MW irradiation. A pulse of 1 µs at 2.7 W corresponding to a flip angle of approximately 
0.3° was used for excitation, and 1024 complex points with a spectral width of 5 MHz were acquired. Short 
MW frequency sweeps were measured with the same parameters, except only with 60 s between each MW 
frequency step and increased receiver gain. The magnetization was saturated before each MW frequency 
step by a train of 3000 pulses of 30° flip angle. Long MW frequency sweeps were monitored for one hour at 
each MW frequency. The NMR signal was destroyed by a train of saturating pulses before each build-up 
(MW frequency), and then measured every 120 s. Similar for long MW power sweeps. The build-up curve 
for each MW frequency or power setting was fitted to a mono-exponential function to obtain asymptotic 
value and time constant. Polarization was quantified by allowing a 30 mM water/glycerol sample to polarize 
towards thermal equilibrium in the magnetic field at 1.12 K over 19 h, and fitting of the build-up curve of 
spectra acquired every 300 s. The background signal from the DNP probe was measured with an empty 
sample cup and subtracted from the data to determine the thermal signal from the sample. 100 kHz 
exponential line broadening was applied to the data, which were analyzed in MATLAB (Mathworks, Natick, 
MA, USA). 
Sample preparation: Solutions of 20 and 30 mM TEMPO (2,2,6,6-Tetramethylpiperidine 1-oxyl, 98%, Sigma 
Aldrich, Denmark) in H2O/glycerol (both Sigma Aldrich, Denmark) 1:1 (w/w), and 30 mM TEMPO in 
H2O/DMSO-d6 (Dimethyl sulfoxide-d6, Sigma Aldrich, Denmark) 1:1 (w/w), was prepared. Dissolution 
medium consisted of D2O (99.90%, Euriso-top, Saint-Aubin, France) with 1 mM calcium disodium 
ethylenediaminetetraacetic acid (EDTA) and 9 g/L NaCl. Sodium chloride was added to provide an isotonic 
solution. 
Fluid path filling: The fluid path consists of a syringe, two concentric tubes leading to a sample vial and an 
exit tube. The dissolution medium is heated in the syringe, and transferred via the inner tube to the sample 
   93 
 
vial for dissolution of the sample, before being flushed back to the syringe via the outer lumen and a three-
way valve. The exit tube leads the dissolved sample from the syringe valve to a receiver.  
The 1100 mg (~1 mL) sample was injected into the sample vial by the large sample filling method introduced 
in [41]. This procedure resulted in actual sample mass of 1099.8 ±12.6 mg (N = 5). 7.6 g (5 mL) NFBME 
(≥99%, Sigma Aldrich, Denmark) and 17.72 g (16 mL) dissolution medium was filled in the syringe and 
degassed by bubbling with helium gas for 10 minutes by inserting a tube through an adapter that led the 
moist gas away from the fluid path openings. In experiments without NFBME, another 12 mL of dissolution 
medium was added. The fluid path syringe was closed off before freezing the sample vial in liquid nitrogen 
for 2 minutes to avoid cryo pumping of moisture into the fluid path. Samples to be degassed were exposed 
to vacuum and sealed off before melting and sonicating the sample vial. The sample was frozen again; the 
cycle was repeated three times (freeze-pump-thaw). After freezing, the fluid path was flushed with helium 
gas for 2 minutes to remove air and provide a helium atmosphere. The sample vial was rapidly transferred 
from the liquid nitrogen bath to the polarizer.  
Dissolution: The syringe was inserted into a heater/pressure module, where the dissolution medium and 
NFBME were heated to a temperature of 130 °C over 30 min at 2.75 bar. The sample was raised 140 mm out 
of the helium bath before the dissolution medium syringe three-way valve was switched, releasing the 
piston in the syringe driven with 16 bar pressure. The 50 cm outlet tube was inserted into a closed 150 mL 
separatory funnel containing 25 mL degassed heptane (≥99%, Sigma Aldrich, Denmark), which was shaken 
vigorously during dissolution and a further 10 s. The aqueous phase was drawn into a syringe, and 1.5 mL 
was rapidly injected into an injection line entering a 5 mm NMR tube situated in the NMR spectrometer, 
which had been flushed with helium gas and sealed before the experiment. The dead volume of the 
injection line was 0.6 mL. Temperature was measured with an RTD thermometer (OMEGA HH804U, 
Stamford, CT, USA) within 30 s from dissolution. 
Liquid state NMR: NMR measurements of the dissolved sample were performed on a 400 MHz 
spectrometer (Agilent, Palo Alto, CA). A series of 200 spectra were acquired at 1 s intervals with 31200 
points, sweep width of 50 kHz and a 1° flip angle of pulse length 1 µs at approximately 0.4 W. The integral 
was measured as the first point in the FID, and the decay was fitted to estimate the radiation damping time 
constant. A spectrum of the fully relaxed sample with identical acquisition parameters was measured to 
quantify the enhancement factor, and thus polarization. The longitudinal relaxation time constant, T1, was 
obtained from the decay of the hyperpolarized signal. The T1 for the same sample was subsequently 
confirmed by measuring the NMR signal build-up at 9.4 T when quickly inserting the nonpolarized (earth 
field) sample. from the build-up of the magnetization after relaxation outside the magnet. Quantitative 
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NMR measurements were performed to determine the final proton concentration in the dissolved sample. 
0.2 M potassium formate in D2O was added for reference. With the probe used, this concentration did not 
significantly change the 90° flip angle. Data were analyzed using VnmrJ (Agilent Technologies, Palo Alto, CA, 
USA) and MATLAB (Mathworks, Natick, MA, USA).  
Radiation damping in thermal experiments: Solutions of equally distributed water/D2O volume ratios from 
10% to 100%, corresponding to 11.08 M to 110.82 M, were prepared. A series of 10 NMR experiments with 
parameters identical to those of the hyperpolarized experiments was measured, and the linewidth was 
determined.  
Optical absorbance measurements: The final concentration of TEMPO radical was determined by optical 
absorbance measurements with an Ocean Optics DH-2000 Deuterium-Halogen light source and an Ocean 
Optics USB2000+UV-VIS spectrometer in quartz cuvettes of 10 mm path length. The absorbance at λ = 240 
nm was compared to a reference curve of TEMPO in water at 125, 250, 375 and 500 µM.  
Clinical polarizer compatibility: Organic solvents tend to weaken the fluid path syringe when heated for 
longer periods, as when inserted in clinical polarizers. To avoid syringe damage during these experiments, 
the protocol was modified by leaving out the NFBME. Additional dissolution medium was added to a total 
volume of 28.0 mL. Experiments were performed on a 5 T SPINlab (GE Healthcare, Brøndby, Denmark). 
Results 
 
Figure 1: Build-up of the 1H NMR signal to thermal equilibrium for a 30 mM TEMPO in water/glycerol 1:1 
(w/w) sample at 6.7 T after subtraction of background signal. The T1 was 583 min. 
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The solid state polarization from an 1100 mg 30 mM TEMPO in H2O/glycerol 1:1 (w/w) sample was 
measured (Figure 1), and showed a T1 of 583 ± 62 min. The asymptotic value corresponds to a thermal 
polarization of 0.61%, and was used for quantification of the DNP enhanced polarization. 
Short MW frequency sweeps for three different samples are shown in Figure 2. The polarization of the 30 
mM TEMPO in water/glycerol 1:1 (w/w) sample in Figure 2a increases by 30% at the optimal MW frequency 
and modulation amplitude of 50 MHz. The maximum of the DNP profile left shifts for increasing modulation 
amplitude, as the MW frequencies giving rise to negative polarization are irradiated. A similar picture is 
seen for a 20 mM sample (Figure 2b). However, the lower concentration appears to benefit from larger 
modulation amplitudes. This trend is even more pronounced for samples using DMSO-d6 as glassing agent, 
Figure 2c. An increase in polarization at optimum MW frequency is observed up to amod of 125 MHz. The 
effect of frequency modulation is more pronounced for this sample. Without modulation, the DNP 
enhancement is significantly lower. 
 
Figure 2: Short MW frequency sweeps. a) 30 mM TEMPO in water/glycerol 1:1 (w/w) with no frequency 
modulation (○) and modulation amplitude of 25 MHz (+), 50 MHz (*) and 75 MHz (x). b) 20 mM TEMPO in 
water/glycerol 1:1 (w/w) with modulation amplitude of 25 MHz (+), 50 MHz (*) and 75 MHz (x). c) 30 mM 
TEMPO in water/DMSO-d6 1:1 (w/w) with no frequency modulation (○) and modulation amplitude of 25 MHz 
(+), 50 MHz (*), 75 MHz (x), 100 MHz (□), 125 MHz (◊), 150 MHz (Δ) and 200 MHz (▽). Modulation 
frequency fmod = 1 kHz.  
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Figure 3: Long MW frequency sweep without modulation. Final polarization (○) and DNP time constant (□) of 
build up for 30 mM TEMPO in water/glycerol 1:1 (w/w) sample. 
A long MW frequency sweep without frequency modulation is shown in Figure 3, for the 30 mM TEMPO in 
glycerol/water 1:1 (w/w) sample. The polarization resembles the short build-ups of Figure 2a. However, the 
optima are shifted towards the center in short sweeps due to the faster build up in the central region (τDNP 
curve).  
 
Figure 4: DNP power sweep of 20 mM TEMPO in water/glycerol 1:1 (w/w) for microwave power 5 to 55 mW 
at 188.06 GHz with modulation amplitude 50 MHz and frequency 1 kHz. Polarization after 1 hr DNP (Δ), 
asymptotical max polarization (○) with linear fit and DNP time constant estimated from a fit of 60 min 
polarization (□, build up at 5 mW was too slow to estimate time constant) with fit of inverse square root. 
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A long power sweep is shown in Figure 4. The asymptotical maximum polarization is reached for 30 mW 
power. The DNP polarization after 1 hr increases linearly with the available MW power and the DNP build-
up time constant decreases with MW power with a square-root of power dependence. The linear relation 
between MW power and polarization is valid over the entire DNP spectrum, Figure 5, i.e. the data confirms 
that build-up rate constant is independent of MW frequency. 
 
Figure 5: Short MW frequency sweep for 20 mM TEMPO in water/glycerol 1:1 (w/w) at 60 mW (□) and 30 
mW MW power (○). 60 s MW irradiation with frequency modulation of amod = 50 MHz and fmod = 1 kHz was 
applied. The data confirms that build-up rate constant is independent of MW frequency. 
The build-up curves of several sample compositions have been measured to study the radical concentration, 
removal of dissolved oxygen and glassing matrix. The build-up time constants and polarizations after 60 min 
DNP are presented in Table 1. 
Experiment  N P (1 hr) [%] DNP time const. 
20 mM TEMPO in water/glycerol at 188.12 ± 0.05 GHz 6 48.1 ± 4.9 37 ± 5 min 
30 mM TEMPO in water/glycerol at 188.12 ± 0.05 GHz 4 63.1 ± 3.7 24 ± 4 min 
Degassed 30 mM TEMPO in water/glycerol at 188.06 ± 0.05 GHz 5 71.5 ± 4.5 23 ± 2 min 
Degassed 30 mM TEMPO in water/DMSO-d6 at 188.06 ± 0.05 GHz 3 42.8 ± 1.7 41 ± 2 min 
Table 1: DNP results for various sample compositions and polarization parameters.   
The dissolution resulted in 16 ± 1 mL (N = 8) aqueous phase entering the heptane bath, to reach a common 
temperature of 50 ± 2 °C (N = 6). The total time of dissolution, extraction and transferring of sample from 
separatory funnel via syringe and tubing to acquisition in NMR spectrometer was less than 25 s. The first  
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Figure 6: a) Spectrum of hyperpolarized 30 mM TEMPO in water/glycerol 1:1 (w/w) sample after dissolution. 
The small shoulder represents the glycerol protons. 50% linewidth of 1166 Hz. b) Linear regression of 
linewidth of thermal spectra from samples of varying H2O:D2O ratio. 
spectrum is shown in Figure 6a. The water peak has a line width of 1166 Hz due to the radiation damping 
caused by the large magnetization of the sample. The peak of the glycerol aliphatic protons is apparent in 
the spectrum, indicating that these protons are hyperpolarized along with the water protons.  
In this particular experiment, we achieved an enhancement factor of 3,761 at 9.4 T, corresponding to a 
polarization of 12.1%. A signal time series is shown in Figure 7. The estimated T1 after correction for signal 
loss from previous excitations is 17.0 s. The relation between linewidth (full with at half maximum, FWHM) 
due to radiation damping and water concentration was found to be FWHM(cW) = 0.0691 Hz ⋅ cW + 1.92 Hz, 
where cW is the proton concentration in the sample (Figure 6b). Thus, the linewidth of 1,166 Hz corresponds 
to an polarization of 11.7%, when corrected for the 111 M proton concentration in water and the 4.6 M 
proton concentration in the dissolved sample, in close agreement with the time domain integral estimate. 
The thermal signal and T1 was measured by acquiring the NMR signal from the sample as it was introduced 
into the 9.4 T magnet, Figure 7. The  measurement was done 5 min after dissolution when the sample was 
fully relaxated. A consistent T1 of 16.6 s was measured.  
The polarizations and T1’s in the liquid state at 9.4 T for several samples are shown in Table 2. The 30 mM 
TEMPO in water/glycerol 1:1 (w/w) sample showed large fluctuations in the observed polarization, with an 
average of 7.8%. The polarization was significantly lower when the NFBME was omitted, where the standard 
fluid path exit tube set-up yielded polarizations below 3%. However, a significant increase in polarization 
was achieved when the exit tube was reduced from 210 cm to 50 cm – a setup that requires minor 
modifications of a SPINlab. Shortening the exit tube increased the temperature in the dissolved  
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Figure 7: Normalized NMR signal of hyperpolarized water sample (○) (30 mM TEMPO in water/glycerol 1:1 
(w/w)) and build-up of relaxed sample at 9.4 T to validate T1 (□). The initial hyperpolarized signal is 3,761 
times that at thermal equilibrium. The T1 for the hyperpolarized sample was 17.0 s, whereas the build-up to 
thermal equilibrium had a T1 of 16.6 s (sample at room temperature). 
sample with approximately 10 °C, which we believe to be the main reason for the increased polarization. In 
addition, the shorter time from dissolution to extraction may also play a role.   
Larger enhancements were achieved when the 30 mM TEMPO in water/glycerol 1:1 (w/w) sample was 
degassed in the fluid path before polarization, which can be attributed to the increased solid state 
polarization (Table 1). However, the degassing only increased the solid state polarization by 13%, whereas 
the liquid state polarization increased by more than 50%. The amount of oxygen removed from the sample 
has insignificant impact on the liquid state relaxation rate, and no further T1 prolongation was observed.  
The liquid state polarization of the degassed water/DMSO-d6 1:1 (w/w) sample was 7.2%, significantly lower 
than the degassed water/glycerol 1:1 (w/w) sample of 13.0%. The difference is explained by the significantly 
lower solid state polarization of the water/DMSO-d6 sample. 
The method was tested with a sample of half size (550 mg) (30 mM TEMPO in water/glycerol 1:1 (w/w)) 
dissolved in half the volume of dissolution medium (8 mL) and the standard 5 mL NFBME. Polarization of 
12% and T1 of 17.0 s confirm that the method scales to smaller samples. 
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Experiment N Pol. [%] T1 [s] 
20 mM TEMPO in water/glycerol 1:1 (w/w) 5 8.6 ± 1.5 16.1 ± 1 
30 mM TEMPO in water/glycerol 1:1 (w/w)  6 7.8 ± 3.3 17.0 ± 0.9 
Degassed 30 mM TEMPO in water/glycerol 1:1 (w/w) 3 13.0 ± 0.9 15.7 ± 1.2 
Degassed 30 mM TEMPO in water/DMSO-d6 1:1 (w/w) 2 7.2 ± 1.3 18.8 ± 1.6 
30 mM TEMPO in water/glycerol 1:1 (w/w) without NFBME, long exit tube 2 2.4 ± 0.6 19.6 ± 0.8 
30 mM TEMPO in water/glycerol 1:1 (w/w) without NFBME, short exit tube 2 4.8 ± 0.5 20.1 ± 1.3 
SPINlab polarization 4* 5.3 ± 0.9 24.1 ± 1.0 
Table 2: Liquid state polarization and T1 at 9.4 T. *Measured at 3 T, from [42]. 
The partition coefficient of TEMPO in water/heptane, water/NFBME and water/[NFBME/heptane 1:3 (V/V)] 
were similar. The scheme of extraction in the separatory funnel was investigated by a series of dissolutions 
with varying shaking time. An equilibrium was observed for approx. 5 s vigorous shaking, and 10 s shaking 
time was chosen to ensure complete equilibrium in all experiments. With 10 s shaking in 25 mL heptane, we 
observed a final TEMPO concentration of 50 ± 12 µM (30 mM TEMPO in water/glycerol 1:1 (w/w), N = 5) 
and 35 ± 6 µM (20 mM TEMPO in water/glycerol 1:1 (w/w), N = 5), corresponding to relaxation rate 
contributions of R30 mM = 0.028 s-1 and R20 mM = 0.019 s-1, respectively.  
The average final proton concentration in the dissolved glycerol/water 1:1 (w/w) sample was measured to 
5.0 ± 0.5 M (N = 18), compared to the calculated value of 4.6 M. The proton concentration of the 
water/DMSO-d6 sample was not measured, but should be 3.6 M if full recovery is assumed. 
Discussion and Conclusion 
The presented method enables experiments where large quantities of hyperpolarized water protons are 
required, e.g. imaging experiments in large animals. We demonstrate 13% 1H polarization and T1 of 16 s for 
a 16 mL sample with 5 M protons in D2O on a polarizer operating at 6.7 T and 1.2 K. This is enabled by the 
fluid path that accommodates up to 2 mL of sample. The method has been used in a SPINlab (5 T/0.8 K) for 
hyperpolarized water studies in a pig model [42], where dynamic angiography time series and perfusion 
maps were produced. The fluid path is already used in clinical studies [43] and it is reasonable to expect that 
the presented method can be translated into a sterile operation. The safety of the formulation needs to be 
established.  
At maximum power, the DNP time constant was 86 min, whereas the samples were polarized for 60 min. 
Thus, the reported liquid state polarization could have been increased further by a factor two by longer 
polarization time. The polarization after 1 hr showed a linear trend in the available power range (Figure 4), 
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indicating that higher polarization after 1 hr could be realized by increasing the microwave power above 55 
mW through a shortening of the build-up time constant. The build-up time constant follows an inverse 
square-root of microwave power dependence, i.e. is inversely proportional to the microwave B1 field. This is 
the expected dependence of the rate constant for both the solid-effect and thermal mixing [44]. The MW 
power at the entry to the cavity was measured to be approx. 5 mW, but since we do not have details about 
the power distribution within the cavity, all data has been referenced to the source output power.  
The MW frequency modulation increased DNP efficiency for all tested samples. The 20 mM water/glycerol 
1:1 (w/w) sample was tested for modulation amplitude of 25, 50, and 75 MHz, respectively, and 50 MHz 
gave the largest DNP gain. 75 MHz modulation amplitude was the optimal of the three for 30 mM 
water/glycerol 1:1 (w/w) sample, whereas the 30 mM water/DMSO-d6 1:1 (w/w) sample polarized most 
efficiently at 125 MHz. Thus, both sample composition and radical concentration affect the frequency 
modulation performance. The modulation of the MW frequency is beneficial due to the inhomogeneous 
nature of the nitroxide EPR line at high magnetic field that restricts spectral diffusion. The inhomogeneity of 
the EPR line could probably have been overcome by increasing the nitroxide concentration further, but this 
may lead to shortening of T1 in the liquid state and/or further loss in the dissolution. 
Optimal MW frequencies were determined for several sample compositions at 6.7 T. Polarizers at other 
field strengths have other DNP frequency profiles, where optimal frequency modulation parameters are 
shifted. For polarizers without 1H detection, the 13C frequency sweeps can be used for localization of 
optimum EPR frequencies, and applied to protons due to the broad linewidth of the nitroxide radical. This is 
in principle how the SPINlab experiments were performed. 
We have demonstrated that large volumes of hyperpolarized water can be produced with the fluid path 
technology. The 30 mM water/glycerol 1:1 (w/w) sample polarized 30% better than the corresponding 20 
mM sample, whereas the dissolved state polarization was 10% higher for the 20 mM sample. The lower 
radical concentration in the dissolved state is the obvious reason. Degassing of the sample only increased 
the solid state polarization by 13%, but increased liquid state polarization by 51%. This is in good agreement 
with [24] where an approx. 50% increase of the liquid state enhancement is observed after degassing. 
Some liquid state polarization measurements showed large deviations. Only small variance in the solid state 
polarization was observed, which means that the dissolution process, extraction and sample transfer are the 
dominating sources of variability. The manual extraction process, where a funnel was shaken by hand, is 
inevitably a variable operation. The variation in the transfer time should be a minor contribution if the 
measured T1 values are constant during the process. However, the relaxivity of the nitroxide is about the 
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double in low field, and a shorter T1 during the extraction and transfer should be expected. However, a 
more systematic variation in performance was also observed over time, possibly due to e.g. variation in 
microwave power delivery due to waveguide contamination. 
Dissolving the frozen sample in heptane yielded low final polarizations. The low-density heptane places 
itself in the top in the dissolution medium syringe, and thus exits first. Thus, the sample was melted without 
being diluted until the aqueous phase appeared, causing a loss in polarization from relaxation by the high 
radical and proton concentration. Secondly, the fluid path plastic did not tolerate well the heated heptane 
and showed tendency of cracking. Instead, NFBME was determined to have TEMPO partition coefficient 
similar to that of heptane, and was tested with volume of 5, 8, 11 mL, where the lower volume yielded the 
most controlled and efficient dissolution, and highest polarization in the liquid state.  
NFBME volumes above 5 mL resulted in uncontrolled dissolution, where the exit tube was blown out of the 
receiver or the sample was spurted out of the funnel due to high pressure sample and gas from the exit 
tube. An extraction system with a fixed, stirred receiver or application of a filter at the exit tube may allow 
larger NFBME volume, resulting in faster, warmer dissolutions. In addition, this would allow larger sample 
sizes, so the full potential of the 2 mL vial could be utilized. The water/glassing agent ratio was not 
investigated. Smaller glassing agent volume may yield faster sample melting and lower radical concentration 
in the dissolved state, but the glassing ability of such sample should be verified first.  
The radical removal may be optimized, e.g. by automatization of the extraction, which could also reduce the 
variance in the dissolved state polarization. Although radical quenching can be done efficiently, removal is 
preferred for in vivo studies and future clinical applications. Thus, filtering, reverse phase or ion exchange 
extraction of the radical may prove useful.  
We did not observe relaxation times above 40 s, as demonstrated in [24]. We believe that the decrease in 
temperature from dissolution to NMR acquisition is the main reason. In [24], the dissolved sample of 52 °C 
was transferred in a preheated transfer line into a preheated NMR tube at 60 °C , whereas the 50 °C 
dissolved sample of the present study was cooled in the transferring syringe, injection line and NMR tube at 
room temperature. Since the aim of our study was to enable in vivo studies, the sample temperature should 
be conditioned to 30-35 °C at time of injection. The slightly longer T1 at 3 T support this, as the larger sample 
volume used in these experiments will stay at the higher solvent exit temperature of the polarizer during 
measurement. 
The liquid state NMR signal yielded robust polarization quantification, and the radiation damping time 
constant was demonstrated to give consistent measure of polarization. 
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The T1 of the hyperpolarized samples in the liquid state are in the range 15-20 s, with uncertainty of the 
temperature and field dependence during transfer. With a dissolution, extraction and transfer time of 
approx. 25 s, the relaxation loss amounts to approx. 70% (e-25 s/20 s = 0.3). This explains most of the 
polarization loss from the solid state (P=70%) to the liquid state (P=13%), but probably not entirely. Further 
optimization and automation of the radical removal and transfer may reduce this loss further, e.g. by 
sample injection systems. Similarly, the 1H concentration may be further reduced to prolong T1 for the given 
transfer time.   
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Abstract: Magnetic resonance angiography (MRA) is a non-invasive technology that can be used for diagnosis and monitoring of 
cardiovascular disease; the number one cause of mortality worldwide.   
Hyperpolarized imaging agents provide signal enhancement of more than 10, 000 times, which implies large reduction in acquisition time 
and improved spatial resolution. We review the role of hyperpolarized 13C agents for MR angiography and present the literature in the field. 
Furthermore, we present a study of the benefit of intra-arterial injection over intravenous injection of hyperpolarized agent for cerebral 
angiography in the rat, and compare the performance of two standard angiographic pulse sequences, the gradient echo (GRE) sequence and 
the balanced steady-state free precession (bSSFP).   
2D coronal cerebral angiographies using intra-arterial injections were acquired with a GRE sequence with in-plane resolution of 0.27 mm 
and matrix size 256x128, and 2D coronal cerebral angiographies were acquired with a bSSFP sequence with in-plane resolution of 0.55 
mm and matrix size 128x64.   
The bSSFP sequence provides higher SNR in phantoms than the GRE sequence. Similarly, intravenous injections are imaged with higher 
SNR with the bSSFP sequence, where the signal destruction of the GRE sequence is avoided. However, for intra-arterial injections, the 
bSSFP sequence results in strong artefacts, and the GRE sequence is preferred.   
Hyperpolarized MRA presents many challenges and cannot currently compete with conventional contrast enhanced MRA. Further research 
may change this since hyperpolarization is still an immature methodology.  
Keywords: Magnetic resonance angiography, hyperpolarization, 13C, HP001, DNP.  
 
INTRODUCTION  
 Angiographic techniques are important in the diagnosis and 
treatment of medical conditions such as emboli, stenosis and 
intracranial aneurysms. The most frequently applied 
angiographic techniques are ultrasound imaging (US), computed 
tomography (CT), and nuclear medicine imaging such as PET 
[1]. US is non-invasive, but has its limitations in imaging of the 
cerebrovascular system, where cranium and tissue-bone 
interfaces cause attenuation and disturbance of the signal. CT 
provides high resolution images within short acquisition time, 
but the radiation exposure is a major limitation of repeated use. 
PET angiography can provide information about the functional 
metrics in the vascular system, however the low spatial 
resolution and the administration of radioactive contrast agent 
makes PET less preferable [2, 3]. Magnetic resonance 
angiography (MRA) is generally used with a contrast agent based 
on e.g. gadolinium [4] that reduces the T1 of the blood, but flow 
dependent techniques such as time-of-flight (TOF) or phase 
contrast can also be employed without injections [5, 6]. One class 
of MRA contrast agents includes blood pool agents such as 
Clariscan™; ultra-small super paramagnetic iron oxide particles 
that stay in circulation for hours [7]. Thus, the arterial vascular 
system alone can be imaged during the first pass of the contrast 
agent, whereas the entire vascular system can be acquired in a 
large time window allowing signal averaging for high resolution. 
Time-resolved fast imaging can be applied to capture the 
dynamics [8].  
Hyperpolarized 13C MRA   
 Conventional coronary proton MRA acquisition time depends 
on parameters such as matrix size and repetition time, and is  
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 typically acquired over several minutes [9]. Thus, respiratory 
and cardiac motion, as well as movements of the patient will 
affect the image quality. The need for faster image acquisition 
has catalyzed research in hyperpolarized (HP) MRI, where the 
signal can be enhanced by orders of magnitude compared to the 
thermal signal [10]. The polarization is obtained via dissolution 
Dynamic Nuclear Polarization (DNP). The sample is mixed with 
an Electron Paramagnetic Agent (EPA) and cooled to low 
temperature in a magnetic field, by which the unpaired electrons 
of the EPA reach a polarization of unity. The polarization of the 
electrons is transferred to the nuclear spins by irradiating with 
microwaves at the resonance frequency of the electrons. The 
high polarization of the nuclear spins are preserved to the liquid 
phase by rapidly dissolving in a dissolution medium, before the 
agent is injected. The polarization of the injected volume is more 
than 4 orders of magnitude larger than the thermal signal of 13C. 
Therefore, the signal in a 13C image obtained after injection of a 
hyperpolarized substance is proportional to the concentration of 
the agent in question, and the image acts as a qualitative map of 
perfusion [11-14]. Likewise, the conversion of hyperpolarized 
13C-labelled compounds such as pyruvate can be followed with 
Magnetic Resonance Spectroscopic Imaging (MRSI) [15-17], 
and the metabolic activity monitored [18].  
 Hyperpolarized MRA provides imaging of the injected 
substance in the vascular system, and thus provides a direct 
signal from the hyperpolarized spins in the blood. In addition, 
hyperpolarized MRA is not dependent on flow velocity as e.g. 
TOF-imaging, where flow close to the vessel walls appears with 
a low signal due to low flow velocity. In 2002 Golman et al. 
demonstrated that angiography in rats using hyperpolarized 13C 
is possible with bis-1, 1(hydroxymethyl)-[1-13C]cyclopropane-
D8 (HP001) as imaging agent and demonstrated that both 
ParaHydrogen-Induced Polarization (PHIP) [19] and dissolution 
DNP [20] can be used for hyperpolarized 13C angiography with 
i.v. agent administration (Fig. 1).  
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Svensson et al. [21] studied 13C cerebral MRA in the rat and 
found that high SNR can be obtained in both the head and neck 
area (Fig. 2) and in the thoracic/abdominal region using the 
balanced steady state  
free precision pulse sequence (bSSFP). Later, Olsson et al. [22] 
presented a study on hyperpolarized 13C coronary MRA in a pig 
model with i.a. injection. Recently, hyperpolarized H2O has been 
applied in angiography with the advantage of applicability on 
clinical scanners with 1H channels only, as well as higher 
achievable magnetization due to a larger magnetic moment [23].  
 
Fig. (1). Angiographic image of the rat heart region after i.v. injection in 
the tail vein. Acquired with a gradient spoiled, gradient echo sequence 
(TE/TR = 4 ms/9.5 ms, α = 10°, FOV = 70x70 mm2, matrix = 128x128, 
slice = 30 mm, scan time = 2 s). With permission from [19] and Elsevier.  
 
Fig. (2). First image in a series of angiograms covering the head and neck 
region. The image has been acquired on a 2.35 T animal MRI system with 
a trueFISP sequence (TE/TR = 1.8 ms/3.6 ms, FOV = 70x70 mm2, and 
matrix = 64x64, with read oversampling). Major vessels appear with SNR 
of 74-76, but some enhancement of other tissue is observed as well. With 
permission from [21] and John Wiley and Sons.  
 For cerebral angiography in the rat, the hyperpolarized substance 
is typically injected using either intravenous (i.v.) injection 
through one of the tail veins, or intra-arterial (i.a.) injection 
where a catheter is operated into one of the carotid arteries. The 
injection method affects the system in various ways and e.g. 
movement of the catheter and the reaction of the vessels to 
increased pressure will result in difference in signal-to-noise 
ratio (SNR) and artefacts in the images. Thus, the  
 
MR sequence must be chosen and optimized in accordance with 
the injection method. Furthermore, the injection type will 
enhance specific characteristics of the arterial and venous 
network. An even distribution in the vasculature should be 
observed with an intravenous injection when the hyperpolarized 
substance is distributed through the heart of the animal. When 
the substance is injected in a carotid artery, only arteries 
branching from that specific carotid artery as well as the 
corresponding veins are highlighted.  
 
13C Agent and MRI Considerations  
 The 13C-labelled agent HP001 is chosen for its long T1 (in vitro, 
2.35 T: T1 ≈ 82 s, T2 ≈18 s; in vivo, 2.35 T: T1 ≈ 38 s, T2 ≈ 1.3 
s) [21]. This means that the signal decay should be caused mainly 
by dilution in the vasculature and extravasation of the agent to 
the surrounding tissue, and to a smaller extent by relaxation 
processes.  
 The bSSFP imaging technique has been demonstrated to be a 
rapid, high-SNR technique for angiography and spectroscopic 
applications using hyperpolarized substances (Fig. 2) [21, 22, 24, 
25]. The gradient echo (GRE) technique has been used 
extensively for single resonance HP lung imaging [26-28], but 
less for HP- angiography using 13C-labeled substances. A 
theoretical basis and in vitro measurement comparison between 
bSSFP and GRE for the HP angiography application was 
performed by Svensson et al. [21], but in vivo comparisons 
between the combinations of the two imaging techniques (bSSFP 
and GRE) and the two injection techniques (i.v. and i.a.) is to our 
knowledge not performed.  
 In this review we demonstrate the current possibilities of a 
hyperpolarized 13C-labelled agent for MRA and investigate the 
difference between intravenous and intra-arterial injection with 
the GRE and bSSFP imaging sequences.  
METHODS  
Polarization  
 Bis-1, 1-(hydroxymethyl)-[1-13C]cyclopropane-D8 (HP001) 
was used as the imaging agent to obtain long relaxation times of 
the 13C nuclei. Trityl OX063 (Oxford Instruments, Abingdon 
UK) was used as paramagnetic agent. A batch consisting of 18.0 
mg OX063, 500 mg HP001, 180 mg water and 15 L Dotarem (1: 
10 dilution, Guerbet, Paris, France) was prepared. 100 L sample 
was polarized using an Oxford Instruments Hypersense, 3.35 T, 
1.4 K, by irradiation with microwaves at 94.112 GHz for one 
hour. The polarization time constant was 1800 s. The sample was 
dissolved in 1 mL PBS buffer with 0.01 g/L EDTA diluted in 3 
mL NaCl (9 g/L). The 13C concentration in the final solution was 
100 mmol/L. The solution temperature was approximately 37 °C 
   113 
 
and the pH 7.5-8. The time from dissolution to injection start was 
14-18 s and the polarization was 20-25% at time of injection.  
Animal Preparation  
 All animal experiments were carried out in compliance with the 
guidelines for use and care of laboratory animals and were 
approved by the Danish Inspectorate of Animal Experiments, 
approval 2012-15-2934-00244.  
 Male Sprague Dawley rats weighing 240-320 g were 
anaesthetized with 1.8% isoflurane in air mixed with 5 % oxygen 
adjusted to a respiration rate of 75±10 min-1 and mounted in an 
animal holder. The body temperature was kept at 38±1 °C with 
hot air flow.  
 Tail vein catherization: A catheter was inserted in a tail vein for 
i.v. contrast agent administration. A volume of 1.5 mL was 
injected over 6-9 s.  
 Carotid artery catherization: Carotid artery injections were 
prepared by incision in the ventral neck of the rat and isolation 
of the right carotid artery, before inserting and securing the 
catheter in the artery. The catheter was fixed to the skin with tape. 
A volume of 1.0 mL was injected over 6-9 s.  
 
  
Fig. (3). The vertical sensitivity profile of the coil from a sum of squares 
CSI image of a spherical bicarbonate phantom (small insert). The FOV 
and slab position of the i.v. (bSSFP) acquisitions and the thinner slab of 
the i.a. (GRE) acquisitions are indicated.  
MR Scanner System and Pulse Sequences  
 Data was acquired on a 4.7 T imaging system (Agilent, Direct 
Drive, VnmrJ 4.0) using a 13C/1H RF volume coil combined with 
a 13C 4-channel surface array coil (receive-only, 50 mm inner 
diameter, RAPID Biomedical GmbH, Germany). The receiver 
coil was placed dorsal with the animal supine. Fig. 3 shows the 
profile of the coil sensitivity measured as the sum-of-squares 
image of a CSI acquisition of a spherical bicarbonate phantom. 
The position of the GRE slab is indicated as the shaded area. The 
bSSFP slab is overlapping, but extends 10 mm in the anterior 
direction. The sensitivity is highest in the region closest to the 
coil elements, thus the sensitivity of the vessels in this region is 
more than twice the sensitivity in the outer region of the slab. The 
system was shimmed to a proton line width of less than 110 Hz 
over the field-of-view (FOV). The image reconstruction applied 
the sum-of-squares algorithm where the signal in each pixel is 
the square root of the sum of the squares of the signal from each 
individual array coil element. The background noise is measured 
in a ROI of 20x20 pixels in an area away from the hyperpolarized 
signal.  
  Coil Sensitivity measurements: The coil sensitivity is 
assessed with a CSI pulse sequence with FOV 80x80 mm2, 
matrix size 16x16, α = 10°, TR = 75 ms on a spherical 
phantom of 1.0 M bicarbonate (38 mm diameter).  
 HP-13C-MRA - bSSFP: The hyperpolarized signals were 
acquired using a single-shot bSSFP sequence with 110° flip angle 
(α). An /2-pulse preparation pulse was implemented at time TR/2 
before the first excitation pulse to approach a steady state like 
situation faster and a corresponding flip-back pulse was 
implemented at the end of each image acquisition to restore the 
longitudinal magnetization for the following time frame. The 
angiographic images had a Field-Of-View (FOV) of 70x35 mm2 
and a slab thickness of 30 mm placed coronal in the head and 
neck region. The matrix size was 128x64. The repetition time and 
echo time were set to minimum, TR/TE = 6.95/3.48 ms. A 
bandwidth of 50 kHz yielded a total image acquisition of 450 ms 
for each image. The sequence was started when the solution had 
been fully injected to capture the maximum possible signal.  
 HP-13C-MRA, GRE: The GRE sequence was applied with an 
FOV of 70x35 mm2, a slab thickness of 20 mm and with matrix 
size 256x128. The pulse length was 2 ms and the repetition and 
echo times were TR/TE = 10.16/5.10 ms. The total acquisition 
time for an image was 1300 ms with α = 5° and imaging was 
repeated over 30 time frames. Acquisition was started when 
injection was initiated to capture the maximum signal strength.  
1H MRA: Proton angiographic images were acquired with a 
1H quadrature coil (M2M imaging corporation, Cleveland, Ohio, 
USA) with inner diameter of 35 mm. A 3D GRE sequence with 
TR/TE = 90/2.47 ms, α = 40°, FOV of 30x35x20 mm3, matrix 
size 256x256x64 was used after an intravenous injection of 50 L 
Clariscan™ (NC100150, NYCOMED IMAGING AS, Oslo, 
Norway). The total acquisition time was 25 minutes.  
 
Fig. (4). Coronal image of cerebral vessel structure acquired with a 3D 
gradient echo sequence after injection of NC100150. The large arrow 
indicates the superior sagittal sinus, the small arrows indicate the 
transverse sinuses, and the dotted arrows indicate the superficial temporal 
vein.  
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Fig. (6). Image of GRE sequence (4th frame) initiated after injection of 
hyperpolarized HP001 through the right carotid artery as overlay on the 
proton image of Fig. 4. The veins SSS, TRS (right) and STEMV (right) 
coincide and the structure of finer vessels appear in the overlay.  
 
RESULTS 
1H MRA: Fig. 4 shows a contrast enhanced H 3D GRE image of 
the cerebral vascular system. The large arrow indicates the 
superior sagittal sinus (SSS), the small arrows indicate the 
transverse sinuses (TRS) and the dotted arrows indicate the 
superficial temporal vein (STEMV), posterior facial.  
HP-13C-MRA, GRE: An excitation pulse flip angle of 5° was 
found the optimal compromise between signal strength and 
conversion of magnetization during the time series in a 
separate study (data not shown). A time series of 8 frames 
during intra-arterial injection is shown in Fig. 5. The best 
image is the 4th time frame. The rat brain was centered in the 
FOV, and arteries and veins of the right side of the head  
 
 
 
 
 
 
 
 
 
 
appear with the largest denseness around the brain and towards 
the nose region. Only a few veins appear in the left half of the 
image, and only minor signal contribution is visible in the eye 
region of the right side. Fig. 6 shows the 4th frame as overlay 
on the proton image. Though the two angiographies are 
obtained on different animals and positioning, the images are 
in agreement and major venal structures (SSS, TRS, STEMV) 
of the right side are identified.  
 A series of 3 consecutive intra-arterial injections of 
hyperpolarized HP001 in an animal with intervals of 
approximately one hour gave SNR 26, 19 and 20, as measured as 
the ratio between the largest signal observed and the background 
noise, and demonstrates reproducibility of the result.  
 18 injections in 10 animals yielded SNR of 17.6±4.5 
(Mean±SD).  
 The corresponding GRE acquisition after an intravenous 
injection yielded signal from the larger veins but with SNR lower 
than 10 (acquired in 3 animals, image not shown).  
HP-13C-MRA, bSSFP: The signal acquisition bandwidth was 
studied in the range of 20-100 kHz, and we found 50 kHz to be 
the optimal balance between high signal and minimal flow 
artefacts. The sequence was started when the solution had been 
fully injected to capture the maximum possible signal. In 
separate experiments (data not shown), the flip angle for the 
bSSFP- sequence was optimized on thermal phantom 
experiments where a flip angle of 110° yielded a 22% higher 
SNR than the corresponding experiment with 60° flip angle and 
where flip angles higher than 110° did experiments on HP in vivo 
experiments with the bSSFP (data not shown). A time series of 
bSSFP acquired images with one second intervals is shown in 
Fig. 7. SNR of 36 is observed in the first frame and the signal 
decays rapidly in the following frames. The larger veins (SSS, 
TRS, STEMV) identified from the overlay appear distinctly in a 
symmetrical shape, and smaller venal structure appears towards 
the nose region.  
 5 injections in 4 different animals yielded SNR of 31.3±20.0 
(Mean±SD).  
  
  
  
  
  
Fig. (5). Time series of GRE images initiated after injection of hyperpolarized HP001 through the right carotid artery. 1.3 s between each frame.  
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Fig. (7). bSSFP time series after finished injection of hyperpolarized 
HP001 though the tail vein, 1 s between frames. Right image shows the 
first image as overlay on the proton image of Fig. 4. The veins SSS, TRS 
and STEMV coincide while smaller vessels are not distinguishable.   
DISCUSSION  
 In this study we injected a dose close to the anticipated clinical 
dose of ca. 0.4 mmol/kg, which is only 25-50% of the dose used 
in previous studies with a similar polarization. We obtained 
results similar to Golman et al., where an SNR of 34 was 
demonstrated in a 128x128 matrix (70x70 mm2) in the rat heart 
with an injection of 2-3 mL of 200 mM (ca. 1.5 mmol/kg) 
solution with polarization of ca. 15% [19]. Svensson et al. 
obtained SNR of 74-76 in a lower resolution of a 64x64 matrix 
(70x70 mm2) placed in the rat head and neck region with 
injection of 3-3.5 mL of 200 mM solution with a polarization of 
ca. 15% [21].   
 The bSSFP sequence proved best for injections through the tail 
vein where the physiological and physical reactions of the animal 
are negligible, in contrary to injections through a carotid artery, 
which caused minor mechanical movements of the neck and head 
region where the catheter is inserted, as well as possible 
physiological reactions in the imaged region due to the injected 
bolus’ impact on the vessels due to pressure, pH, temperature and 
tonicity. These movements caused motion artefacts in the bSSFP 
acquisition, whereas a GRE sequence was more robust to 
displacements and hence better suitable. Images of carotid artery 
injection acquired with bSSFP (Fig. 8) showed a very high SNR 
of 137. Even though this large signal from the high agent 
concentration in the arteries was observed, the details of the 
vascular system were indistinguishable. The sequence was 
applied with TR/TE = 6.95/3.48 ms, α = 60° in a 128x128 matrix 
with FOV 60x60 mm2 in a 30 mm slab.  
The strong artefacts may be caused by motion due to the injection  
as well as B0-field disturbances caused by the large difference in 
oxygenated blood and the water introduced with the injection 
[29].  
 The contrast agent is further diluted for tail vein injections. The 
combination of small flip angle GRE acquisition and large 
dilution in the vascular system resulted in SNR below 10. 
Therefore, a bSSFP sequence with high flip angle is preferred.   
 The bSSFP-sequence had a slab thickness of 30 mm. In some 
experiments, the transverse sinuses align orthogonally to the slice 
and thus contribute with a large signal in the projection (arrow in 
Fig. 7). These outliers cause the large variance where single  
         
 
Fig. (8). bSSFP acquired image after intra-arterial injection demonstrates 
high SNR of 137 and artefacts due to motion and susceptibility change.  
pixels have yielded signal strength much larger than the rest of 
the vasculature.  
Large parts of the image characteristics in Fig. 5 are observed 
throughout the series, while some features are vanishing in the 
later time steps. The fact that the operated carotid has been sealed 
off beneath the catheter explains that some of the branches have 
closed off during several hours of occlusion in the scanner. The 
image series and the consistency in the SNR indicate that 
polarization, injection and data acquisition is reproducible.   
 When the bSSFP sequence was applied following an intraarterial 
injection, we observe motion artefacts in the phase encoding 
direction as shown in Fig. 8.  
 Polarizers for DNP have now been installed in several clinics 
around the world, and studies of HP 13C in humans initiated [30]. 
As this equipment is being implemented, the application of 
hyperpolarized agents for angiography will be further studied, 
and a potential translation towards application in clinical practice 
explored.   
 In conclusion, intravenous and intra-arterial injection techniques 
were used in combinations with optimized GRE- and bSSFP-
imaging, respectively, for rat cerebral MRA with a 
hyperpolarized 13C-labelled agent, and resulted in bSSFP-
imaging being preferable for intravenous injections, and GRE-
imaging being preferable for the intra-arterial injection 
technique.  
 Hyperpolarized 13C MRA is currently unable to compete with 
contrast enhanced MRA. Considering the complexity of the 
method (primarily the need for polarizer hardware and the short 
life time of the signal) it is unlikely that it will become an 
attractive method. However, hyperpolarization is still an 
immature methodology, and there are areas where current MRA 
falls short. With further research into hyperpolarization to 
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increase the available signal, and possibly increase the life time, 
there are opportunities for significant improvement.  
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Renal MR Angiography and Perfusion in the Pig Using 
Hyperpolarized Water 
Kasper Wigh Lipsø,1 Esben Søvsø Szocska Hansen,2,3 Rasmus Stilling Tougaard,2,4 
Christoffer Laustsen,2 and Jan Henrik Ardenkjær-Larsen1,5* 
Purpose: To study hyperpolarized water as an angiography and 
perfusion tracer in a large animal model. 
Methods: Protons dissolved in deuterium oxide (D2O) were 
hyperpolarized in a SPINlab dissolution dynamic nuclear polarization 
(dDNP) polarizer and subsequently investigated in vivo in a pig model 
at 3 Tesla (T). Approximately 15 mL of hyperpolarized water was 
injected in the renal artery by hand over 4–5 s.  
Results: A liquid state polarization of 5.3±6 0.9% of 3.8 M protons in 
15 mL of deuterium oxide was achieved with a T1 of 24±6 1 s. This 
allowed injection through an arterial catheter into the renal artery and 
subsequently high-contrast imaging of the entire kidney parenchyma 
over several seconds. The dynamic images allow quantification of 
tissue perfusion, with a mean cortical perfusion of 504 ± 123 mL/100 
mL/min.  
Conclusion: Hyperpolarized water MR imaging was successfully 
demonstrated as a renal angiography and perfusion method. 
Quantitative perfusion maps of the kidney were obtained in agreement 
with literature and control experiments with gadolinium contrast.  
Magn Reson Med 000:000–000, 2016. © 2016 International Society 
for Magnetic Resonance in Medicine 
Key words: perfusion; magnetic resonance angiography; 
hyperpolarization; DNP 
INTRODUCTION 
Magnetic resonance angiography (MRA) is an important tool for 
diagnosing various medical conditions such as emboli, stenosis, and 
aneurysms. More specifically, renal artery MRA allows detection 
of renal vascular diseases such as fibromuscular dysplasia, venous 
thrombosis, and arterial dissection (1). Submillimeter resolution 
can be obtained with proton imaging, and further optimization can 
be obtained by employing vascular contrast agents 
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such as gadolinium (Gd) based blood pool agents (2) or 
nanoparticles (3). Despite significant improvement in scanner 
technology and reconstruction methods (4–6), MRA evaluation of 
small vessels is still challenging. This is primarily due to the 
inherent low sensitivity of MR, in which the signal is proportional 
to the polarization of protons in the blood stream. 
It has been demonstrated that this sensitivity problem can be 
overcome by hyperpolarizing nuclear spins (7). The method has 
recently been introduced in patients using [1-13C]pyruvate (8). By 
enhancing the polarization of 13C by many orders of magnitude, 
the detected signal is increased dramatically, allowing in situ 
conversion of metabolic 13C-containing compounds to be imaged. 
The procedure of increasing polarization beyond thermal level, 
hyperpolarization (HP), can be achieved by dissolution dynamic 
nuclear polarization (dDNP), in which the high polarization of the 
high-gamma electrons, at cryogenic temperature and high 
magnetic field strength, is transferred to the nuclei by irradiation 
with microwaves. By rapid dissolution in a hot medium, the 
hyperpolarized nuclei can be brought to liquid state and injected 
into the patient before the polarization is lost as a result of 
longitudinal relaxation (7). Alternatively, metabolically inert 13C-
labeled molecules can be used for angiographic imaging (9–11), as 
demonstrated in rodent and porcine models, and for perfusion of 
rodent organs (12–15) or of tumor models (16,17). 13C or 15N-
labeled molecules for angiography and perfusion imaging exploits 
the long T1 for selected 13C and 15N molecules and the low signal 
background (18). Despite these advantages, these molecules 
exhibit partial permeability and active transport limitations. 
A more accurate technique for water perfusion measurements is 
therefore necessary (19,20). A way to measure the perfusion of 
water molecules directly exists, using 15O-labeled water as a tracer 
for positron emission tomography (PET) imaging (21,22), with the 
main drawbacks being the use of a radioactive tracer and the 
limited spatial and temporal resolution of PET. Using 
hyperpolarized water for angiographic and perfusion imaging 
overcomes several of these limitations. Water protons for imaging 
have previously been hyperpolarized by use of the Overhauser 
effect (23). However, the maximum achievable magnetization is 
limited. Typically, an enhancement of 100 times at 0.35T can be 
obtained for pure water (H2O), corresponding to a polarization of 
0.001%. Higher polarizations have been reached with dissolution-
DNP using the 3.35T HyperSense polarizer, in which 3–4mL of 
5M 1H in D2O with a polarization of 3–5% have been applied to 
biomolecular NMR studies 
© 2016 International Society for Magnetic Resonance in Medicine 1 
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(24) or MR angiographies in the rat (25). Correcting for the 
difference in proton concentration, this corresponds to an available 
signal of two orders of magnitude larger than the Overhauser 
experiments. Imaging of hyperpolarized protons allows for the use 
of coils and pulse sequences already available in the clinical setting. 
Much more effort has gone into optimizing pulse sequences for 
optimal performance for proton imaging than for other nuclei. 
Moreover, the magnetization achievable with hyperpolarized water 
is superior to other nuclei, because of its large gyromagnetic ratio 
(γ1H ≈ 4 · γ13C) and the potentially high proton concentration. As a 
tracer for perfusion, hyperpolarized water has additional interesting 
properties. Water diffuses freely in the vascular bed and 
intracellularly, hence providing information not obtainable with 
larger compounds such as Gd-based MR contrast agents or larger 
nuclear tracers. Compared with the slow washout rate of 
conventional MR contrast agents (26), the T1 value of 
hyperpolarized tracers hampers image acquisition, as well as 
reduces the spatial range of measurable perfusion. However, the 
signal enhancement of hyperpolarization facilitates higher 
resolution and faster image acquisition, which allow us to trace the 
permeable protons in detail—with the stated limitations. 
The purpose of this study was to demonstrate that hyperpolarized 
water can be used as a tracer to provide subsecond, high-resolution 
angiographies in pigs by intra-arterial injection in the renal artery, 
and that accurate perfusion maps can be obtained with good signal-
to-noise ratio (SNR). 
 
METHODS 
The polarizer and fluid path have been described in detail in (27). 
Briefly, the dDNP polarizer operates at 5T and approximately 0.9 
K. The sample and solvent was loaded into a fluid path that allows 
the sample to be polarized in the magnetic field at low temperature 
under microwave irradiation. The solvent was contained in a 
syringe that connects to the vial using two concentric tubes (inner 
and outer tube) and a valve. The syringe was placed in a 
heater/pressure module outside the polarizer cryostat. During 
dissolution, the hyperpolarized solution leaves the polarizer 
through an exit tube. 
Sample and Solvent Preparation 
A sample of 1mL 30mM TEMPO (2,2,6,6-Tetramethylpiperidine 
1-oxyl, 98%, Sigma Aldrich, Copenhagen, Denmark) in 
H2O/glycerol 1:1 (w/w) was prepared. The sample was placed in 
the fluid path vial and frozen in liquid nitrogen. Dissolution 
medium (DM) consisted of D2O with 1mM calcium disodium 
ethylenediaminetetraacetic acid (EDTA) and 9g/L NaCl (both 
Sigma Aldrich, Denmark). 
31.01g DM (28mL) was filled in the syringe and degassed by 
bubbling with helium gas for 10min. The fluid path was flushed 
with helium gas for 2min to remove air and ensure clear passage. 
Polarization 
The sample vial was rapidly transferred from the liquid nitrogen 
bath to the 5T magnet in the polarizer (SPINlab, GE Healthcare, 
Brøndby, Denmark). The sample was irradiated with approximately 
50 mW microwaves at 139.923 GHz for 1h. 
Dissolution 
The syringe containing the DM was heated to 130C for 1h before 
dissolution while being under pressure. The piston of the syringe 
was driven with 16-bar pressure during dissolution. The dissolved 
sample was injected through the exit tube into a separatory funnel 
(100mL) containing 25mL of heptane (>99%, Sigma Aldrich, 
Copenhagen, Denmark) to extract the radical from the aqueous 
phase. The heptane had been degassed by flushing with helium gas 
in the funnel for 10min. The funnel was shaken heavily during 
dissolution for a total of 10 s from dissolution start. The lower, 
aqueous phase was extracted into a syringe before transferring to 
the scanner room. The proton concentration in the dissolved sample 
was analyzed by NMR after the addition of 2M formate solution as 
reference. 
Animal Protocol 
All animal experiments were carried out in compliance with the 
guidelines for use and care of laboratory animals and were approved 
by the Danish Inspectorate of Animal Experiments. Four healthy 
30-kg female Danish domestic pigs were presedated with 
intramuscular injection of Stressnil (1mL/kg) and Midazolam 
(1mL/kg), and anesthesia was maintained by continuous infusion of 
Propofol (0.4mg/kg/h) and Fentanyl (8mg/kg/h). The animals were 
intubated and mechanically ventilated with a 60% O2-air mix. 
A 6-F introducer sheath was positioned in the left common 
femoral artery by ultrasound guidance to allow access for a 6F, JR 
4.0 angiography catheter to be placed in the left main renal artery 
using X-ray guidance. The angiography catheter was repeatedly 
flushed with heparinized sterile water to avoid occlusion. 15mL HP 
water was injected over 5 s, initiated approximately 22 s after 
dissolution. 
Through a vein access in the right ear, a bolus of 0.2 mmol/kg 
Gd-DTPA (Gadobutrol, Gadovist, Bayer Schering Pharma, Berlin, 
Germany) was administered manually for conventional T1-DCE-
MRI. 
MRI Acquisition 
MRI detection was performed on a 3T GE HDx with an eight-
channel cardiac array receiver coil (GE Healthcare, Milwaukee, 
Wisconsin, USA). Phantom experiments were performed with a 
gradient echo sequence using a flip angle of 1°, matrix size 128 x 
128, field of view (FOV)=(24mm)2 in a slab of 40 mm with 
repetition time (TR)=3 ms, echo time (TE)=0.784 ms. The 
acquisition time of each frame was 450 ms, and images were 
acquired with a time delay of 1 s. 
Axial and coronal images were acquired to cover both kidneys to 
allow for planning of the angiography slice 
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for hyperpolarized water imaging. The planning sequence (before 
injection of hyperpolarized water) was as follows: a standard 
steady-state free precession sequence (TE=1.1 ms, TR=2.7 ms, flip 
angle (FA) of 35°, image matrix of 256×256, FOV=340×340 mm2, 
in-plane resolution = 1.3 mm, slice thickness = 3 mm). 
Angiographies (during injection of the hyperpolarized water) 
were acquired in the coronal plane of the left kidney using a gradient 
echo sequence with 5° FA, slice thickness 40 mm, TR=3.4 ms, 
TE=0.984 ms, 256×256 matrix, FOV=140×140mm2. The 
acquisition time was 870 ms. The Gd-perfusion sequence was 
executed with the following parameters: spoiled gradient echo, 
inversion time = 850 ms, 10° FA, slice thickness 50 mm, TR=2 s, 
TE=1.4 ms, 128×128 matrix, FOV = 290×290 mm2. 
MRI Postprocessing 
Phantom data were analyzed using MATLAB (MathWorks, Natick, 
Massachusetts, USA). Renal perfusion maps were calculated in 
OsiriX (Pixmeo, Geneva, Switzerland) using an open source OsiriX 
plug-in for DCE-MRI perfusion analysis (29). A pixel-by-pixel 
model-free fast deconvolution was applied, assuming a direct signal 
enhancement of the hyperpolarized water, a hematocrit of 0.45 and 
a regularization of 0.15. The hyperpolarized arterial input function 
(AIF) was fixed at the end of the arterial bolus (7 s in Fig. 2), to 
avoid the injection characteristics of the AIF. The Gd-T1-DCE 
contrast was similarly analyzed by a pixel-by-pixel model-free fast 
deconvolution, assuming a relative signal enhancement accounting 
for the signal modulations by the contrast agent. 
RESULTS 
The average proton concentration in the dissolved sample was 
3.846±0.22 M (n=10). 18±1 mL of dissolved sample was produced. 
The polarization was measured by placing a syringe with dissolved 
hyperpolarized sample next to a similar syringe of saline and image 
a slice of 40 mm (same sequence as for the angiographies). The 
signal obtained from the phantoms is plotted in Figure 1. 
 
 
The initial hyperpolarized signal was 211 times the mean signal in 
the thermal phantom (110M 1H) of Boltzmann polarization (10.5 
ppm). Thus, after correction for the proton concentration, the 
polarization was 5.3±0.9% (n=4). A T1 of 24±1 s was measured. 
Angiographies of the arterial system of the left kidney were 
produced with hyperpolarized water in four animals (Fig. 2). 
Perfusion maps were calculated for the four animals (Fig. 3). A 
mean cortical perfusion of 504±123mL/100mL/min was found. 
Some folding of the signal from the catheter appears in the images 
in Figure 3c and 3d. The arterial input function is shown in Figure 
2 along with the cortical signal curve. The arterial input function is 
heavily modulated by the direct injection, as seen by the flat top of 
the input from 3–7 s. Trimming the AIF to the end of the injection 
was found to reproducibly reflect the average perfusion found by 
Gd-T1DCE analysis of 450 mL/100mL/min (n=2). 
DISCUSSION 
The main finding of this study was the demonstration of a feasible 
method for acquiring reproducible renal angiograms and perfusion 
maps using hyperpolarized water with both high resolution and high 
SNR in a large animal model resembling human renal anatomy and 
physiology. The produced volume of 15mL exceeds the previously 
demonstrated volumes of 4mL produced on the HyperSense (25), 
and the SPINlab and fluid path technology facilitates sterile 
samples for clinical applications (27). Good agreement was found 
between the calculated hyperpolarized water perfusion and both the 
reported Gd-based perfusion values in healthy porcine models (30) 
and with our Gd-based perfusion measurements (average of 
450mL/100mL/min). Further optimization of MRI sequence, 
sample preparation, radical extraction, as well as automation and 
consistency of the injection process are likely to enhance image 
quality and applicability further. A longer bolus injection to 
approximate a Heaviside input function may improve accuracy. The 
primary limitation is the short lifetime of the hyperpolarized water, 
reducing its applicability to highly perfused organs. The use of 
direct arterial injection imposes 
Renal MR Angiography and Perfusion in the Pig Using Hyperpolarized Water 3 
FIG. 1. ROI signal means of the 
hyperpolarized 1H in D2O (green, decaying 
signal) and the H2O thermal phantoms (blue, 
steady signal). The phantoms consist of two 
syringes inside a loading phantom (ring 
structure). Images (individually scaled) are 
shown at 0 and 200 s. The hyperpolarized 
MR signal is initially 211 times stronger 
than the thermal H2O signal, and the T1 of 
the decay is 24 s. The hyperpolarized signal 
decays into the noise, as the 1H density is 
approximately 20 times lower than the 
thermal H2O sample. 
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FIG. 2. Image intensity in the arterial input ROI and cortex ROI for the same pig. Images visualize time steps at 3, 5, 7, and 9 s. 
challenges on both animal handling (future clinical usability) 
and on the modeling of the perfusion information. The 
angiograms are of excellent quality; however, Gd-based and 
noncontrast angiography of the renal arteries is currently 
providing sufficient diagnostic quality. In contrast, since the 
discovery of Nephrogenic Systemic 
 
FIG. 3. A, B, C, D show perfusion maps generated from four individual pigs with a mean cortical perfusion of 504 ± 123 mL/100 mL/min. C is 
the same pig as shown in Figure 2. 
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Fibrosis, new MR methods to measure perfusion may have a 
role. In addition to the specific extravasation properties of 
water relative to any other molecule, the signal that can be 
created by hyperpolarized 1H exceeds that of any other 
magnetic nucleus (eg, 13C). 
Both the radical and molecular oxygen in the sample 
induce dipolar relaxation that reduces the longitudinal 
relaxation time T1. Thus, the radical extraction in the organic 
phase as well as the oxygen removal during preparation are 
crucial elements for achieving long T1 and, ultimately, high 
polarization after substance transferring. TEMPO was 
chosen without optimization as a good compromise between 
water solubility and preferential partitioning to the heptane 
phase. The proton concentration was chosen as an optimal 
compromise between the limitation of the intermolecular 
dipolar relaxation between proton nuclei and achievement of 
high signal in the injectable sample. We believe that the 1 H 
signal (polarization) can be further increased by a factor of 
five by optimization of the solid-state DNP polarization and 
the reduction of losses in the dissolution. 
The ability to hyperpolarize water protons in a polarizer 
designed for clinical use, with sufficient polarization to allow 
ultrafast angiographic and perfusion assessment, shows great 
promise for future clinical translation. 
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Abstract 
Rationale: Magnetic resonance imaging is a safe modality providing high-resolution images of soft tissue. 
However, the inherent low sensitivity limits the achievable signal and contrast. Hyperpolarization has been shown 
to increase the signal several orders of magnitude, and recently been translated to human cardiac application.  The 
use of hyperpolarization suggests that large reductions in scan time can be achieved, enabling the high temporal 
resolution required to acquire dynamic cardiac images without motion artifacts for coronary flow and tissue 
perfusion assessment.  
Objective: To demonstrate the first dynamic coronary magnetic resonance angiographies using hyperpolarized 
water. 
Methods and Results: Water was hyperpolarized using dissolution dynamic nuclear polarization at 5 T to a 
polarization of  >5% in a clinical polarizer. Sample was injected into the coronary arteries of Danish landrace 
pigs (N = 9, 3 injections in 3 different animals) over 6 s. MRI images were acquired with a gradient echo 
sequence of 5° flip angle in a tilted slab covering the main right coronary arteries. The acquisition time of each 
frame was 870 ms. 
Conclusions:  High signal-to-noise MR angiography of the coronary arteries of a large animal model with high 
spatial resolution and temporal resolution was demonstrated. The dynamic first pass nature of the positive 
contrast examination, allows perfusion analysis of the water movement from the arteries to the capillary bed of 
the cardiac tissue.  
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Magnetic Resonance Angiography (MRA) for coronary artery imaging has so far failed to translate into 
widespread clinical use1,2. This is partly due to the inherent low sensitivity of current MRA methods, extending 
the acquisition time to several minutes and multiple respiration and heart cycles3. Coronary arteries are challenging 
structures to image with MRI due to the small and tortuous vessel structures and motion. Therefore, successful 
coronary MRA requires high-resolution, whole-heart imaging, and effective motion suppression. Current free-
breathing protocols use segmented acquisitions with prospective electrocardiography (ECG) and navigator gating 
to suppress cardiac and respiratory motion artefacts and blurring. The current strategy for cardiac gating means 
that the acquisition window is well within one of the quiescent periods, leaving the remaining time (80-90%) 
unused.  
Today, the typical first-line test for evaluation of Coronary Artery Disease (CAD) is stress SPECT Myocardial 
Perfusion Imaging (MPI) or contrast-enhanced Coronary CT coronary Angiography (CCTA)4. Increasing evidence 
support the altered myocardial perfusion as an accurate diagnostic marker of CAD4. Water perfusion is of 
particular interest and has been demonstrated with 15O-labeled water in positron emission tomography (PET)5–8. 
To date, MR contrast agents consist of other compounds (primarily Gadolinium-based chelates), with different 
permeability dynamics than water9,10. Recent advances have introduced Arterial Spin Labeling (ASL) to map the 
perfusion of blood in the myocardial tissue11,12, however, common to these methods is the inherent low sensitivity, 
and thus lack of robustness and diagnostic quality.  
One way to dramatically increase the sensitivity of MRI is hyperpolarization. In hyperpolarization, we detect the 
magnetic resonance signal from a molecule that has gone through an activation process, hyperpolarization, to 
enhance the nuclear spin polarization by many orders of magnitude13. The hyperpolarized state decay at a rate that 
is slow enough to allow us to follow the fate of the molecule for seconds to minutes. Hyperpolarization is typically 
performed on endogenous, metabolically active 13C labelled molecules, such as [1-13C]pyruvate. The method that 
has recently been translated to human use for characterization of cancer14 or assessment of myocardial 
metabolism15. Imaging of hyperpolarized inert 13C labelled molecules for angiography and perfusion has been 
demonstrated in both rodent and large animal models16–20. The direct detection of signal from injected molecules, 
improves the quantification of the perfusion compared to conventional perfusion methods21–27. 
MRI of hyperpolarized carbon-13 suffers from needing specialized scanner hardware and coils and a lack of 
optimized pulse sequences. Instead, hyperpolarization of the protons of water molecules would allow the use of 
conventional MR hardware and pulse sequences. In addition to compatibility with existing equipment, protons 
have the advantage of a four times higher magnetic moment than that of 13C, resulting in a larger magnetization, 
and hence signal. The main drawback of hyperpolarized water is the short relaxation time.  After hyperpolarization, 
during handling, transfer and injection, the relaxation time is 20-30 s28,29, but as soon as the water protons have 
been injected into the blood stream, the relaxation time reduces to a few seconds30 requiring intra-arterial injection. 
Hyperpolarized water has been demonstrated for MRI angiographies in small animal models, where the cerebral 
network and the vena cava were imaged30, and was recently applied for angiographies of the pig renal arteries, and 
perfusion measurements of the kidney tissue29. In this study, we hypothesize that high resolution dynamic coronary 
MRA and myocardial perfusion can be acquired using hyperpolarized water. This may be combined with the 
metabolic assessment as demonstrated by Cunningham et al.13 to provide both metabolic and hemodynamic 
information within the same scan session. 
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Methods 
Sample and medium preparation: A sample of 1 mL 30 mM TEMPO (2,2,6,6-Tetramethylpiperidine 1-oxyl, 98%) 
in H2O/glycerol 1:1 (w/w) was prepared. Dissolution medium consisted of D2O with 1 mM calcium disodium 
ethylenediaminetetraacetic acid (EDTA) and 9 g/L NaCl (all from Sigma Aldrich, Denmark). 
Fluid path filling: The fluid path consisted of a syringe, from which the heated dissolution medium was transferred 
in an inner concentric tube to the sample vial for dissolution of the sample. The dissolved sample was transferred 
out of the magnetic field in the outer concentric tube. 
The sample was placed in the vial using a 150 cm filling tube31 and frozen in liquid nitrogen. 31.01 g dissolution 
medium (28 mL) was filled in the syringe and degassed by bubbling with helium gas for 10 minutes. The fluid 
path was flushed with helium gas for 2 minutes in order to remove air and ensure clear passage. 
Polarization: The sample vial was rapidly transferred from the liquid nitrogen bath to the 5 T magnet in the 
polarizer (SPINlab, GE Healthcare, Brøndby, Denmark). The sample was irradiated with app. 50 mW microwaves 
at 139.923 GHz for one hour. 
Dissolution: The syringe containing the dissolution medium was heated to 130 °C one hour before dissolution. 
The piston in the syringe was driven with 16 bar pressure. The dissolved sample was injected into a sealed 
separatory funnel (150 mL) containing 25 mL of heptane (>99%, Sigma Aldrich, Denmark). The heptane had been 
degassed by flushing with helium gas in the funnel for 10 minutes. The funnel was shaken heavily during 
dissolution for a total of 10 s from dissolution start. The lower, aqueous phase was extracted into a syringe before 
transferring to the scanner room. The proton concentration in the dissolved sample was analyzed by NMR after 
addition of 0.2 M potassium formate (Sigma Aldrich, Denmark) as reference. 
Animal protocol: All animal experiments were carried out in compliance with the guidelines for use and care of 
laboratory animals and were approved by the Danish Inspectorate of Animal Experiments. Three healthy 30 kg 
female Danish domestic pigs were pre-sedated with intramuscular injection of Stressnil (1 mL/kg), and Midazolam 
(1 mL/kg), and anesthesia was maintained by continuous intravenous infusion of Propofol (0.4 mg/kg/h) and 
Fentanyl (8 ng/kg/h). The animals were intubated and mechanically ventilated with a 60 % O2-air mix. 
A 6 F introducer sheath was positioned in the left common femoral artery by ultrasound guidance to allow access 
for a 6F, JR 4.0, angiography catheter to be placed in the left LAD coronary artery via x-ray guidance. The 
angiography catheter was repeatedly flushed with heparinized sterile water to avoid occlusion. 15 mL 
hyperpolarized water was injected over 5 s, initiated approximately 22 s after dissolution. 
MRI acquisition: MRI detection was performed on a 3 T GE HDx with an 8-channel cardiac array receiver coil 
(GE Healthcare, Milwaukee, WI, USA). Axial and coronal images were acquired to cover the heart to allow for 
planning of the angiography slab for hyperpolarized water imaging. The sequence was as follows: a 3D T1 
weighted sequence with a standard steady state free precession sequence (TE = 1.1 ms, TR = 2.7 ms, FA = 35°, 
image matrix 256x256, FOV = 340x340 mm2, in-plane resolution of 1.3 mm and slice thickness of 3 mm). 
Angiographies were acquired in a tilted plane covering the left anterior descending artery (LAD) using a gradient 
echo sequence with FA = 5°, slice thickness of 40 mm, TR = 3.4 ms, TE = 0.984 ms, matrix size 256x256 and 
FOV = 140x140 mm2. The acquisition time was 870 ms. 
ROI analysis of the images were performed in OsiriX (Pixmeo, Geneva, Switzerland). Apparent signal-to-noise 
ratio (aSNR) and coronary sharpness were measured to quantify image performance32. aSNR was measured at the 
left main stem coronary artery where the catheter was positioned (signal at bolus peak / SD prior injection) and 
coronary sharpness was measured in the proximal LAD at bolus peak – reported as mean and standard deviation 
between the individual shots (N = 8). 
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Results 
A water proton polarization of 5.3 ± 0.9 % and relaxation time T1 = 24 ± 1 s (N = 4) was estimated by injecting 
the sample into a phantom placed in the 3 T scanner next to a thermally polarized water reference sample, Figure 
1, recently published elsewhere29. 
 
Figure 1: The graph shows ROI signal means of the hyperpolarized 1H in D2O (green, decaying signal) and the 
H2O thermal phantoms (blue, steady signal). The phantoms consist of two syringes. Stacked images (same scale) 
are shown from 0 to 240 s with an image every 6 s. The hyperpolarized MR signal is initially 211 times stronger 
than the thermal H2O signal, and the T1 of the decay is 24 s. The hyperpolarized signal decays into the noise since 
the 1H density is ca 20 times lower than the thermal H2O sample. Data published in 
29. 
Reproducible hyperpolarized MRA examinations in healthy pigs (N=3) were demonstrated with three successive 
acquisitions of coronal angiographies (Figure 2). The aorta injection site, the LAD and the left circumflex appear 
with the highest intensity, and their branches with smaller diameter and lower intensity. The presented images are 
acquired 5 s after injection of hyperpolarized sample, and some leaking into the vascular  
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Figure 2: Coronary angiographies after hyperpolarized water injections in three different animals. Images 5 s 
after injection of sample. 
bed is observed in between arteries. The orientation and projection are different in the three animals, but the images 
in each individual animal were reproducible. aSNR from the left main stem was 269±169 and coronary sharpness 
from proximal LAD was 0.31±0.086 mm-1. 
A time series of angiographies is presented in Figure 3, initiated from the first observed hyperpolarized signal and 
11 additional time steps of 1 s each. High intensity signal was evident in the main coronary arteries in frames 3-7, 
during which fresh sample was injected. After that, the maximum intensity decreased due to relaxation and wash 
out of the sample. No hyperpolarized signal was observed after 14 s. Frames 3, 4, 6, 7 and 12 of the series suffers 
from motion artefacts, possibly from cardiac contractions. 
 
 
Figure 3: Time series of consecutive images acquired every second from injection of sample. Major and minor 
vessels of the coronary tree can easily be identified. 
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The signal in the minor branch arteries appeared after the first few time steps, and appeared increasingly 
more distinct throughout the series until vanishing due to relaxation and washout. Similarly, the signal 
in the tissue occurred with a time delay from the arterial signal. The temporal profile is shown in Figure 
4, where the average signal intensity in regions of interest (ROI) in the proximal LAD, medial LAD and 
at a distal branch of LAD. The signal increase is first observed in the proximal LAD, and later in the 
medial and distal branch of the LAD, describing the perfusion from injection site into the vasculature.  
 
Figure 4: Time of arrival of hyperpolarized water at proximal LAD, medial LAD and at a distal branch of LAD. 
Discussion 
The main finding of this study was the demonstration of the feasibility of using hyperpolarized water for 
dynamic coronary angiography and perfusion mapping. The high reproducibility and quality of the 
images in a large animal model shows great promise for future applications in humans. The coronary 
arteries in the porcine model resembles human cardiac anatomy, and thus portrays the clinical situation 
well. The coronary arteries were imaged with high resolution and SNR. The angiograms are of high 
quality, and is superior to coronary MRA available in today’s clinical practice. A main drawback of the 
method is the invasive nature of the catheterization. 
The images are acquired in less than one second, providing series of high temporal resolution. Thus the 
perfusion of the cardiac tissue can be evaluated by fitting the signal with a model function, where also 
the relaxation of the signal is accounted for. This technique would provide perfusion values of water, 
contrary to most established perfusion measurement techniques, where the perfusion of contrast 
enhancing compounds is recorded, without exposing patients to ionizing irradiation. The high perfusion 
of the cardiac muscle as well as its importance in cardiovascular disease makes it an obvious organ for 
hyperpolarized water perfusion imaging. The motion of the heart is a key challenge for authentic 
measurements. Thus, ECG triggered acquisition and respiratory control is required for automated 
perfusion data analysis, something we do not have access to in the current setup. In general, the scanner 
used in this study is not optimized for cardiac imaging and the performance inferior to current state of 
the art33–35. 
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The hyperpolarization method yielded consistent, reproducible sample properties; MR signal in 
particular. The images in this study were obtained with 5% proton polarization. We believe that ten times 
higher polarization is achievable, dramatically improving the image quality over what is presented here. 
The method presented in this study should be translational to clinical use. The same polarizer (SPINlab) 
used for clinical studies with [1-13C]pyruvate was used,  providing the possibility of producing sterile 
samples. The safety profile of the formulation needs to be established, and the catheterization of coronary 
arteries may be the largest challenge for clinical translation. 
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